Docstoc

registration with the cvm does not imply appreciation ... - Hypermarcas

Document Sample
registration with the cvm does not imply appreciation ... - Hypermarcas Powered By Docstoc
					FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION              Corporate Law
ITR – QUARTERLY INFORMATION                   Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES
Spontaneous Resubmission


REGISTRATION WITH THE CVM DOES NOT IMPLY APPRECIATION OF THE COMPANY, WHOSE
ADMINISTRATORS (DIRECTORS AND OFFICERS) ARE LIABLE FOR ANY INFORMATION
PROVIDED HEREIN.

01.01 – IDENTIFICATION
1 – CVM CODE                       2 – CORPORATE NAME                              3 – CNPJ
02143-1                            HYPERMARCAS S.A.                                02.932.074/0001-91
4 – NIRE
35300353251


01.02 – HEADQUARTERS
1 – COMPLETE ADDRESS                                                          2 – NEIGHBORHOOD OR DISTRICT
Av.Juscelino Kubitschek. Nº 1217, house 07                                    Vila Olímpia
3 – CEP (Zip Code)            4 – MUNICIPALITY                                                          5 – STATE
04543-090                     São Paulo                                                                 SP
6 – Area Code          7 – TELEPHONE No.           8 – TELEPHONE No.          9 – TELEPHONE No.         10 – TELEX
11                     3627-4200                   -                          -
11 – Area Code         12 – FAX                    13 – FAX                   14 – FAX
11                     3627-4200                   -                          -
15 – E-MAIL
www.hypermarcas.com.br


01.03 – INVESTOR RELATIONS OFFICER (Company Mail Address)
1 – NAME
Martim Prado Mattos
2 – COMPLETE ADDRESS                                                          3 – NEIGHBORHOOD OR DISTRICT
Av.Juscelino Kubitschek, nº 1217, house 07                                    Vila Olímpia
4 – CEP (Zip Code)            5 – MUNICIPALITY                                                          6 – STATE
04543-090                     São Paulo                                                                 SP
7 – Area Code          8 – TELEPHONE No.           9 – TELEPHONE No.          10 – TELEPHONE No.        11 – TELEX
11                     3627-4200                   -                          -
12 – Area Code         13 – FAX                    14 – FAX                   15 – FAX
11                     3627-4200                   -                          -
16 – E-MAIL
rj@hypermarcas.com.br


01.04 – REFERENCE / AUDITOR
    CURRENT FISCAL YEAR                          CURRENT QUARTER                         PRECEDENT QUARTER
                                                       4–                                       7–
1- BEGINNING          2- ENDO       3 – NUMBER                    5 – END      6 – NUMBER                    8 – END
                                                    BEGINNING                               BEGINNING
  01/01/2010          12/31/2010             1      01/01/2010   03/31/2010         3        10/01/2009     12/31/2009
9 – NAME/ AUDITOR’S CORPORATE NAME                                                          10 –CVM CODE
Pricewaterhousecoopers Auditores Independentes                                              00287-9
11 – NAME OF THE TECHNICAL PERSON IN CHARGE                                                 12 – CPF OF THE
Douglas Souza de Oliveira                                                                   TECHNICAL PERSON IN
                                                                                            CHARGE
                                                                                            118.968.468-31




                                                                                                              1
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION              Corporate Law
ITR – QUARTERLY INFORMATION                   Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES
Spontaneous Resubmission

01.01 – IDENTIFICATION
1. CVM CODE             2. CORPORATE NAME                                                      3. CNPJ
02143-1                 HYPERMARCAS S.A.                                                       02.932.074/0001-91


01.05 – COMPOSITION OF THE CAPITAL STOCK
       Number of Shares         1 – CURRENT QUARTER         2 – PRECEDENT QUARTER          3 – SAME QUARTER PRECEDENT
         (Thousand)                    03/31/2010                   12/31/2009                      FISCAL YEAR
                                                                                                      03/31/2010
Paid-In Capital Stock
1 – Common                                        481,201                   481,201                                     198,601
2 – Preferred                                          0                            0                                        0
3 – Total                                         481,201                   481,201                                     198,601
Treasury Shares
4 – Common                                             0                            0                                        0
5 – Preferred                                          0                            0                                        0
6 – Total                                              0                            0                                        0



01.06 – CHARACTERISTICS OF THE COMPANY
1 – TYPE OF COMPANY
Commercial, Manufacturing And Other Companies
2 – TYPE OF CONDITION
Operational
3 – NATURE OF THE SHARE OWNERSHIP - CONTROL
Brazilian Private Company
4 –ACTIVITY CODE
1190 – Commerce (Wholesale and Retail)
5 – MAIN BUSINESS
Manufacture and Sale of Consumer Products


6 – TYPE OF CONSOLIDATED
Total
7 – TYPE OF AUDITOR’S OPINION
Unqualified


01.07 – COMPANIES NOT INCLUDED IN THE CONSOLIDATED FINANCIAL STATEMENTS
1 – ITEM        2 – CNPJ                    3 – CORPORATE NAME


01.08 – CASH PROCEEDS DECLARED AND/OR PAID DURING AND AFTER THE QUARTER
1 – ITEM        2 – EVENT        3 – APPROVAL      4 – PROCEED     5 – BEGINNING        6 – TYPE AND      7 – VALUE OF THE
                                                                   OF PAYMENT           CLASS OF          PROCEED PER
                                                                                        SHARES            SHARE




                                                                                                                    2
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                                                               Corporate Law
ITR – QUARTERLY INFORMATION                                                                                                   Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES
Spontaneous Resubmission



01.01 – IDENTIFICATION
1. CVM CODE                         2. CORPORATE NAME                                                    3. CNPJ
02143-1                             HYPERMARCAS S.A.                                                     02.932.074/0001-91



01.09 – PAID-IN CAPITAL STOCK AND CHANGES DURING THE CURRENT FISCAL YEAR
1 – ITEM 2 – DATE OF         3 – VALUE OF         4 – VALUE OF THE       5 – ORIGIN OF THE CHANGE   7 – NUMBER OF         8 – PRICE OF SHARE
           CHANGE           CAPITAL STOCK              CHANGE                                       ISSUED SHARES             AT ISSUANCE
                           (in Reais Thousand)    (in Reais Thousand)                                  (Thousand)                 (Reais)
   01        04/23/2008                 714,959                304,309                                          35,801            17.0000000000
   02        05/16/2008                 718,731                  3,772                                              222           17.0000000000
   03        07/01/2008               1,592,177                873,446                                          39,720            21.9900000000
   04        06/30/2009               1,544,177               (47,747)                                           4,759         10.034.0000000000
   05        06/30/2009               1,592,177                 47,747                                           4,750         10.034.0000000000
   06        07/14/2009               1,822,177                230,000                                          20,000            23.0000000000
   07        07/21/2009               1,873,927                 51,750                                           4,500            23.0000000000
   08        12/30/2009               2,555,552                681,625                                          17,500            38.9500000000
   09        03/31/2010           3,094,538,754                536,754                                          52,176            21.0000000000
   10        04/05/2010               3,161,629                 67,323                                           6,520            21.0000000000
   11        04/16/2010               3,168,195                  6,565                                           1,164             5.6400000000


01.10 –INVESTORS’ RELATIONS OFFICER
1 –DATE                   2 - SIGNATURE
05/27/2010




                                                                             Page 3
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                               Corporate Law
ITR – QUARTERLY INFORMATION                                                                    Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01.01 - IDENTIFICATION
1. CVM CODE         2. CORPORATE NAME                                                                 3. CNPJ
02143-1             HYPERMARCAS S.A.                                                                  02.932.074/0001-91


02.01 –BALANCE SHEET - ASSETS (in Reais Thousand)
    1 – CODE                     2 – DESCRIPTION                             3 – 03/31/2010                     4 – 12/31/2009
1               Total Assets                                                                  6,568,922                          6,173,764
1.01            Current Assets                                                                1,912,708                          1,727,878
1.01.01         Cash Equivalents                                                               607,337                            499,137
1.01.02         Credits                                                                        632,398                            723,567
1.01.02.01      Clients                                                                        632,398                            723,567
1.01.02.02      Miscellaneous Credits                                                                0                                  0
1.01.03         Inventories                                                                    251,872                            236,554
1.01.04         Others                                                                         421,101                            268,620
1.01.04.01      Miscellaneous Advancements                                                      16,701                             14,172
1.01.04.02      Taxes Recoverable                                                              265,668                            197,808
1.01.04.03      Advanced Expenses                                                               80,123                             32,208
1.01.04.04      Other Credits                                                                    7,290                              5,844
1.01.04.05      Tax Credits                                                                     51,319                             18,588
1.02            Non-Current Assets                                                            4,656,214                          4,445,886
1.02.01         Long Term Receivables                                                          306,342                            305,482
1.02.01.01      Miscellaneous Credits                                                                0                                  0
1.02.01.02      Related Parties’ Credits                                                             0                                287
1.02.01.02.01   Affiliates’ and Similar Entities’ Credits                                            0                                  0
1.02.01.02.02   Controlled Entities’ Credits                                                         0                                  0
1.02.01.02.03   Other Affiliated Entities’ Credits                                                   0                                287
1.02.01.03      Others                                                                         306,342                            305,195
1.02.01.03.01   Tax Credits                                                                    276,495                            276,494
1.02.01.03.02   Taxes Recoverable                                                                  716                                772
1.02.01.03.03   Court Deposits and Others                                                       11,805                             10,683
1.02.01.03.04   Advanced Expenses                                                                1,431                              1,059
1.02.01.03.05   Temporary Investments                                                           15,895                             16,187
1.02.02         Permanent Assets                                                              4,349,872                          4,140,404
1.02.02.01      Investments                                                                    345,445                            132,933
1.02.02.01.01   Interests held in Affiliated and Similar Entities                                    0                                  0
1.02.02.01.02   Interests held in Affiliated and Similar Entities-                                   0                                  0
                Premium
1.02.02.01.03   Interests held in Controlled Entities                                          115,948                             82,362
1.02.02.01.04   Interests held in Controlled Entities-Premium                                  229,210                             50,284
1.02.02.01.05   Other Investments                                                                  287                                287
1.02.02.02      Property, Plant & Equipment                                                    222,930                            222,870
1.02.02.03      Intangibles                                                                   3,781,039                          3,784,051
1.02.02.04      Deferred                                                                           458                                550




                                                                    Page 4
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                          Corporate Law
ITR – QUARTERLY INFORMATION                                                               Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission

01.01 - IDENTIFICATION
1. CVM CODE         2. CORPORATE NAME                                                            3. CNPJ
02143-1             HYPERMARCAS S.A.                                                             02.932.074/0001-91


02.02 – BALANCE SHEET - LIABILITIES (in Reais Thousand)
    1 – CODE                       2 – DESCRIPTION                      3 – 03/31/2010                     4 – 1231//2009
2               Aggregate Liabilities                                                    6,568,922                          6,173,764
2.01            Current Liabilities                                                      1,136,077                          1,219,899
2.01.01         Loans and Financings                                                      354,221                            391,592
2.01.02         Debentures                                                                  3,924                                  0
2.01.03         Suppliers                                                                 136,685                            131,843
2.01.04         Taxes, Duties and Contributions                                            22,181                             17,232
2.01.04.01      Income Tax and Social Security Contributions                                    0                              3,887
2.01.04.02      Taxes Payable                                                              22,181                             13,345
2.01.05         Dividends Payable                                                               0                             27,685
2.01.06         Provisions                                                                      0                                  0
2.01.07         Debts with Affiliated Entities                                                  0                                  0
2.01.08         Others                                                                    619,066                            651,547
2.01.08.01      Salaries and Social Security Charges                                       39,475                             37,211
2.01.08.02      Accounts Payable                                                          117,364                            124,339
2.01.08.03      Notes Payable                                                             462,227                            489,997
2.01.08.04      Other Accounts Payable                                                          0                                  0
2.02            Non-Current Liabilities                                                  1,902,899                          1,516,555
2.02.01         Long Term Liabilities                                                    1,902,899                          1,516,555
2.02.01.01      Loans and Financings                                                      467,585                            378,758
2.02.01.02      Debentures                                                                199,470                                  0
2.02.01.03      Provisions                                                                 25,948                             25,284
2.02.01.03.01   Provisions for Contingency                                                 25,948                             25,284
2.02.01.04      Related Parties’ Debts                                                      1,774                                346
2.02.01.05      Advancements for Future Capital Increases                                       0                                  0
2.02.01.06      Others                                                                   1,208,122                          1,112,167
2.02.01.06.01   Income Taxes and Social Security Contributions                            225,311                            157,236
2.02.01.06.02   Notes Payable                                                             953,820                            925,368
2.02.01.06.03   Other Accounts Payable                                                     28,991                             29,563
2.03            Income from Future Fiscal Years                                                 0                                  0
2.05            Net Shareholders Equity                                                  3,529,946                          3,437,310
2.05.01         Paid-In Capital Stock                                                    2,555,552                          2,555,552
2.05.02         Capital Reserves                                                          795,762                            792,877
2.05.03         Revaluation Reserves                                                            0                                  0
2.05.03.01      Own Assets                                                                      0                                  0
2.05.03.02      Controlled/Affiliated/Similar Entities                                          0                                  0
2.05.04         Profit Reserves                                                           116,566                             88,881
2.05.04.01      Legal                                                                       5,828                              5,828
2.05.04.02      Statutory                                                                  44,327                             83,053
2.05.04.02.01   Profits Available to Shareholders’ Meeting                                      0                             83,053
2.05.04.02.02   Expansion Profit Reserve                                                   44,327                                  0
2.05.04.03      for Contingencies                                                               0                                  0




                                                               Page 5
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                    Corporate Law
ITR – QUARTERLY INFORMATION                                                         Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission


01.01 - IDENTIFICATION
1. CVM CODE         2. CORPORATE NAME                                                        3. CNPJ
02143-1             HYPERMARCAS S.A.                                                         02.932.074/0001-91


02.02 – BALANCE SHEET - LIABILITIES (in Reais Thousand)
   1 – CODE                      2 – DESCRIPTION                   3 – 03/31/2010                     4 – 12/31/2009
2.05.04.04      for Realizable Profits                                              27,685                             0
2.05.04.05      Profit Withholding                                                      0                              0
2.05.04.06      Special for Non-Distributed Dividends                                   0                              0
2.05.04.07      Other Profit Reserves                                               38,726                             0
2.05.04.07.01   Tax Incentive Reserve                                               38,726                             0
2.05.05         Equity Valuation Adjustments                                            0                              0
2.05.05.01      Securities Adjustments                                                  0                              0
2.05.05.02      Accrued Conversion Adjustments                                          0                              0
2.05.05.03      Business Combination Adjustments                                        0                              0
2.05.06         Accrued Profit/Loss                                                 62,066                             0
2.05.07         Advancement for Future Capital Increase                                 0                              0




                                                          Page 6
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                                Corporate Law
ITR – QUARTERLY INFORMATION                                                                     Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


01.01 – IDENTIFICATION
1. CVM CODE                            2. CORPORATE NAME                                                                                                   3. CNPJ
02143-1                                HYPERMARCAS S.A.                                                                                                    02.932.074/0001-91


03.01 – STATEMENT OF INCOME (in Reais Thousand)
1 – CODE      2 – DESCRIPTION                                             03 – 01/01/2010 to 03/31/2010   4 – 01/01/2010 to 03/31/2010   5 – 01/01/2009 to 03/31/2009   6 – 01/01/2009 to 03/31/2009
3.01          Gross Revenue of Sales and/or Services                                           817,633                       817,633                        489,231                         489,231
3.02          Deductions from Gross Revenue                                                  (139,320)                      (139,320)                      (104,766)                      (104,766)
3.03          Net Revenue of Sales and/or Services                                             678,313                       678,313                        384,465                         384,465
3.04          Cost of Products/Services Sold                                                 (310,878)                      (310,878)                      (161,267)                      (161,267)
3.05          Gross Income                                                                     367,435                       367,435                        223,198                         223,198
3.06          Operational Expenses/Revenue                                                   (270,025)                      (270,025)                      (159,895)                      (159,895)
3.06.01       With Sales                                                                     (192,121)                      (192,121)                      (108,553)                      (108,553)
3.06.02       General and Administrative                                                      (47,542)                       (47,542)                       (20,888)                       (20,888)
3.06.03       Financial                                                                       (59,087)                       (59,087)                       (27,977)                       (27,977)
3.06.03.01    Financial Revenue                                                                 13,919                         13,919                          6,287                          6,287
3.06.03.02    Financial Expenses                                                              (73,006)                       (73,006)                       (34,264)                       (34,264)
3.06.04       Other Operational Revenue                                                         25,424                         25,424                            320                            320
3.06.05       Other Operational Expenses                                                        (2,954)                       (2,954)                          (189)                          (189)
3.06.05.01    Amortization of Premium/Discount, Net                                                  0                              0                              0                              0
3.06.05.02    Other Expenses                                                                    (2,954)                       (2,954)                          (189)                          (189)
3.06.06       Equity Method Result                                                               6,255                          6,255                        (2,608)                         (2,608)
3.07          Operational Income                                                                97,410                         97,410                         63,303                         63,303
3.08          Non-Operational Income                                                                 0                              0                              0                              0
3.08.01       Revenues                                                                               0                              0                              0                              0
3.08.02       Expenses                                                                               0                              0                              0                              0
3.09          Income before Tax/Equity Interests                                                97,410                         97,410                         63,303                         63,303
3.10          Provision for Income Tax and Social Security Contribution                         56,443                         56,443                         34,536                         34,536
3.11          Deferred Income Tax                                                             (91,787)                       (91,787)                       (21,531)                       (21,531)
3.11.01       Deferred Income Tax and Social Security Contribution                            (91,787)                       (91,787)                       (21,531)                       (21,531)
3.12          Equity Interests/Statutory Contributions                                               0                              0                              0                              0
3.12.01       Equity Interests                                                                       0                              0                              0                              0
3.12.02       Contributions                                                                          0                              0                              0                              0




                                                                                                  Page 7
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                Corporate Law
ITR – QUARTERLY INFORMATION                                                     Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01.01 – IDENTIFICATION
1. CVM CODE                       2. CORPORATE NAME                                                                                     3. CNPJ
02143-1                           HYPERMARCAS S.A.                                                                                      02.932.074/0001-91



03.01 – STATEMENT OF INCOME (in Reais Thousand)
1 – CODE      2 – DESCRIPTION                                 03 – 01/01/2010 to 03/31/2010 4 – 01/01/2010 to 03/31/2010 5 – 01/01/2009 to 03/31/2009 6 – 01/01/2009 to 03/31/2009
3.13          Reversal of Interests on Shareholders’ Equity                                0                           0                           0                            0
3.15          Profit/Loss of the Period                                              62,066                      62,066                       76,308                       76,308
              NUMBER OF SHARES (EX-TREASURY) (Thousand)                            481,201                      481,201                      198,601                      198,601
              PROFIT PER SHARE (in Reais)                                          0,12898                      0,12898                      0,38423                      0,38423
              LOSS PER SHARE (in Reais)




                                                                                  Page 8
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                             Corporate Law
ITR – QUARTERLY INFORMATION                                                                  Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


01.01 – IDENTIFICATION
1. CVM CODE                       2. CORPORATE NAME                                                                                                 3. CNPJ
02143-1                           HYPERMARCAS S.A.                                                                                                  02.932.074/0001-91


04.01 – STATEMENT OF CASH FLOWS - INDIRECT METHOD (in Reais Thousand)
1 – CODE      2 – DESCRIPTION                                       03 – 01/01/2010 to 03/31/2010   4 – 01/01/2010 to 03/31/2010   5 – 01/01/2009 to 03/31/2009   6 – 01/01/2009 to 03/31/2009
4.01          Net Cash from Operational Activities                                       120,665                       120,665                        104,395                        104,395
4.01.01       Cash Generated by Operations                                               163,853                       163,853                        102,347                        102,347
4.01.01.01    Income before Tax/equity interests                                          97,410                         97,410                         63,303                         63,303
4.01.01.02    Depreciation and Amortization                                               10,865                         10,865                          8,477                          8,477
4.01.01.03    Amortization of Premium                                                          0                              0                              0                              0
4.01.01.04    Revenue from Sale of Permanent Assets                                        (139)                          (139)                           (18)                           (18)
4.01.01.05    Equity Method                                                               (6,255)                       (6,255)                          2,608                          2,608
4.01.01.06    Foreign Exchange Gains/Losses                                               16,027                         16,027                          (806)                          (806)
4.01.01.07    Interest Expenses                                                           43,060                         43,060                        28,783                         28,783
4.01.01.08    Stock Option Expenses                                                        2,885                          2,885                              0                              0
4.01.02       Assets and Liabilities Variations                                         (43,188)                       (43,188)                          2,048                          2,048
4.01.02.01    (Increase) Reduction in Accounts Receivable                                 91,169                         91,169                        58,160                         58,160
4.01.02.02    (Increase) Reduction in Inventories                                       (15,318)                       (15,318)                            391                            391
4.01.02.03    (Increase) Reduction in Taxes Recoverable                                 (67,804)                       (67,804)                         17,920                         17,920
4.01.02.04    (Increase) Reduction in Court Deposits                                      (1,122)                       (1,122)                          (357)                          (357)
4.01.02.05    (Increase) Reduction in Other Accounts Receivable                         (52,262)                       (52,262)                          (295)                          (295)
4.01.02.06    (Increase) Reduction in Suppliers                                            4,842                          4,842                       (43,188)                       (43,188)
4.01.02.07    (Increase) Reduction in IRPJ and CSLL Paid                                  (3,887)                       (3,887)                        (2,265)                        (2,265)
4.01.02.08    (Increase) Reduction in Taxes Payable                                        8,843                          8,843                        (2,115)                        (2,115)
4.01.02.09    (Increase) Reduction in Salaries and Social Charges                          2,288                          2,288                          (794)                          (794)
4.01.02.10    (Increase) Reduction in Accounts Payable                                    (6,975)                       (6,975)                       (24,430)                       (24,430)
4.01.02.11    (Increase) Reduction in Interests Paid                                      (3,528)                       (3,528)                          (446)                          (446)
4.01.02.12    (Increase) Reduction in other Accounts Payable                                 566                            566                          (533)                          (533)
4.01.03       Others                                                                           0                              0                              0                              0
4.02          Net Cash from Investment Activities                                      (201,142)                      (201,142)                          2,119                          2,119
4.02.01       Acquisition of Companies Less Net Cash                                   (206,256)                      (206,256)                              0                              0
4.02.02       Purchase of Property, Plant & Equipment                                     (5,986)                       (5,986)                        (2,777)                        (2,777)




                                                                                               Page 9
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                           Corporate Law
ITR – QUARTERLY INFORMATION                                                                Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01.01 – IDENTIFICATION
1. CVM CODE                        2. CORPORATE NAME                                                                                              3. CNPJ
02143-1                            HYPERMARCAS S.A.                                                                                               02.932.074/0001-91



04.01 – STATEMENT OF CASH FLOWS - INDIRECT METHOD (in Reais Thousand)
1 – CODE      2 – DESCRIPTION                                     03 – 01/01/2010 to 03/31/2010   4 – 01/01/2010 to 03/31/2010   5 – 01/01/2009 to 03/31/2009   6 – 01/01/2009 to 03/31/2009
4.02.03       Expenses with Deferred                                                         0                              0                              0                              0
4.02.04       Purchase of Intangibles                                                   (1,880)                       (1,880)                          (439)                          (439)
4.02.05       Proceeds from Sale of Equipment                                              183                            183                            251                            251
4.02.06       Interests Received                                                        12,797                         12,797                          5,084                          5,084
4.03          Net Cash from Financing Activities                                       188,677                       188,677                           (620)                          (620)
4.03.01       Proceeds from Issuance of Shares                                               0                              0                              0                              0
4.03.02       Proceeds from Borrowings                                                 402,246                       402,246                        112,921                        112,921
4.03.03       Payment of Loans and Borrowings                                        (217,569)                      (217,569)                      (104,653)                      (104,653)
4.03.04       Interests Paid for Loans                                                   4,000                          4,000                        (8,888)                        (8,888)
4.04          Foreign Exchange Variation on Cash and Cash                                    0                              0                              0                              0
              Equivalents
4.05          (Increase) Reduction on Cash and Cash Equivalents                        108,200                       108,200                        105,894                        105,894
4.05.01       Initial Balance of Cash and Cash Equivalents                             499,137                       499,137                        149,705                        149,705
4.05.02       Final Balance of Cash and Cash Equivalents                               607,337                       607,337                        255,599                        255,599




                                                                                             Page 10
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                            Corporate Law
ITR – QUARTERLY INFORMATION                                                                 Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01.01 – IDENTIFICATION
1. CVM CODE                             2. CORPORATE NAME                                                                                   3. CNPJ
02143-1                                 HYPERMARCAS S.A.                                                                                    02.932.074/0001-91



05.01 – STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY FROM 01/01/2010 TO 03/31/2010 (in Reais Thousand)
                                                                                                                                                    8 - EQUITY 9 - TOTAL
                                                               3 - CAPITAL    4 - CAPITAL        5 - REVALUATION   6 - PROFIT        7 - ACCRUED   VALUATION SHAREHOLDERS
  1 - CODE                      2 - DESCRIPTION                   STOCK        RESERVES               RESERVES     RESERVES         PROFIT/LOSSES ADJUSTMENTS    EQUITY
5.01          Initial Balance                                     2,555,552          792,877                   0          88,881                0                0   3,437,31 0
5.02          Adjustments of Previous Fiscal Years                       0                   0                 0                0               0                0           0
5.03          Adjusted Balance                                    2,555,552          792,877                   0          88,881                0                0   3,437,31 0
5.04          Profit / Loss of the Period                                0                   0                 0                0          62,066                0      62,066
5.05          Applications                                               0                   0                 0          27,685                0                0      27,685
5.05.01       Dividends                                                  0                   0                 0          27,685                0                0      27,685
5.05.02       Interests on Shareholders’ Equity                          0                   0                 0                0               0                0           0
5.05.03       Other Applications                                         0                   0                 0                0               0                0           0
5.05.03.01    Profits Available to the Shareholders’ Meeting             0                   0                 0        (83,053)                0                0           0
5.05.03.02    Constitution of Tax Incentive Reserve                      0                   0                 0          38,726                0                0           0
5.05.03.03    Constitution of Statutory Reserve                          0                   0                 0          44,327                0                0           0
5.06          Realization of Profit Reserves                             0                   0                 0                0               0                0           0
5.07          Equity Valuation Adjustments                               0                   0                 0                0               0                0           0
5.07.01       Securities Adjustments                                     0                   0                 0                0               0                0           0
5.07.02       Accrued Conversion Adjustments                             0                   0                 0                0               0                0           0
5.07.03       Business Combination Adjustments                           0                   0                 0                0               0                0           0
5.08          Increase/Reduction of Capital Stock                        0                   0                 0                0               0                0           0
5.09          Constitution/Realization of Capital Reserves               0             2,885                   0                0               0                0       2,885
5.09.01       Stock Purchase Option                                      0             2,885                   0                0               0                0       2,885
5.10          Treasury Shares                                            0                   0                 0                0               0                0           0
5.11          Other Capital Transactions                                 0                   0                 0                0               0                0           0
5.12          Others                                                     0                   0                 0                0               0                0           0
5.13          Final Balance                                       2,555,552          795,762                   0         116,566           62,066                0   3,529,946



                                                                                            Page 11
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                            Corporate Law
ITR – QUARTERLY INFORMATION                                                                 Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01.01 – IDENTIFICATION
1. CVM CODE                             2. CORPORATE NAME                                                                                   3. CNPJ
02143-1                                 HYPERMARCAS S.A.                                                                                    02.932.074/0001-91


05.02 – STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY FROM 01/01/2010 TO 03/31/2010 (in Reais Thousand)
                                                                                                     5-                                            8 - EQUITY 9 - TOTAL
                                                               3 - CAPITAL    4 - CAPITAL       REVALUATION       6 - PROFIT        7 - ACCRUED   VALUATION SHAREHOLDERS
  1 - CODE                      2 - DESCRIPTION                   STOCK        RESERVES           RESERVES        RESERVES         PROFIT/LOSSES ADJUSTMENTS    EQUITY
5.01          Initial Balance                                     2,555,552          792,877                  0          88,881                0                 0   3,437,31 0
5.02          Adjustments of Previous Fiscal Years                       0                  0                 0                0               0                 0           0
5.03          Adjusted Balance                                    2,555,552          792,877                  0          88,881                0                 0   3,437,31 0
5.04          Profit / Loss of the Period                                0                  0                 0                0          62,066                 0      62,066
5.05          Applications                                               0                  0                 0          27,685                0                 0      27,685
5.05.01       Dividends                                                  0                  0                 0          27,685                0                 0      27,685
5.05.02       Interests on Shareholders’ Equity                          0                  0                 0                0               0                 0           0
5.05.03       Other Applications                                         0                  0                 0                0               0                 0           0
5.05.03.01    Profits Available to the Shareholders’ Meeting             0                  0                 0        (83,053)                0                 0           0
5.05.03.02    Constitution of Tax Incentive Reserve                      0                  0                 0          38,726                0                 0           0
5.05.03.03    Constitution of Statutory Reserve                          0                  0                 0          44,327                0                 0           0
5.06          Realization of Profit Reserves                             0                  0                 0                0               0                 0           0
5.07          Equity Valuation Adjustments                               0                  0                 0                0               0                 0           0
5.07.01       Securities Adjustments                                     0                  0                 0                0               0                 0           0
5.07.02       Accrued Conversion Adjustments                             0                  0                 0                0               0                 0           0
5.07.03       Business Combination Adjustments                           0                  0                 0                0               0                 0           0
5.08          Increase/Reduction of Capital Stock                        0                  0                 0                0               0                 0           0
5.09          Constitution/Realization of Capital Reserves               0             2,885                  0                0               0                 0       2,885
5.09.01       Stock Purchase Option                                      0             2,885                  0                0               0                 0       2,885
5.10          Treasury Shares                                            0                  0                 0                0               0                 0           0
5.11          Other Capital Transactions                                 0                  0                 0                0               0                 0           0
5.12          Others                                                     0                  0                 0                0               0                 0           0
5.13          Final Balance                                       2,555,552          795,762                  0         116,566           62,066                 0   3,529,946




                                                                                            Page 12
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                             Corporate Law
ITR – QUARTERLY INFORMATION                                                                  Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01.01 - IDENTIFICATION
1. CVM CODE         2. CORPORATE NAME                                                                  3. CNPJ
02143-1             HYPERMARCAS S.A.                                                                   02.932.074/0001-91


08.01 – CONSOLIDATED BALANCE SHEET - ASSETS (in Reais Thousand)

    1 – CODE                     2 – DESCRIPTION                          3 – 03/31/2010                        4 – 12/31/2009
1               Total Assets                                                               6,671,661                             6,278,152
1.01            Current Assets                                                             2,050,758                             1,836,317
1.01.01         Cash Equivalents                                                            641,922                               499,279
1.01.02         Credits                                                                     633,260                               724,630
1.01.02.01      Clients                                                                     633,260                               724,630
1.01.02.02      Miscellaneous Credits                                                             0                                     0
1.01.03         Inventories                                                                 328,971                               319,492
1.01.04         Others                                                                      446,605                               292,916
1.01.04.01      Miscellaneous Advancements                                                   26,975                                20,132
1.01.04.02      Taxes Recoverable                                                           271,613                               206,499
1.01.04.03      Advanced Expenses                                                            81,198                                32,525
1.01.04.04      Other Credits                                                                 7,290                                 5,844
1.01.04.05      Tax Credits                                                                  59,529                                27,916
1.02            Non-Current Assets                                                         4,620,903                             4,441,835
1.02.01         Long Term Receivables                                                       312,480                               310,407
1.02.01.01      Miscellaneous Credits                                                             0                                     0
1.02.01.02      Related Parties’ Credits                                                          0                                     0
1.02.01.02.01   Affiliates’ and Similar Entities’ Credits                                         0                                     0
1.02.01.02.02   Controlled Entities’ Credits                                                      0                                     0
1.02.01.02.03   Other Affiliated Entities’ Credits                                                0                                     0
1.02.01.03      Others                                                                      312,480                               310,407
1.02.01.03.01   Tax Credits                                                                 279,925                               279,378
1.02.01.03.02   Taxes Recoverable                                                             1,218                                 1,280
1.02.01.03.03   Court Deposits and Others                                                    14,011                                12,503
1.02.01.03.04   Advanced Expenses                                                             1,431                                 1,059
1.02.01.03.05   Temporary Investments                                                        15,895                                16,187
1.02.02         Permanent Assets                                                           4,308,423                             4,131,428
1.02.02.01      Investments                                                                     287                                   287
1.02.02.01.01   Interests held in Affiliated/Similar Entities                                     0                                     0
1.02.02.01.02   Interests held in Controlled Entities                                             0                                     0
1.02.02.01.03   Other Investments                                                               287                                   287
1.02.02.01.06   Temporary Investments                                                             0                                     0
1.02.02.02      Property, Plant & Equipment                                                 296,732                               295,539
1.02.02.03      Intangibles                                                                4,010,946                             3,835,052
1.02.02.04      Deferred                                                                        458                                   550




                                                                Page 13
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                          Corporate Law
ITR – QUARTERLY INFORMATION                                                               Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01.01 - IDENTIFICATION
1. CVM CODE         2. CORPORATE NAME                                                               3. CNPJ
02143-1             HYPERMARCAS S.A.                                                                02.932.074/0001-91


08.02 – CONSOLIDATED BALANCE SHEET - LIABILITIES (in Reais Thousand)

    1 – CODE                      2 – DESCRIPTION                      3 – 03/31/2010                        4 – 12/31/2009
2               Aggregate Liabilities                                                   6,671,661                             6,278,152
2.01            Current Liabilities                                                     1,210,127                             1,291,781
2.01.01         Loans and Financings                                                     362,723                               398,885
2.01.02         Debentures                                                                 3,924                                     0
2.01.03         Suppliers                                                                141,120                               120,477
2.01.04         Taxes, Duties and Contributions                                           65,329                                78,700
2.01.04.01      Income Tax and Social Security Contributions                               2,831                                 4,931
2.01.04.02      Taxes Payable                                                             62,498                                73,769
2.01.05         Dividends Payable                                                              0                                27,685
2.01.06         Provisions                                                                     0                                     0
2.01.07         Debts with Affiliated Entities                                                 0                                     0
2.01.08         Others                                                                   637,031                               666,034
2.01.08.01      Salaries and Social Security Charges                                      49,590                                46,158
2.01.08.02      Accounts Payable                                                         125,214                               129,879
2.01.08.03      Notes Payable                                                            462,227                               489,997
2.01.08.04      Other Accounts Payable                                                         0                                     0
2.02            Non-Current Liabilities                                                 1,931,588                             1,549,061
2.02.01         Long Term Liabilities                                                   1,931,588                             1,549,061
2.02.01.01      Loans and Financings                                                     483,351                               396,937
2.02.01.02      Debentures                                                               199,470                                     0
2.02.01.03      Provisions                                                                40,645                                39,957
2.02.01.03.01   Provisions for Contingency                                                40,645                                39,957
2.02.01.04      Related Parties’ Debts                                                         0                                     0
2.02.01.05      Advancements for Future Capital Increases                                      0                                     0
2.02.01.06      Others                                                                  1,208,122                             1,112,167
2.02.01.06.01   Income Taxes and Social Security Contributions                           225,311                               157,236
2.02.01.06.02   Notes Payable                                                            953,820                               925,368
2.02.01.06.03   Other Accounts Payable                                                    28,991                                29,563
2.03            Income from Future Fiscal Years                                                0                                     0
2.04            Interests held by Non-Controlling Shareholders                                 0                                     0
2.05            Net Shareholders Equity                                                 3,529,946                             3,437,310
2.05.01         Paid-In Capital Stock                                                   2,555,552                             2,555,552
2.05.02         Capital Reserves                                                         795,762                               792,877
2.05.03         Revaluation Reserves                                                           0                                     0
2.05.03.01      Own Assets                                                                     0                                     0
2.05.03.02      Controlled/Affiliated/Similar Entities                                         0                                     0
2.05.04         Profit Reserves                                                          116,566                                88,881
2.05.04.01      Legal                                                                      5,828                                 5,828
2.05.04.02      Statutory                                                                 44,327                                83,053
2.05.04.02.01   Profits Available to Shareholders’ Meeting                                     0                                83,053
2.05.04.02.02   Expansion Profit Reserve                                                  44,327                                     0




                                                             Page 14
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                     Corporate Law
ITR – QUARTERLY INFORMATION                                                          Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01.01 - IDENTIFICATION
1. CVM CODE         2. CORPORATE NAME                                                         3. CNPJ
02143-1             HYPERMARCAS S.A.                                                          02.932.074/0001-91


08.02 – CONSOLIDATED BALANCE SHEET - LIABILITIES (in Reais Thousand)

   1 – CODE                      2 – DESCRIPTION                    3 – 03/31/2010                     4 – 12/31/2009
2.05.04.03      for Contingencies                                                        0                              0
2.05.04.04      for Realizable Profits                                               27,685                             0
2.05.04.05      Profit Withholding                                                       0                              0
2.05.04.06      Special for Non-Distributed Dividends                                    0                              0
2.05.04.07      Other Profit Reserves                                                38,726                             0
2.05.04.07.01   Tax Incentive Reserve                                                38,726                             0
2.05.05         Equity Valuation Adjustments                                             0                              0
2.05.05.01      Securities Adjustments                                                   0                              0
2.05.05.02      Accrued Conversion Adjustments                                           0                              0
2.05.05.03      Business Combination Adjustments                                         0                              0
2.05.06         Accrued Profit/Loss                                                  62,066                             0
2.05.07         Advancement for Future Capital Increase                                  0                              0




                                                          Page 15
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                                       Corporate Law
ITR – QUARTERLY INFORMATION                                                                            Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


01.01 – IDENTIFICATION
1. CVM CODE                            2. CORPORATE NAME                                                                                                      3. CNPJ
02143-1                                HYPERMARCAS S.A.                                                                                                       02.932.074/0001-91


09.01 – STATEMENT OF CONSOLIDATED INCOME - (in Reais Thousand)
       1 – CODE                      2 – DESCRIPTION                          03 – 01/01/2010 to 03/31/2010   4 – 01/01/2010 to 03/31/2010   5 – 01/01/2009 to 03/31/2009   6 – 01/01/2009 to 03/31/2009
3.01              Gross Revenue of Sales and/or Services                                           820,489                       820,489                        489,538                        489,538
3.02              Deductions from Gross Revenue                                                  (163,706)                      (163,706)                      (104,807)                      (104,807)
3.03              Net Revenue of Sales and/or Services                                             656,783                       656,783                        384,731                        384,731
3.04              Cost of Products/Services Sold                                                 (274,253)                      (274,253)                      (163,761)                      (163,761)
3.05              Gross Income                                                                     382,530                       382,530                        220,970                        220,970
3.06              Operational Expenses/I Revenue                                                 (281,716)                      (281,716)                      (157,571)                      (157,571)
3.06.01           With Sales                                                                     (193,887)                      (193,887)                      (108,625)                      (108,625)
3.06.02           General and Administrative                                                      (50,378)                       (50,378)                       (21,711)                       (21,711)
3.06.03           Financial                                                                       (59,925)                       (59,925)                       (27,448)                       (27,448)
3.06.03.01        Financial Revenue                                                                 13,992                         13,992                          6,289                          6,289
3.06.03.02        Financial Expenses                                                              (73,917)                       (73,917)                       (33,737)                       (33,737)
3.06.04           Other Operational Revenue                                                         25,681                         25,681                            402                            402
3.06.05           Other Operational Expenses                                                        (3,207)                       (3,207)                          (189)                          (189)
3.06.05.01        Amortization of Premium/Discount, Net                                                  0                              0                              0                              0
3.06.05.02        Other Expenses                                                                    (3,207)                       (3,207)                          (189)                          (189)
3.06.06           Equity Method Result                                                                   0                              0                              0                              0
3.07              Operational Income                                                               100,814                       100,814                          63,399                         63,399
3.08              Non-Operational Income                                                                 0                              0                              0                              0
3.08.01           Revenues                                                                               0                              0                              0                              0
3.08.02           Expenses                                                                               0                              0                              0                              0
3.09              Income before Tax/Equity Interests                                               100,814                       100,814                          63,399                         63,399
3.10              Provision for Income Tax and Social Security Contribution                         53,612                         53,612                         34,536                         34,536
3.11              Deferred Income Tax                                                             (92,360)                       (92,360)                       (21,627)                       (21,627)
3.11.01           Deferred Income Tax and Social Security Contribution                            (92,360)                       (92,360)                       (21,627)                       (21,627)
3.12              Equity Interests/Statutory Contributions                                               0                              0                              0                              0
3.12.01           Equity Interests                                                                       0                              0                              0                              0
3.12.02           Contributions                                                                          0                              0                              0                              0




                                                                                                          Page 16
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                            Corporate Law
ITR – QUARTERLY INFORMATION                                                                 Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01.01 – IDENTIFICATION
1. CVM CODE                           2. CORPORATE NAME                                                                                            3. CNPJ
02143-1                               HYPERMARCAS S.A.                                                                                             02.932.074/0001-91



09.01 – STATEMENT OF CONSOLIDATED INCOME - (in Reais Thousand)
       1 – CODE                   2 – DESCRIPTION                  03 – 01/01/2010 to 03/31/2010   4 – 01/01/2010 to 03/31/2010   5 – 01/01/2009 to 03/31/2009   6 – 01/01/2009 to 03/31/2009
3.13              Reversal of Interests on Shareholders’ Equity                               0                              0                              0                              0
3.14              Interests held by Non-Controlling Shareholders                              0                              0                              0                              0
3.15              Profit/Loss of the Period                                              62,066                         62,066                         76,308                         76,308
                  NUMBER OF SHARES (EX-TREASURY)                                        481,201                       481,201                        198,601                        198,601
                  (Thousand)
                  PROFIT PER SHARE (in Reais)                                           0,12898                       0,12898                        0,38423                        0,38423
                  LOSS PER SHARE (in Reais)




                                                                                               Page 17
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                             Corporate Law
ITR – QUARTERLY INFORMATION                                                                  Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


01 – IDENTIFICATION
1. CVM CODE                       2. CORPORATE NAME                                                                                                 3. CNPJ
02143-1                           HYPERMARCAS S.A.                                                                                                  02.932.074/0001-91


10.01 – STATEMENT OF CONSOLIDATED CASH FLOWS - INDIRECT METHOD (in Reais Thousand)
1 – CODE      2 – DESCRIPTION                                       03 – 01/01/2010 to 03/31/2010   4 – 01/01/2010 to 03/31/2010   5 – 01/01/2009 to 03/31/2009   6 – 01/01/2009 to 03/31/2009
4.01          Net Cash from Operational Activities                                       136,217                       136,217                        126,047                        126,047
4.01.01       Cash Generated by Operations                                               177,414                       177,414                          99,594                         99,594
4.01.01.01    Net Profit/Loss of the Fiscal Year                                         100,814                       100,814                          63,399                         63,399
4.01.01.02    Depreciation and Amortization                                               13,934                         13,934                          8,766                          8,766
4.01.01.03    Amortization of Premium                                                          0                              0                              0                              0
4.01.01.04    Income from Sale of Permanent Assets                                         (143)                          (143)                           (18)                           (18)
4.01.01.05    Equity Method                                                                    0                              0                              0                              0
4.01.01.06    Foreign Exchange Gains/Losses                                               16,295                         16,295                          (747)                          (747)
4.01.01.07    Interest Expenses                                                           43,629                         43,629                         28,194                         28,194
4.01.01.08    Stock Option Expenses                                                        2,885                          2,885                              0                              0
4.01.02       Assets and Liabilities Variations                                         (41,197)                       (41,197)                         26,453                         26,453
4.01.02.01    (Increase) Reduction in Accounts Receivable                                 91,370                         91,370                         65,773                         65,773
4.01.02.02    (Increase) Reduction in Inventories                                         (8,739)                       (8,739)                          3,635                          3,635
4.01.02.03    (Increase) Reduction in Taxes Recoverable                                 (64,976)                       (64,976)                         18,175                         18,175
4.01.02.04    (Increase) Reduction in Court Deposits                                      (1,508)                       (1,508)                          (179)                          (179)
4.01.02.05    (Increase) Reduction in Other Accounts Receivable                         (57,334)                       (57,334)                        (6,698)                        (6,698)
4.01.02.06    (Increase) Reduction in Suppliers                                           20,643                         20,643                       (25,725)                       (25,725)
4.01.02.07    (Increase) Reduction in IRPJ and CSLL Paid                                  (4,931)                       (4,931)                        (2,265)                        (2,265)
4.01.02.08    (Increase) Reduction in Taxes Payable                                     (11,264)                       (11,264)                            420                            420
4.01.02.09    (Increase) Reduction in Salaries and Social Charges                          3,457                          3,457                          (836)                          (836)
4.01.02.10    (Increase) Reduction in Accounts Payable                                    (4,668)                       (4,668)                       (24,746)                       (24,746)
4.01.02.11    (Increase) Reduction in Interests Paid                                      (3,837)                       (3,837)                          (574)                          (574)
4.01.02.12    (Increase) Reduction in other Accounts Payable                                 590                            590                          (527)                          (527)
4.01.03       Others                                                                           0                              0                              0                              0
4.02          Net Cash from Investment Activities                                      (178,742)                      (178,742)                          1,703                          1,703
4.02.01       Acquisition of Companies Less Net Cash                                   (181,256)                      (181,256)                              0                              0
4.02.02       Purchase of Property, Plant & Equipment                                     (8,785)                       (8,785)                        (3,194)                        (3,194)




                                                                                                Page 18
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                           Corporate Law
ITR – QUARTERLY INFORMATION                                                                Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01 – IDENTIFICATION
1. CVM CODE                        2. CORPORATE NAME                                                                                              3. CNPJ
02143-1                            HYPERMARCAS S.A.                                                                                               02.932.074/0001-91



10.01 – STATEMENT OF CONSOLIDATED CASH FLOWS - INDIRECT METHOD (in Reais Thousand)
1 – CODE      2 – DESCRIPTION                                     03 – 01/01/2010 to 03/31/2010   4 – 01/01/2010 to 03/31/2010   5 – 01/01/2009 to 03/31/2009   6 – 01/01/2009 to 03/31/2009
4.02.03       Expenses with Deferred                                                         0                              0                              0                              0
4.02.04       Purchase of Intangibles                                                   (1,884)                       (1,884)                          (439)                          (439)
4.02.05       Proceeds from Sale of Equipment                                              325                            325                            251                            251
4.02.06       Interests Received                                                        12,858                         12,858                          5,085                          5,085
4.03          Net Cash from Financing Activities                                       185,168                       185,168                        (21,906)                       (21,906)
4.03.01       Proceeds from Issuance of Shares                                               0                              0                              0                              0
4.03.02       Proceeds from Borrowings                                                 400,556                       400,556                          53,757                         53,757
4.03.03       Payment of Loans and Borrowings                                        (219,436)                      (219,436)                       (66,745)                       (66,745)
4.03.04       Interests Paid for Loans                                                   4,048                          4,048                        (8,918)                        (8,918)
4.04          Foreign Exchange Variation on Cash and Cash                                    0                              0                              0                              0
              Equivalents
4.05          (Increase) Reduction on Cash and Cash Equivalents                        142,643                       142,643                        105,844                        105,844
4.05.01       Initial Balance of Cash and Cash Equivalents                             499,279                       499,279                        149,759                        149,759
4.05.02       Final Balance of Cash and Cash Equivalents                               641,922                       641,922                        255,603                        255,603




                                                                                              Page 19
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                            Corporate Law
ITR – QUARTERLY INFORMATION                                                                 Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01.01 – IDENTIFICATION
1. CVM CODE                             2. CORPORATE NAME                                                                                    3. CNPJ
02143-1                                 HYPERMARCAS S.A.                                                                                     02.932.074/0001-91


11.01 – STATEMENT OF CHANGES IN CONSOLIDATED SHAREHOLDERS’ EQUITY FROM 01/01/2010 TO 03/31/2010 (in Reais Thousand)
                                                                                                      5-                                            8 - EQUITY 9 - TOTAL
                                                               3 - CAPITAL    4 - CAPITAL        REVALUATION       6 - PROFIT        7 - ACCRUED   VALUATION SHAREHOLDERS
  1 - CODE                      2 - DESCRIPTION                   STOCK        RESERVES            RESERVES        RESERVES         PROFIT/LOSSES ADJUSTMENTS    EQUITY
5.01          Initial Balance                                     2,555,552          792,877                   0          88,881                0                 0   3,437,31 0
5.02          Adjustments of Previous Fiscal Years                       0                  0                  0                0               0                 0           0
5.03          Adjusted Balance                                    2,555,552          792,877                   0          88,881                0                 0   3,437,31 0
5.04          Profit / Loss of the Period                                0                  0                  0                0          62,066                 0      62,066
5.05          Applications                                               0                  0                  0          27,685                0                 0      27,685
5.05.01       Dividends                                                  0                  0                  0          27,685                0                 0      27,685
5.05.02       Interests on Shareholders’ Equity                          0                  0                  0                0               0                 0           0
5.05.03       Other Applications                                         0                  0                  0                0               0                 0           0
5.05.03.01    Profits Available to the Shareholders’ Meeting             0                  0                  0        (83,053)                0                 0           0
5.05.03.02    Constitution of Tax Incentive Reserve                      0                  0                  0          38,726                0                 0           0
5.05.03.03    Constitution of Statutory Reserve                          0                  0                  0          44,327                0                 0           0
5.06          Realization of Profit Reserves                             0                  0                  0                0               0                 0           0
5.07          Equity Valuation Adjustments                               0                  0                  0                0               0                 0           0
5.07.01       Securities Adjustments                                     0                  0                  0                0               0                 0           0
5.07.02       Accrued Conversion Adjustments                             0                  0                  0                0               0                 0           0
5.07.03       Business Combination Adjustments                           0                  0                  0                0               0                 0           0
5.08          Increase/Reduction of Capital Stock                        0                  0                  0                0               0                 0           0
5.09          Constitution/Realization of Capital Reserves               0             2,885                   0                0               0                 0       2,885
5.09.01       Stock Purchase Option                                      0             2,885                   0                0               0                 0       2,885
5.10          Treasury Shares                                            0                  0                  0                0               0                 0           0
5.11          Other Capital Transactions                                 0                  0                  0                0               0                 0           0
5.12          Others                                                     0                  0                  0                0               0                 0           0
5.13          Final Balance                                       2,555,552          795,762                   0         116,566           62,066                 0   3,529,946




                                                                                                Page 20
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                            Corporate Law
ITR – QUARTERLY INFORMATION                                                                 Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01.01 – IDENTIFICATION
1. CVM CODE                             2. CORPORATE NAME                                                                                    3. CNPJ
02143-1                                 HYPERMARCAS S.A.                                                                                     02.932.074/0001-91


11.02 – STATEMENT OF CHANGES IN CONSOLIDATED SHAREHOLDERS’ EQUITY FROM 01/01/2010 TO 03/31/2010 (in Reais Thousand)
                                                                                                      5-                                            8 - EQUITY 9 - TOTAL
                                                               3 - CAPITAL    4 - CAPITAL        REVALUATION       6 - PROFIT        7 - ACCRUED   VALUATION SHAREHOLDERS
  1 - CODE                      2 - DESCRIPTION                   STOCK        RESERVES            RESERVES        RESERVES         PROFIT/LOSSES ADJUSTMENTS    EQUITY
5.01          Initial Balance                                     2,555,552          792,877                   0          88,881                0                 0   3,437,31 0
5.02          Adjustments of Previous Fiscal Years                       0                  0                  0                0               0                 0           0
5.03          Adjusted Balance                                    2,555,552          792,877                   0          88,881                0                 0   3,437,31 0
5.04          Profit / Loss of the Period                                0                  0                  0                0          62,066                 0      62,066
5.05          Applications                                               0                  0                  0          27,685                0                 0      27,685
5.05.01       Dividends                                                  0                  0                  0          27,685                0                 0      27,685
5.05.02       Interests on Shareholders’ Equity                          0                  0                  0                0               0                 0           0
5.05.03       Other Applications                                         0                  0                  0                0               0                 0           0
5.05.03.01    Profits Available to the Shareholders’ Meeting             0                  0                  0        (83,053)                0                 0           0
5.05.03.02    Constitution of Tax Incentive Reserve                      0                  0                  0          38,726                0                 0           0
5.05.03.03    Constitution of Statutory Reserve                          0                  0                  0          44,327                0                 0           0
5.06          Realization of Profit Reserves                             0                  0                  0                0               0                 0           0
5.07          Equity Valuation Adjustments                               0                  0                  0                0               0                 0           0
5.07.01       Securities Adjustments                                     0                  0                  0                0               0                 0           0
5.07.02       Accrued Conversion Adjustments                             0                  0                  0                0               0                 0           0
5.07.03       Business Combination Adjustments                           0                  0                  0                0               0                 0           0
5.08          Increase/Reduction of Capital Stock                        0                  0                  0                0               0                 0           0
5.09          Constitution/Realization of Capital Reserves               0             2,885                   0                0               0                 0       2,885
5.09.01       Stock Purchase Option                                      0             2,885                   0                0               0                 0       2,885
5.10          Treasury Shares                                            0                  0                  0                0               0                 0           0
5.11          Other Capital Transactions                                 0                  0                  0                0               0                 0           0
5.12          Others                                                     0                  0                  0                0               0                 0           0
5.13          Final Balance                                       2,555,552          795,762                   0         116,566           62,066                 0   3,529,946




                                                                                                Page 21
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                 Corporate Law
ITR – QUARTERLY INFORMATION                                      Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


________________________________________________________________________
02143-1                  HYPERMARCAS S.A.              02.932.074/0001-91
________________________________________________________________________
________________________________________________________________________
06.01 - EXPLANATORY NOTES
________________________________________________________________________
1.     Operational context
Hypermarcas S.A. is Brazilian manufacturer of mass consumption products operating
in four main lines of business, with a large portfolio of traditional trademarks: (i)
household cleaning products; (ii) food products; (iii) cosmetics and personal care
products, and (iv) OTC medicaments and prescription medicaments. Among the
numerous trademarks of our portfolio, we highlight the following: Assolan, Mat Inset,
Etti, Salsaretti, Finn, Zero Cal, Monange, Paixão, Cenoura & Bronze, Avanço, Rastro,
Trés Marchand, Éh!, Apracur, Atroveran, Benegrip, Biotônico Fontoura, Doril,
Engov, Epocler, Estomazil, Gelol, Lactopurga, Melhoral, Merthiolate, Rinosoro,
Lisador, Tamarine, Lucretin, Bozzano, NY.Looks, Personna, Risqué, Biocolor,
Biorene, Pom Pom, Bigfral, Olla, Neo Química Genéricos and Jontex.

The manufacture of goods pertaining to the pharmaceutical, cosmetics and personal
care segments is substantially carried out by the controlled company Cosmed Indústria
de Cosméticos e Medicamentos S.A.

Industrial plants and distribution centers are located in the cities of São Paulo, Barueri,
Araçatuba, Taboão da Serra, Cajamar, São Roque and Guarulhos, in the state of São
Paulo, Goiânia and Anápolis in the state of Goiás, Itajaí in the state of Santa Catarina,
Porto Alegre in the state of Rio Grande do Sul, and Juiz de For a in the state of Minas
Gerais and Maceió, in the state of Alagoas.

Corporate Structure

On April 16, 2008, the Brazilian Securities and Exchange Commission - “CVM”
granted Hypermarcas S.A. the registration as a publicly-held corporation listed in the
Novo Mercado segment of the São Paulo Stock Exchange - BOVESPA, for purposes
of trading of common shares of its issuance.

In July, 2009 and April, 2010, primary public distributions of shares were carried out.

The proceeds obtained from offers have as primary application the acquisition of new
companies, assets and trademarks and the launching of new products.

Ever since the beginning of its activities, the Company has carried out several
corporate transactions in line with its expansion strategy and investment in a portfolio
of trademarks and products.

                                                                                          22
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                Corporate Law
ITR – QUARTERLY INFORMATION                                     Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Acquisitions represent a strategic focus on the search for opportunities that take
advantage from synergies in sales, distribution, operational and administrative
structures, as well as on benefiting from non-exploited growth potential of dormant
trademarks. The following are the main corporate transactions and/or acquisitions of
trademarks and rights of use effected, carried out with third parties, the detail of which
are summarized in Note 12:

2007

Strategic acquisitions in the segments of: (i) food products, cosmetics and
medicaments, particularly represented by DM Indústria Farmacêutica Ltda., Finn
Administradora de Marcas Ltda. and Éh Cosméticos S.A. (50%), and (ii) insecticides
and sanitizers, with the acquisition of Sul Química Ltda. During this same year, such
companies were merged into the Company as well as Etti Produtos Alimentícios Ltda.,
Quimivale Industrial Ltda. and Distribuidora Clean Ltda., which were acquired until
2006.

2008

The main acquisitions during that year were Laboratório Americano de Farmacoterapia
S.A. - Farmasa, of the medicament sector, Niasi Indústria e Comércio Ltda. (currently
known as Cosmed) and Aprov Comércio de Cosméticos Ltda., of the cosmetics and
personal care segment. Except for Niasi, all other ones were incorporated by the
Company in 2008.

2009

Through partial spin-off and merger transactions, the Company decided to concentrate
in its controlled entity Cosmed Indústria e Comércio de Medicamentos S.A. its
manufacturing activities pertaining to medicaments, cosmetics and personal care
products. During the second half of that year, Pom Pom Produtos Higiênicos Ltda,
Indústria Nacional de Artefatos de Látex Ltda. (Inal) e Laboratório Neo Química
Comércio and Indústria S.A. were acquired.

2010

In March, 2010, the Company acquired Versoix Participações Ltda. (owner of
trademark Jontex) of the male contraceptives segment.

2.     Presentation of Financial Information

Our financial information was prepared and is being presented in accordance with
Brazilian accounting principles, based upon the provisions of the Corporations Law,

                                                                                         23
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                Corporate Law
ITR – QUARTERLY INFORMATION                                     Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


rules and instructions issued by the CVM, technical pronouncements issued by
IBRACON - Brazilian Institute of Certified Accountants and Auditors and resolutions
of the Federal Accounting Council - “CFC”.

In preparing such financial information, it was necessary to rely upon estimates to
account for certain assets, liabilities and other transactions. Financial information
therefore include several estimates pertaining to provisions for credit losses, inventory
obsolescence, selection of useful lives of property, plant & equipment, passive
contingencies, determination of provision for income tax and similar items. Actual
results may differ from the estimates.

3.    Rules and interpretation of rules not yet in force

The following rules and interpretation of rules were published and the adoption thereof
is mandatory for fiscal years beginning on or after January 1st, 2010. In addition to
those, other rules and interpretations have been published changing the accounting
principles adopted in Brazil, within the scope of a convergence effort with
international rules. The rules mentioned herein below are solely those likely to more
substantially impact the Company’s financial statements. Pursuant to such new rules,
figures of the 2009 fiscal year presented herein shall be re-submitted for comparison
purposes upon presentation of the financial statements for the fiscal year to end
December 31, 2010. The Company did not adopt such rules in advance during the first
quarter of 2010, in reliance upon the election provided for in CVM Deliberation No.
603/09.

(a)   Pronouncements of the Accounting Pronouncement Committee (“CPC”)

            CPC 15 - Combination of Businesses
            CPC 16 - Inventories
            CPC 18 - Investments in Affiliated Entities
            CPC 20 - Costs of Loans
            CPC 21 - Interim Statements
            CPC 22 - Information per Segment
            CPC 23 - Accounting policies, change of estimates and rectification of
                      errors
            CPC 24 - Subsequent Events
            CPC 25 - Provisions, Contingent Liabilities and Assets
            CPC 26 - Presentation of Accounting Statements


                                                                                         24
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                               Corporate Law
ITR – QUARTERLY INFORMATION                                    Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


            CPC 27 - Property, Plant & Equipment
            CPC 30 - Revenues
            CPC 32 - Taxation of Profits
            CPC 36 - Consolidated Statements
            CPC 37 - Initial Adoption of International Accounting Rules
            CPC 38 - Financial Instruments: recognition and measurement
            CPC 39 - Financial Instruments: presentation
            CPC 40 - Financial Instruments: evidencing
            CPC 43 - Initial Adoption of Technical Pronouncements 15 and 40.

(b)   Interpretations

            ICPC 04 - Scope of CPC 10 - Stock-Based Compensation
            ICPC 05 - CPC 10 - Stock-Based Compensation
            ICPC 08 - Accounting of dividend payment proposal
            ICPC 09 - Individual, separate and consolidated accounting statements
                           and application of the equity method
            ICPC 10 - Clarification on CPC 27 and CPC 28
            ICPC 12 - Changes in liabilities owing to discontinuation, reinstatement
                          and other similar liabilities.

(c)   Estimate of Effects

Owing to the complexity of the matters and to the need to change control procedures
and systems, as well as to the development of more detailed reviews, thus allowing an
adequate determination of the effects resulting from new Technical Pronouncements,
Interpretations and Orientations issued by the Accounting Pronouncement Committee
to be adopted for 2010, it was not practicable so far to complete proper quantification,
assessment and disclosure of possible impacts of such effects in our income and
shareholders’ equity.

4.    Main Accounting Practices

The main accounting practices adopted in the preparation of the financial statements
are set forth herein below:

(a)   Cash and Cash Equivalents


                                                                                        25
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                Corporate Law
ITR – QUARTERLY INFORMATION                                     Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Cash and cash equivalents include money in cash, bank deposits, high-liquidity short-
term investments with insignificant risk of change of value.

(b)   Financial Instruments

      (i)    Classification and Measurement

The Company classifies its financial assets under the following categories: measured
by fair value by means of the result, loans and receivables, and cash assets for sale.
Classification depends on the purpose for which the financial assets were acquired.
Management determines the classification of the financial assets in the initial
recognition.

Financial assets measured by fair value by means of the result

Financial assets measured by fair value by means of the result are financial assets kept
for active and frequent trading. Derivatives are also categorized as kept for trading
purposes and, accordingly, are classified in that category. Assets belonging in such
category are classified as current assets. Gains or loss resulting from variations in the
fair value or financial assets measured by fair value are presented in the statement of
income, under line item “financial income (loss)” in the period in which they occurred.
In this case, variations are recognized in the same line item of the income affected by
the transaction in question.

Loans and Receivables

This category includes loans granted and receivables that are non-derivative financial
assets such as fixed or determinable payments not listed in an active market. They are
recorded as current assets, except those having a maturity term exceeding 12 months
after the balance sheet date (which are non-current assets). The Company’s loans and
financings comprise loans granted to affiliated entities, accounts receivable from
clients, other accounts receivable and cash and cash equivalents other than short-term
investments.

Fair Value

Fair value of publicly listed financial instruments are based upon the current purchase
prices. For financial assets that do not have an active market or public listing, the
Company determines the fair value through the use of valuation techniques. Such
techniques include the use of recent transactions entered into with third parties
reference to other substantially similar instruments, analysis of discounted cash flows
and pricing models that use as much as possible information generated by the market


                                                                                         26
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                 Corporate Law
ITR – QUARTERLY INFORMATION                                      Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


and rely as little as possible upon information generated by the management of the
company involved.

As of the balance sheet date, the Company evaluates whether there is objective
evidence that a certain financial asset or group of financial assets is recorded for a
value higher than its recoverable value (impairment).

       (ii)   Derivative instruments and Hedging activities

The Company engages in transactions involving derivative financial instruments
carried on for the purpose of mitigating the effects of foreign exchange volatility,
primarily on its notes payable. Such derivative instruments are not used for
speculative purposes and are registered by their fair value on the date of execution of
the relevant derivative agreement and are subsequently re-measured also by their fair
value, and any variations in the fair value are charged to income.

The fair value of the derivative instruments is disclosed in Note 28(i).

(c)    Accounts Receivable from Clients

Accounts receivable from clients are deducted from the provision for doubtful
accounts. Provisions for doubtful accounts are established whenever there is objective
evidence that the Company will not be able to collect all of the amounts owed by its
clients. Such evaluation is made based upon an individual analysis of defaulting
clients taking into account their payment ability, the guaranties offered and the
evaluation made by counsel and specialized collection companies. The value of the
provision is the difference between the book value and the recoverable value.

(d)    Inventories

Raw material and packing material inventories are valued and demonstrated at the
average cost of purchase, which are lesser than the replacement cost or the realization
values. The cost is determined using the Weighed Average method. Cost of finished
products and of products under manufacturing process comprises raw materials, direct
labor, other direct costs and related general manufacturing expenses always taking into
account normal operational capacity. The net realizable value is the estimated selling
price for ordinary course of business, minus execution costs and selling expenses.
Ongoing imports are demonstrated at the accrued value of each import.

(e)    Deferred Income Tax and Social Security Charges

Deferred income tax and social security charges, active and passive, are calculated
over income tax loss, the negative base of the social security contribution and the

                                                                                          27
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                 Corporate Law
ITR – QUARTERLY INFORMATION                                      Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


corresponding temporary differences between the tax calculation basis and the book
values of the financial statements. The rate of such taxes, currently established for
determination of such deferred credits, are of 25% for income tax and 9% for social
security contribution (Note 16).

Active deferred taxes are recognized to the extent that the taxable future profit is likely
to be available to be used to offset temporary differences and/or tax losses, based upon
future result forecasts brought to present value (note 16(b)). Such forecasts are based
upon technical reviews prepared and backed-up by internal assumptions and future
economic scenarios that may, therefore, be varied.

Tax credits pertaining to premium determined in accordance with CVM Instructions
Nos. 319 and 349, namely, net of provision for tax realization, are recorded at their
realization value. Such premium are based upon future profitability expectations.

(f)    Investments in Controlled Entities

       (i)    Cost and/or book value

Investment in controlled entities is recorded and valued pursuant to the equity method,
and any adjustments are recognized in the result of the fiscal year as operational
revenue (expense). For purposes of calculation of equity, gains or transactions
realizable between the Company and its controlled entity are eliminated to the extent
of the Company’s share.

When the Company’s share in accrued losses of affiliated and controlled entities shall
equal or exceed the value of the investment, the Company recognizes additional losses
by virtue of obligations or payments on behalf of those entities.

       (ii)   Premium

Premium determined upon the acquisition of an investment is calculated as the
difference between the purchase value and the book value of the net equity of the
acquired entity. Premium is recorded as part of intangibles.

Premium determined by the controlling entity upon the acquisition of incorporated
companies are based upon future profitability. Until December 31, 2008, premium
was amortized and from that date onwards the balances are subject to impairment test.

Premium pertaining to acquired companies that have already been incorporated into
the acquiring entity are recorded under intangibles. Premium resulting from
companies not yet incorporated into the acquiring entity are recorded under


                                                                                          28
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                             Corporate Law
ITR – QUARTERLY INFORMATION                                  Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


investments of the controlling company and reclassified to intangibles in the
consolidated financial statements.

(g)   Foreign Currency Conversion

Foreign currency transactions are converted into Brazilian Reais using exchange rates
in force on the dates of such transactions. Balances of balance sheet accounts are
converted at the exchange rate in force as of the date of the balance sheet. Foreign
exchange gains and losses resulting from the settlement of such transactions and from
the conversion of monetary assets and liabilities denominated in foreign currency are
recognized in the statement of income.

(h)   Property Plant & Equipment

Lands, buildings, machines and facilities embrace primarily manufacturing plants and
are demonstrated at their historical acquisition cost.

Depreciation is calculated by the straight-line method, in accordance with the rates
disclosed in Note 11.

Gains and losses upon disposals are determined by comparing the disposal values with
the book value and are included in the result.

(i)   Intangibles

Research & Development

Expenditures with research are recognized as expenses when incurred in.

Computer Software

Software licenses acquired are capitalized and amortized along their estimated useful
lives, at the rates set forth in Note 12.

Expenditures associated with software development or maintenance are recognized as
expenses as they are actually incurred in. Expenditures related to implementation of
systems, particularly consulting services, are recognized as assets and are amortized
pursuant to the straight-line method.

(j)   Reduction to recoverable value of assets

Property, plant & equipment and other non-current assets, including premium and
intangible assets are reviewed annually to identify evidences of unrecoverable
impairment, or upon the occurrence of any event or change in circumstances indicating

                                                                                      29
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                Corporate Law
ITR – QUARTERLY INFORMATION                                     Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


that the book value may be unrecoverable. When this shall be the case, the recoverable
amount is calculated to verify if there is impairment. If positive, impairment is
recognized at the amount by which the book value of the asset exceeds its recoverable
value, which is the higher between the net selling price and the value in use of the
asset. For valuation purposes, assets are grouped in the smaller group of assets for
which there are severally identifiable cash flows.

(k)   Lease Arrangements

Lease arrangements involving property, plant & equipment under which the Company
retains substantially all of the risks and benefits of the ownership are classified as
lease-purchase arrangements. Lease-purchase arrangements are registered as purchase
on credit, recognized at their beginning a property, plant & equipment asset and a
financing liability (lease-purchase). The property, plant & equipment asset acquired
under lease-purchase arrangements is depreciated at the rates set forth in Note 11.

Lease arrangements in which a substantial portion of the risks and benefits of the
ownership lies with the lessor are classified as operational lease arrangements.
Payment of such operational lease arrangements (net of all incentive received from the
lessor) are appropriated to income pursuant to the to straight-line method along the
lease period.

(l)   Deferred

Primarily formed by pre-operational and restructuring expenses. It is amortized along a
period of up to ten (10) years.

(m)   Provisions and other liabilities, other than loans and financings

Provisions are recognized when the Company has a present, legal or non-formalized
obligation, as a result of past events, and an exit of funds is likely to be necessary to
settle such obligation and to allow a reliable estimate of the value. In this connection,
the recognition, measurement and disclosure of provisions and passive contingencies
take into account the criteria set forth in CPC 25 and in CVM Instruction No. 489 as
well as the contractual guarantees provided in connection with the acquisition of the
companies.

Other liabilities are demonstrated at known or calculable amounts, plus the
corresponding charges, if applicable, pertaining to exchange rate variations and
monetary variations incurred. Notes payable indexed to exchange variation and
without interest rates, the Fomentar Loan and the Tax Recovery Program (New
REFIS) are recorded at their present values, in accordance with CVM Deliberation No.
564/08.
                                                                                         30
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                 Corporate Law
ITR – QUARTERLY INFORMATION                                      Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


(n)    Stock Purchase Option Plan

The fair value of the shares granted by the Company to its employees and managers is
recognized as expense in the income statement, during the period in which the right is
acquired after the satisfaction of certain specific conditions. On the dates of the
balance sheets, the estimate of the number of shares, the rights to which shall be
acquired subject to such conditions is reviewed and, whenever applicable, the effect
resulting from the review of the initial estimate is recognized in the result of the period
as counterpart to net equity.

(o)    Loans and financings, promissory notes and debentures

Borrowings are initially recognized at their fair value upon receipt of the funds, net of
transaction costs. Subsequently, such borrowings are registered at their amortized cost,
that is, plus charges and interests accrued pro rata temporis.

(p)    Determination of the result and recognition of revenue

The result of the period is determined by accrual basis accounting.

Sales of products are recognized in the result when the risks and benefits inherent to
the products are transferred to the purchaser.

(q)    Income per share

Calculated taking into account the aggregate number of shares existing as of the end of
each fiscal year, excluding treasury shares, if any.

(r)    Consolidated financial information and consolidation criteria

Consolidated financial information is prepared in accordance with the applicable
consolidation practices and legal provisions in force. Accordingly, interests held by
one company in another, balances of assets and liabilities accounts and revenues and
expenses from transactions between controlled entities are eliminated. Profits not
realized between the companies are also eliminated

Consolidated financial information as of March 31, 2009 comprises financial
information from the controlling company Hypermarcas S.A. and from the controlled
company Cosmed Indústria de Cosméticos e Medicamentos S.A. (formerly known as
Niasi).

Consolidated financial information as of March 31, 20109 comprises financial
information from the controlling company Hypermarcas S.A. and from the controlled


                                                                                          31
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                  Corporate Law
ITR – QUARTERLY INFORMATION                                       Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


companies Cosmed Indústria de Cosméticos e Medicamentos S.A. (formerly known as
Niasi), My Agência de Propaganda Ltda. and Versoix Participações Ltda.

5.       Cash and Cash Equivalents
                                            Controlling Entity         Consolidated
                                       03/31/2010 12/31/2009 03/31/2010 12/31/2009

Cash and banks                             9,857       11,520        10,037         11,662
Financial applications:
Debentures – Committed transactions      367,880      299,832       402,285        299,832
CDB Certificates of Bank Deposit         213,813      172,355       213,813        172,355
Others                                    15,787       15,430        15,787         15,430

                                         597,480      487,617       631,885        487,617


                                         607,337      499,137       641,922        499,279

Committed transactions are remunerated at 100% to 104% of the CDI (Certificate of
Interbank Deposit) variation (weighed average of 101.9%). CDBs are remunerated at
100% to 105% of the CDI variation (weighed average of 101.6%).

6.       Accounts Receivable
                                             Controlling Entity                 Consolidated
                                       03/31/2010 12/31/2009      03/31/2010      12/31/2009

     Clients in Brazil                    649,933      769,997       650,795         771,060
     Clients outside Brazil                 3,123        2,023         3,123           2,023

                                          653,056      772,020       653,918         773,083

     Provision for doubtful accounts     (20,658)      (48,453)      (20,658)       (48,453)

                                          632,398      723,567       633,260         724,630
Reduction of the balance of provisions for doubtful accounts is due to the recognition
of final write-off of clients.



7.       Inventories
                                             Controlling Entity          Consolidated
                                        03/31/2010 12/31/2009 03/31/2010   12/31/2009

 Finished product and resale              165,625      148,271       182,763         180,401
 Half-finished products                    20,258       30,351        26,670          34,929

                                                                                             32
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                           Corporate Law
ITR – QUARTERLY INFORMATION                                                                Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


 Raw material                                                  66,410           54,070         124,100            106,039
 Maintenance and supplies                                      10,219           14,674           17,592             20,450
 Provision for realization of inventories                    (10,640)         (10,812)         (22,154)           (22,327)

                                                              251,872          236,554          328,971            319,492



8.       Taxes Recoverable
                                                            Controlling Entity                             Consolidated
                                                      03/31/2010 12/31/2009               03/31/2010         12/31/2009

     IRPJ recoverable                                       1,646              1,646            2,002                1,985
     CSLL recoverable                                       1,462              1,462            1,594                1,588
     Federal taxes (Pis/Cofins/IPI/others)                104,451             74,169          110,277               82,033
     ICMS (credit balance and tax
     substitution)                                        158,825           121,303           158,958             122,173

                                                          266,384           198,580           272,831             207,779

     Current                                              265,668           197,808           271,613             206,499

     Non-current                                                716               772            1,218               1,280



9.       Advanced Expenses
                                                              Controlling Entity                           Consolidated
                                                        03/31/2010 12/31/2009               03/31/2010       12/31/2009

     Advertising and promotion expenses(1)                    76,341            29,949            76,341            29,949
     Others                                                    5,213             3,318             6,288             3,635

                                                              81,554            33,267            82,629            33,584

     Current                                                  80,123            32,208            81,198            32,525

     Non-Current                                                1,431            1,059             1,431             1,059

       (1) Balance is composed primarily by advertising to be aired during soccer games of the Brazilian championship, regional
            championships and the FIFA World Cup.




10.      Investments in Controlled Entities

         (a)       Investment movement


                                                                                                                           33
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                                    Corporate Law
ITR – QUARTERLY INFORMATION                                                                         Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


                                                      Cosmed                                     My
                                                       Premiu            Cost                 Premiu
                                  Costs                    m                s                     m                   Total

 Balances as of December 31,      17,72
 2008                                 7                 50,557                                                    68,284
                                  47,74
 Acquisition                          7                                    10                                     47,757
                                  16,70
 Equity Method                        5                                   173                                     16,878
 Others                                                  (273)                                                     (273)
 Balances as of December 31,      82,17
 2009                                 9                 50,284            183                                    132,646


                                  Cosmed                                   My                          Versoix
                                            Premiu                Cost             Premiu                                Premiu
                         Costs                  m                    s                 m               Costs                 m           Total

 Balances as of
 December 31,                                                                                                                           132,64
 2009                   82,179              50,284                 183                                                                       6

 Payment/Acquisitio                                                                                                                     206,25
 n                      25,000                                                                          2,331           178,926              7

 Equity Method           6,164                                     144                                   (53)                            6,255

 Balances as of         113,34                                                                                                          345,15
 March 31, 2010              3              50,284                 327                                  2,278           178,926              8




(b)         Equity Method

                                                                                                            Equity
                                                                         Equity
                                                                                      Balance of          Method          Balance of
                                                                       Method
                                                                                     investment           accrued        investment
                                        Profit/                        accrued
                                                                                     as of March       result as of      as of March
                     Net Equity     Loss as of                      result as of
                                                                                             31,         March 31,               31,
                    as of March      March 31,         Equity         March 31,
                       31, 2010          2010        Interest %            2010             2010          de 2009              2009

 Cosmed
 Indústria de
 Cosméticos e
 Medicamentos
 S.A. (i)               113,343           6,164        100%               6,164         113,343            (2,608)            82,179
 My Agência de
 Propaganda
 Ltda. (ii)                 327            144        99,99%                144              327                                  183
 Versoix
 Participações
 Ltda. (iii)              2,278            (53)       99,99%                (53)            2,278


                                                                          6,255         115,948            (2,608)            82,362

(i)    Hypermarcas holds 142,894,037 common shares of Cosmed Indústria de Cosméticos e Medicamentos S.A.


(ii)   Hypermarcas holds 9,999 quotas of My Agência de Propaganda Ltda. of an aggregate number of 10,000 quotas.


(iii) Hypermarcas holds 2,405,201 quotas of Versoix Participações Ltda. of an aggregate number of 2,405,442 quotas.




                                                                                                                                          34
       FEDERAL PUBLIC SERVICE
       CVM – SECURITIES AND EXCHANGE COMMISSION                                                                                     Corporate Law
       ITR – QUARTERLY INFORMATION                                                                                          Base-Date – 03/31/2010
       COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


       11.        Property, Plant & Equipment

       Controlling Entity
                                                  Machinery,                                       Tools,
                                                  equipment                    Furniture       containers                                             Property,
                                  Buildings and           and                       and               and   Total in         Ongoing     Provision      Plant &
                        Lands    improvements       facilities   Vehicles       utensils           others operation            works      for Loss   Equipment
       Balances as
       of Dec. 31,
       2008             2,170           21,645         85,665           401        4,106               4,635     118,622       16,468      (2,901)      132,189
       Additions due
       to
       Incorporations     190           53,631         57,995           545        4,201                 654     117,216       31,627                   148,843
       Additions                           853          8,822           124          914               4,873      15,586        7,128                    22,714
       Cosmed Spin-
       Off
       06.30.2009        (130)          (3,506)       (42,353)      (319)         (2,214)          (2,410)       (50,932)     (12,511)                  (63,443)
       Disposal                                          (288)       (59)           (342)               (2)         (691)           35                     (656)
       Transfer                          4,570           (188)       (40)                              139          4,481      (4,487)                       (6)
       Depreciation/
       Amortization                     (1,677)       (13,115)      (111)              (628)       (1,240)       (16,771)                               (16,771)
       Balances as
       of Dec. 31,
       2009             2,230           75,516         96,538           541        6,037               6,649     187,511       38,260      (2,901)      222,870
       Total Cost
       Accrued
       depreciation     2,230            93,853        226,479      2,405         11,469           13,603        350,039       38,260                    388,299
                                       (18,337)      (129,941)    (1,864)         (5,432)          (6,954)     (162,528)                   (2,901)     (165,429)
       Residual
       value            2,230           75,516         96,538           541        6,037               6,649     187,511       38,260      (2,901)      222,870
       Balances as
       of Dec. 31,
       2009             2,230           75,516         96,538           541        6,037               6,649     187,511       38,260      (2,901)      222,870
       Additions        1,300              126          1,401                        562                 245       3,634        2,350                     5,984
       Disposal                                           (32)                       (11)                            (43)                                   (43)
       Transfer                          1,205          5,190                        800                 45        7,240       (7,263)                      (23)
       Depreciation/
       Amortization                       (974)        (4,114)          (40)           (276)           (454)      (5,858)                                (5,858)
       Balances as
       of March 31,
       2010             3,530           75,873         98,983           501        7,112               6,485     192,484       33,347      (2,901)      222,930
       Total Cost       3,530           95,184        232,956       2,405         12,804           13,892        360,771       33,347                   394,118
       Accrued
       depreciation                    (19,311)      (133,973)    (1,904)         (5,692)          (7,407)     (168,287)                   (2,901)     (171,188)
       Residual
       value            3,530           75,873         98,983           501        7,112               6,485     192,484       33,347      (2,901)      222,930
       Average
       annual
       depreciation
       rates - %                             4             10            20              10              20




       Consolidated

                                                        Machinery,                       Furniture           Tools,                                                 Property,
                                 Buildings and           equipment                            and        containers        Total in      Ongoing     Provision        Plant &
                          Lands improvements           and facilities    Vehicles         utensils       and others      operation         works      for Loss     Equipment

Balances as of Dec.
31, 2008                   2,170           21,645            89,578             401            4,560            5,654       124,008        17,264      (2,901)        138,371
Additions due to
Incorporations               189           53,631            57,995             545            4,202              654       117,216        31,627                     148,843
Additions                                     853            12,941             124            1,005            6,346        21,269        11,130                      32,399
Disposal                                                      (435)             (81)           (386)               (2)        (904)             35                      (869)
Transfer                                    4,570             (187)             (40)                              139         4,482        (4,488)                         (6)
Depreciation/
Amortization                               (1,944)          (18,191)           (161)           (904)           (1,999)      (23,199)                                  (23,199)




                                                                                                                                                                 35
       FEDERAL PUBLIC SERVICE
       CVM – SECURITIES AND EXCHANGE COMMISSION                                                                       Corporate Law
       ITR – QUARTERLY INFORMATION                                                                            Base-Date – 03/31/2010
       COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Balances as of Dec.
31, 2009                    2,359           78,755     141,701         788        8,477             10,792     242,872    55,568       (2,901)        295,539

Total Cost                  2,359           98,935     333,100       3,914       18,169             23,542     480,019    55,568                      535,587

Accrued depreciation                   (20,180)       (191,399)     (3,126)      (9,692)        (12,750)      (237,147)                (2,901)    (240,048)
Residual value              2,359        78,755         141,701         788        8,477          10,792        242,872   55,568       (2,901)      295,539
Balances as of Dec.
31, 2009                    2,359           78,755     141,701         788        8,477             10,792     242,872    55,568       (2,901)        295,539
Additions                   1,300              177       3,738                      602              1,299       7,116     3,186                       10,302
Disposal                                                 (163)                      (19)                         (182)                                  (182)
Transfer                                     1,205       5,189                      814                 44       7,252    (7,276)                         (24)
Depreciation/
Amortization                               (1,129)      (6,483)        (64)       (389)              (838)      (8,903)                               (8,903)
Balances as of March
31, 2010                    3,659           79,008     143,982         724        9,485             11,297     248,155    51,478       (2,901)        296,732
Total Cost                  3,659          100,317     341,680       3,914       19,539             24,885     493,994    51,478                      545,472

Accrued depreciation                   (21,309)       (197,698)     (3,190)     (10,054)        (13,588)      (245,839)                (2,901)    (248,740)
Residual value              3,659        79,008         143,982         724        9,485          11,297        248,155   51,478       (2,901)      296,732

Average annual
depreciation rates - %                          4          4,44         20           10                20




       12.         Intangible

                                                                          Controlling Entity                                Consolidated

                                                                  03/31/2010       12/31/2009          03/31/2010               12/31/2009


        Premium in non-merged company

        Cosmed Indústria de Cosméticos e Medicamentos
        S.A.                                                                                                  50,284                  50,284
        Versoix Participações Ltda.                                                                          178,926


        Premium and discount in the acquisition of
        investments in merged companies
        Laboratório Neo Química Comércio e Indústria Ltda.         1,155,206        1,155,206           1,155,206                   1,155,206
        DM Indústria Farmacêutica Ltda.                             743,029           743,029                743,029                 743,029
        Laboratório Americano de Farmacoterapia S.A. -
        Farmasa                                                     666,808           666,808                666,808                 666,808
        Pom Pom Produtos Higiênicos Ltda.                           318,093           318,093                318,093                 318,093
        Aprov Comércio de Cosméticos Ltda.                          280,147           280,147                280,147                 280,147
        Inal – Indústria Nacional do Látex S/A                      184,271           184,271                184,271                 184,271
        Ceil Comércio e Distribuidora Ltda.                         148,886           148,886                148,886                 148,886
        Barrenne Indústria Farmacêutica Ltda.                         33,955               33,955             33,955                  33,955
        Sul Química Ltda.                                             32,491               32,491             32,491                  32,491
        Etti Produtos Alimentícios Ltda.                              18,319               18,319             18,319                  18,319
        Finn Administradora de Marcas Ltda.                           17,857               17,857             17,857                  17,857
        Éh Cosméticos S.A.                                            15,963               15,963             15,963                  15,963
        Quimivale Industrial Ltda. e Distribuidora Clean Ltda.        10,231               10,231             10,231                  10,231
        Castro Verde Participações Ltda.                                (129)               (129)              (129)                    (129)


                                                                   3,625,127        3,625,127           3,854,337                   3,675,411

                                                                                                                                                 36
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                  Corporate Law
ITR – QUARTERLY INFORMATION                                       Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES



Rights of Use                            54,569      58,033      54,948            58,427


Trademarks and Patents                   71,825      71,826      72,128            72,129


System implantation                       8,338       8,793       8,353             8,813
Product research and development         21,180      20,272      21,180            20,272


                                       3,781,039   3,784,051   4,010,946         3,835,052




       Cosmed and Aprov - on October, 2008, companies Cosmed Indústria de
        Cosméticos e Medicamentos S.A. (current name of Niasi Indústria de
        Cosméticos Ltda.) and Aprov Comércio de Cosméticos Ltda. were acquired in
        exchange for the aggregate amount of R$366,000, which was later reduced to
        R$324,000 by contractual arrangements. Aprov was incorporated in December,
        2008.

       Versoix (Jontex) - In March, 2010, the company Versoix Participações Ltda.
        was acquired in exchange for an amount of R$181,256 million, resulting in a
        premium of approximately R$178,926 million.

       Pom Pom - In November, 2009, the company Pom Pom Produtos Higiênicos
        Ltda. was acquired in exchange for an amount of R$300,0 million, resulting in a
        premium of approximately R$328,0 million. The company was incorporated in
        December, 2009.

       INAL - In November, 2009, the company Indústria Nacional de Artefatos de
        Látex (Inal) was acquired in exchange for an amount of R$212,619, resulting in
        a premium of approximately R$201,483. The company was incorporated in
        December, 2009.

       Neo Química - On December 1st, 2009, the Company acquired the entirety of
        the shares of Hypernova, which controlled Laboratório Neo Química Comércio
        e Indústria S.A. under an agreement providing for incorporation of shares
        executed on December 6, 2009 aiming at incorporating all of the shares
        representing the capital stock of Neo Química into Hypermarcas’ net equity.
        The aggregate value of the transaction was of R$1,368,926; a portion of such
        value was represented by 35,000,000 common shares, after a stock split, issued
        by Hypermarcas in favor of former shareholders of Neo Química, which
        resulted in a capital increase of R$681,625. Such transaction resulted in a
        premium of R$1,163,738. Hypernova and Neo Química were incorporated into
        Hypermarcas in 2009.
                                                                                             37
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                            Corporate Law
ITR – QUARTERLY INFORMATION                                 Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


    DM - In June, 2007, DM Farmacêutica Ltda. was acquired in exchange for an
     amount of R$1,191,689, resulting in a premium of approximately the same
     amount. On the same date, there was a capital increase in the amount of
     R$112,166 upon the subscription and payment of new quotas. The company
     was incorporated in October, 2007.

    Farmasa - On June 1st, 2008, the Company and Laboratório Americano de
     Farmacoterapia S.A. - FARMASA executed and Agreement for the
     Incorporation of Shares providing for the incorporation of all of the shares
     representing the capital stock of FARMASA into Hypermarcas’ net equity, in
     exchange for the subscription by shareholders of FARMASA for new shares
     issued by Hypermarcas. As a consequence of such incorporation, the
     subscribed and paid capital stock of Hypermarcas was increased in R$873,446
     with the issuance of 39,720,140 common shares, representing 20% of its capital
     stock. The Protocol and Justification of Incorporation of Shares determined that
     the incorporation of shares was effective as of July 1st, 2008, which was the
     effective date of the transaction. Such transaction resulted in a premium of
     R$732,254. The company was incorporated in December, 2008.

    Ceil - On July 28, 2008, Ceil Comércio e Distribuidora Ltda. was acquired in
     exchange for the amount of R$173,388, resulting in a premium of
     approximately R$160,357. The company was incorporated in December, 2008.

    Sul Química - In March, 2007, the Company acquired a 90% equity interest in
     Sul Química Ltda. for an amount of R$50,566, resulting in a premium of
     approximately R$42,345. In September, 2007, the Company acquired the
     remainder 10% interest for an amount of R$8,900, resulting in a supplementary
     premium of approximately R$7,700. The company was incorporated in
     October, 2007.

    Etti - In March, 2006, the Company acquired the control of Etti Produtos
     Alimentícios Ltda. for an amount of R$71,400, resulting in a premium of
     approximately R$40,035. The company was incorporated in January, 2007.

    Finn - In March, 2007, a 100% equity interest in Finn Administradora de
     Marcas Ltda. was acquired for R$27,477. The company was incorporated in
     October, 2007.

    Éh Cosméticos - In March, 2007, the Company acquired the control of Éh
     Cosméticos S.A. in the amount of R$12,800. In January, 2008, the Company
     acquired the remainder 50% for R$13,510, resulting in a supplementary


                                                                                     38
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                         Corporate Law
ITR – QUARTERLY INFORMATION                                                              Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


           premium of approximately R$12,150.                     The company was incorporated in
           December, 2008.

          Quimivale and Clean - In February, 2005, the Company acquired the control of
           Quimivale and Distribuidora Clean (through the control of its holding company
           Baule Participações S.A., subsequently incorporated into Hypermarcas) for an
           amount of approximately R$34,700. The companies were incorporated in
           November, 2007.

Premiums are based upon future profitability and are supported by appraisal reports
prepared by expert companies, using the discounted cash flows at present value
method. Discount rates used in the pertinent calculations were determined by the
adoption of the Weighed Average Capital Cost (WACC).

Movement of balances

Controlling Entity

                                          Trademarks &       System            Product      Acquired
                          Rights of Use      patents       implantation         R&D         premiums     Total
Balances as of Dec. 31,
2008                             44,075           68,343           10,124           479      1,967,328 2,090,349
Total cost                      111,203           68,343           16,814           721      2,464,303 2,661,384
Accrued amortization           (67,128)                            (6,690)         (242)     (496,975) (571,035)
Residual value                   44,075           68,343           10,124            479     1,967,328 2,090,349
Balances as of Dec. 31,
2008                             44,075           68,343           10,124           479      1,967,328 2,090,349
Additions by
incorporation                     3,174              164              123        16,992                   20,453
Additions                        23,135            3,622              969         3,102      1,657,799 1,688,627
COSMED Split-Off
06.30.09                          (200)            (303)                                                   (503)
Disposal                           (61)                                                                     (61)
Transfer                            134                              (127)                                     7
Amortization                   (12,224)                            (2,296)         (301)                (14,821)
Balances as of Dec. 31,
2009                             58,033           71,826            8,793        20,272      3,625,127 3,784,051
Total cost                       87,957           71,846           18,159        22,819      3,625,127 3,825,908
Accrued amortization           (29,924)             (20)           (9,366)       (2,547)                (41,857)
Residual value                   58,033           71,826            8,793        20,272      3,625,127 3,784,051
Balances as of Dec. 31,
2009                             58,033           71,826            8,793        20,272      3,625,127 3,784,051
Additions                           530                               117         1,232                    1,879
Transfer                             69                                             (45)                      24
Amortization                    (4,063)              (1)            (572)         (279)                  (4,915)
Balances as of Mar. 31,
2010                             54,569           71,825            8,338        21,180      3,625,127 3,781,039
Total cost                       88,556           71,846           18,276        24,006      3,625,127 3,827,811
Accrued amortization           (33,987)             (21)           (9,938)       (2,826)                (46,772)
Residual value                   54,569           71,825            8,338        21,180      3,625,127 3,781,039
Annual amortization
rates - %                            20                                   20         20



                                                                                                                   39
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                         Corporate Law
ITR – QUARTERLY INFORMATION                                                              Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Consolidated

                          Rights of    Trademarks &       System             Product        Acquired
                            Use           patents       implantation          R&D           premiums        Total

Balances as of Dec. 31,
2008                         44,085            68,343           10,163            479          2,017,885 2,140,955

Total cost                  111,209            68,343           17,018            721          2,517,153 2,714,444
Accrued amortization        (67,124)                            (6,855)          (242)         (499,268)   (573,489)
Residual value               44,085            68,343           10,163            479          2,017,885 2,140,955
Balances as of Dec. 31,
2008                         44,085            68,343           10,163            479          2,017,885 2,140,955
Additions by
incorporation                  3,174              164              123         16,992                        20,453
Acquisitions                 23,363             3,622              970          3,102          1,657,526 1,688,583
COSMED Split-Off
06.30.09                        (61)                                                                            (61)
Transfer                        124                              (118)                                              6
Amortization                (12,258)                            (2,325)          (301)                      (14,884)
Balances as of Dec. 31,
2009                         58,427            72,129            8,813         20,272          3,675,411 3,835,052

Total cost                   89,882            72,149           18,373         22,819          3,675,411 3,878,634
Accrued amortization        (31,455)             (20)           (9,560)        (2,547)                      (43,582)
Residual value               58,427            72,129            8,813         20,272          3,675,411 3,835,052
Balances as of Dec. 31,
2009                         58,427            72,129            8,813         20,272          3,675,411 3,835,052
Acquisition                     534                                117          1,232           178,926     180,809
Transfer                         70                                    (1)        (45)                           24
Amortization                 (4,083)              (1)            (576)           (279)                       (4,939)
Balances as of Mar. 31,
2010                         54,948            72,128            8,353         21,180          3,854,337 4,010,946

Total cost                   90,486            72,149           18,489         24,006          3,854,337 4,059,467
Accrued amortization        (35,538)             (21)          (10,136)        (2,826)                      (48,521)
Residual value               54,948            72,128            8,353         21,180          3,854,337 4,010,946
Annual amortization
rates - %                        20                                    20          20




13.          Deferred - Pre-operational expenses

Controlling Entity and

Consolidated




                                                                                                                        40
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                      Corporate Law
ITR – QUARTERLY INFORMATION                                           Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


                                                         Pre-
                                                  operational
                                                   expenses


      Balances as of December 31, 2008                   973
      Amortization                                      (423)


      Balances as of December 31, 2009                   550



      Total cost                                       4,094
      Accrued amortization                            (3,544)


      Residual value                                     550


      Balances as of December 31, 2009                   550


      Amortization                                       (92)


      Balances as of March 31, 2010                      458


      Total cost                                       4,094
      Accrued amortization                            (3,636)


      Residual value                                     458



      Annual amortization rates - %                     20%


As permitted under Law No. 11,941/2009 and CPC 13, the remaining balance of
deferred assets as of March 31, 2010, which could not be allocated to property, plant &
equipment and intangible assets, shall remain as deferred assets under such
classification until its full amortization, but subject to periodical review as to its
recoverability.

14.      Suppliers
                                                 Controlling Entity                Consolidated
                                         03/31/2010    12/31/2009     03/31/2010     12/31/2009

Suppliers in Brazil                        130,004          124,153     129,997         112,330
Suppliers outside Brazil                     6,681            7,690      11,123           8,147

                                           136,685          131,843     141,120         120,477




                                                                                                  41
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                       Corporate Law
ITR – QUARTERLY INFORMATION                                                            Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


15.       Loans and Financings

                                                                  Controlling Entity               Consolidated
                                  Interest rate - 2010 - %   03/31/2010   12/31/2009      03/31/2010   12/31/2009

Foreign currency

Short-term financing              US$ + 3.7% to 5.3% per
                                  annum                          1,914        91,596          1,914       91,596
Long-term financing               US$ + 3.7% to 5.3% per
                                  annum                         84,397        81,196         84,397       81,196
Short-term financing              Yen (¥) + 5.8225% per
                                  annum                         22,287                       22,287
Hedge                                                            6,591        47,347          6,591       47,347
Finimp                            US$ + 4.5% per annum                                        2,709        2,539


Brazilian currency

Working capital                   CDI + 1.6% per annum        338,413       380,885        338,413      380,885
BNDES (i)                         Prefixed of 4.65% to 6%
                                  per annum+ TJLP             121,936       123,072        132,514      133,617
Debentures non-convertible into
shares (ii)                       113.72% of CDI              203,394                      203,394
Promissory notes (iii)            113.70% of CDI              202,562                      202,562
Financing Centro-Oeste - FCO      8.5% per annum               35,800         37,744        35,800        37,744
Finep                             TJLP                                                       7,698         8,112
Surety letter                                                    3,236         3,361         3,236         3,361
Finame                             TJLP + and 4.5% + per
                                   annum                         2,823         3,110          5,279        6,492
Leasing                            CDI + 4.8% per annum          1,811         2,002          2,638        2,896
Banco Regional de Brasilia – BRB – 2.4265% per annum
PRÓ-DF                                                              36            37             36           37

                                                             1,025,200      770,350       1,049,468     795,822

Current                                                       358,145       391,592        366,647      398,885

Non current                                                   667,055       378,758        682,821      396,937



(i)   Agreements having restrictive clauses regarding disposal, spin-off, merger or
incorporation or any corporate restructuring, which if occurring shall be dependent
upon authorization by the financial agents. If any such events shall happen without
consent from the banks, the outstanding balances become immediately due and
payable.

(ii)   On January 8, 2010 the Company carried out the first Public Issuance of two
hundred debentures non-convertible into shares, with par value as of the date of
issuance of R$1,000 in a single series. Remuneration of such debentures shall include
interests at a rate of 113,72% of the accrued variation of the average daily DI over
extra group rates expressed as a percentage per year, based upon a 252-business-day
year, as calculated and disclosed by CETIP. Interests shall be calculated pro rata
temporis since the date of issuance until the date of maturity, which extends up until
January 8, 2013. AN amount of R$3,924 is recorded under current assets, and
R$199,470 under non-current assets.


                                                                                                                    42
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                           Corporate Law
ITR – QUARTERLY INFORMATION                                                                Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


(iii) On February 4, 2010 the Company effected the first Public Issuance of twenty
promissory notes, with par value as of the date of issuance of R$10,000 in a single
series, and bearing interests at a rate of 113,70% of the CDI rate per year, based upon a
252-business-day year, as calculated and disclosed daily by CETIP. The maturity term
of such notes is of 210 days, expiring on September 02, 2010. A value of R$202,562
is recorded under current assets.

Long-term amounts have the following composition:
                                                          Controlling Entity                             Consolidated
                                        03/31/2010              12/31/2009                03/31/2010       12/31/2009

  2011                                     137,937                    266,391               141,652             271,961
  2012                                      90,642                     43,309                95,097              48,003
  2013                                     355,918                     25,525               359,829              29,576
  from 2014 onwards                         82,558                     43,533                86,243              47,397

                                           667,055                    378,758               682,821             396,937




(a)       Collateral to loans and financings
                                                               Controlling Entity                        Consolidated
                                                         03/31/2010 12/31/2009             03/31/2010      12/31/2009
  Accounts receivable - clients
  Pledged                                                    84,434          90,380            84,434           90,380
  Surety Letter                                              49,983          49,982            68,259           68,584
  Surety from shareholders and former
  shareholders                                               63,072         145,478            63,072          145,478
  Property, plant & equipment, net
  Pledged                                                  119,012          139,177           119,012          139,177
  Financial Applications(Bank Surety
  Escrow Account)                                            97,210          95,180            97,210           95,180

                                                           413,711          520,197           431,987          538,799




16.       Income Tax and Social Security Contributions

(a)       Composition of Deferred Taxes
                                                                     Controlling Entity                  Consolidated
                                                             03/31/2010    12/31/2009       03/31/2010     12/31/2009

      Tax credit:
        Tax losses and negative CSLL basis                     183,254         126,811        186,970         131,716
        Temporary differences, substantially amortized
        premiums                                                 54,611         72,059         62,535          79,366

                                                               237,865         198,870        249,505         211,082



                                                                                                                         43
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                     Corporate Law
ITR – QUARTERLY INFORMATION                                                          Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


      Premium of incorporated companies, as per CVM
      319/99
        Erches Participações Ltda.                           41,035         45,770      41,035       45,770
        Setiba Participações S.A.                            48,914         50,442      48,914       50,442

                                                             89,949         96,212      89,949       96,212

                                                            327,814        295,082     339,454      307,294

      Current Assets                                         51,319         18,588      59,529       27,916

      Non-Current Assets                                    276,495        276,494     279,925      279,378




Tax credit on premium of incorporated companies correspond to deferred income tax
and social security contributions incident upon the difference between the book value
of the premium and its tax basis:

              Erches - On June 2, 2007, Erches Participações Ltda., a company belonging
               to a foreign shareholder, acquired a 38% interest in Hypermarcas’ control,
               by means of a payment of R$480,400. Such acquisition resulted in a
               premium of R$278,517, which was recorded net of the provision for
               realization of tax credit of R$183,822, resulting in a net premium of
               R$94,696, registered under Long-term receivables. The company was
               incorporated in June, 2007.

              Setiba - On March 31, 2008, the controlling entity of Farmasa at that time,
               Setiba Participações S.A. was spun-off and the portion of the investment in
               Farmasa was incorporated on the same date by its controlled entity Farmasa.
               On the value of the premium, a provision in the amount of the difference
               between the aggregate value of the premium and the tax benefit of its
               amortization was established.

(b)         Estimated period of realization
                                                      Controlling Entity             Consolidated
  Year                                                      03/31/2010                 03/31/2010

  2010                                                           51,319                    59,529
  2011                                                           22,231                    22,231
  2012                                                           19,945                    19,945
  2013                                                           41,842                    41,842
  2014                                                           65,887                    65,887
  2015 to 2019                                                  126,590                   130,020

                                                                327,814                   339,454



The estimate of realization of tax credits pertaining to tax losses, negative basis of
social security contribution and temporary differences shall occur until the end of

                                                                                                              44
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                        Corporate Law
ITR – QUARTERLY INFORMATION                                             Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


2019, according to studies conducted by the Company’s Management, in view of the
forecast of future positive results from corporate restructurings already underway, as
mentioned in Note 1, which take into account: (i) a large volume of trademarks well-
positioned in the market ; (ii) diversified presence in four market segment, and (iii)
positive and increasing cash flows.

(c)     Conciliation of income tax and social security contribution expense
                                                         03/31/2010                   03/31/2009
                                          Controlling                  Controlling
                                               Entity   Consolidated        Entity   Consolidated

      Profit before income tax and
      social contribution                    97,410         100,814       63,303          63,399
        Result of equity method              (6,255)                      (2,608)

      Determination basis                    91,155         100,814       60,695          63,399
      Income tax and social
      contribution rate (%)                     34%            34%           34%            34%

      Income tax and social
      contribution - nominal rate           (30,993)        (34,283)     (20,637)        (21,556)

        Provision for doubtful accounts
        and others                           16,989          16,373       10,367          10,367
        Deferred result of foreign
        exchange variation                   12,677          12,677         2,223          2,223

        (Additions)/Exclusions -
        permanent                            (2,408)         (2,521)        (587)             332
        Amortization of tax premium          61,852          61,852       47,188          47,188
        Adjustment to present value          (1,674)         (1,674)      (4,018)         (4,018)
        Set-off of tax loss                                    1,188

      IR/CS on the result - current          56,443          53,612       34,536          34,536



        Realization of IR/CS on
        temporary differences               (29,385)        (29,958)     (14,570)        (14,666)
        IR and CS on premium (CPC
        32)                                 (53,563)        (53,563)
        Realization of deferred tax
        liabilities                          (2,575)         (2,575)        (697)           (697)
        Realization on the premium as
        per CVM 319/99                       (6,264)         (6,264)      (6,264)         (6,264)


      IR/CS on the result - deferred        (91,787)        (92,360)     (21,531)        (21,627)

      Income tax and social
      contribution                          (35,344)        (38,748)      13,005          12,909




                                                                                                    45
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                Corporate Law
ITR – QUARTERLY INFORMATION                                     Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES




The Company used the prerogative provided for in Provisional Measure MP 2.158-
35/2001 to defer income tax and social security contributions incident upon the net
result of foreign exchange variation of rights and obligations.

The controlling and controlled entities adopt the taxable income system and calculated
and registered their taxes based upon prevailing actual rates on the date of preparation
of the financial statements.

(d)   Transition Tax regime

The Transition Tax Regime (“RTT”) shall be in force until the enactment of a law
governing the tax effects of the new accounting methods, aiming at tax neutrality.

Such regime is optional for fiscal years 2008 and 2009, provided that: (i) it is applied
to the 2008-2009 biennium and not to a single calendar year; and (ii) such election is
informed in the Statement Economic-Financial Information of Legal Entities (“DIPJ”).

The Company and its controlled entity Cosmed Indústria de Cosméticos e
Medicamentos S.A. elected to adopt the RTT in 2008. Consequently, for purposes of
determination of the income tax and social security contribution incident upon net
profits for the fiscal years of 2008 and 2009, the Company used the prerogatives
provided for in the RTT.

(e)   Deferred tax liabilities

Such item is formed substantially by deferred tax liabilities referring to income tax and
social contribution in the amount of R$225,311, resulting primarily from the temporary
difference between the tax basis of premium and its book value in the balance sheet,
since premium continues to be amortized for tax purposes, but ceased to be amortized
from January 1st, 2009 onwards, resulting in a lesser tax basis than the book value of
the premium.

Such temporary difference may result in values to be added in the calculation of the
taxable result of coming fiscal years, when the book value of the asset is reduced or
liquidated, making it necessary to establish a deferred tax liability.

17.   Related parties’ transactions

(a)   Transactions and balances

       The main balances of assets and liabilities as well as the transactions that
       affected the result of the fiscal year referring to related parties’ transactions
                                                                                         46
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                                          Corporate Law
ITR – QUARTERLY INFORMATION                                                                               Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


            correspond to transactions between the Company and its controlled entities,
            which the Management deems to have been carried out under arm’s-length
            conditions and ordinary market practices for similar transactions.

            Loans between related parties are updated by reference to the variation of the
            CDI rate with a maturity term of one year.

            Business transactions involving purchase and sale of products and raw
            materials, engagement of services and execution of leases, as well as financial
            transactions of loans and fund raisings among companies of the group are
            demonstrated below:

            (a)       Lease payments owed by TV Serra Dourada are updated by reference to
                      the IGPM - FGV and the maturity of the agreement is in 2013.

            (b)       Lease payments owed by Neo Marcas Indústria Farmacêutica e
                      Alimentos e Participações Ltda. are not subject to updating, and shall
                      expire in 2011.
                                                                          03/31/                                                                03/31/
                                                                          20100                                                                  2009
                     Cosmed          My -        TV          Neo         Total       Cosmed         My -      Maiorem       TV       Farmib     Total
                   Indústria de     Agência     Serra       Marcas                 Indústria de    Agência    S.A de C.    Serra    Administr
                  Cosméticos e    Propaganda   Dourada    Ind. Farm.               Cosméticos     Propagan       V.       Dourada   adora de
                  Medicamentos       Ltda.      Ltda.      E Alim. e                    e          da Ltda.                Ltda.      Bens
                       S.A.                               Participaç               Medicament                                         Ltda.
                                                           ões Ltda                  os S.A.
Balances
Short term
receivables                 740          11                                 751
Clients                     740          11                                 751
Long-term
receivables                                                                                                         53                               53
Loans                                                                                                               53                               53
Current
Liabilities            (44,757)                                         (44,757)
Suppliers              (44,757)                                         (44,757)

Long Term
Payables                  1,615          159                              1,774         20,777                                                  20,777
Loans                     1,615          159                              1,774         20,777                                                  20,777

                                                                                                                                                (24,497
Transactions          (217,925)                                        (217,925)       (24,497)                                                       )
Goods/product
sales                       36                                               36
Goods/product                                                                                                                                   (24,497
purchases             (217,961)                                        (217,961)       (24,497)                                                       )

Miscellaneous
expenses/
revenues                               (445)    (1,607)        (240)     (2,292)                                            (719)       (482)   (1,201)
Advertising                            (450)    (1,502)                  (1,952)                                            (614)                 (614)
Leases                                     5      (105)        (240)       (340)                                            (105)       (482)     (587)

Interests on
Loans                      (25)          (1)                                (26)          (786)                       2                           (784)
Financial
expenses                   (25)          (2)                                (27)          (786)                                                   (786)
Financial
revenues                                   1                                  1                                       2                              2




(b)         Compensation of key management personnel
                                                                                                                                                47
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                  Corporate Law
ITR – QUARTERLY INFORMATION                                                       Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Compensation of the Company’s key management personnel, which includes directors
and officers, members of the Executive Committee and the head of external audit.
Such compensation is demonstrated herein below:

                                                                       Consolidated
                                                   03/31/2010           03/31/2009
        Salaries, gratuities and charges                13,037                  8,526
        Senior Management
        Compensation                                       111                   100
        Stock Option Plan                                 2,638

                                                        15,786                  8,626



18.     Taxes Payable
                                                     Controlling Entity                          Consolidated
                                             03/31/2010    12/31/2009            03/31/2010        12/31/2009

 ICMS payable                                    10,135              3,892              40,553         56,604
 IPI payable                                      1,842              3,461               3,517          5,789
 PIS payable                                        895                 78               2,301            979
 COFINS payable                                   4,343              1,000              11,033          5,328
 Tax Recovery Program (Refis) (i)                 3,268              3,269               3,268          3,269
 Other taxes payable                              1,698              1,645               1,826          1,800

                                                 22,181             13,345              62,498         73,769
(i) Net of adjustment to present value of R$532 as of March 31, 2010. See Note 21(ii).

19.     Accounts Payable
                                                                  Controlling
                                                                       Entity                      Consolidated
                                             03/31/2010           12/31/2009       03/31/2010        12/31/2009

 Freights payable                                13,392               18,955              13,508         19,049
 Services rendered                               10,539               14,570              14,358         16,967
 Agreements, commercial budgets
 and others (i)                                  27,011               41,043              27,011         41,043
 Advertising                                     41,119               25,924              41,119         25,924
 Advancements to clients                            638                  525                 638            525
 Representatives’ commissions                       678                  835                 678            835
 Leases                                             535                1,362                 988          1,839
 Others                                          23,452               21,125              26,914         23,697

                                                117,364              124,339            125,214         129,879

(i) Agreements, commercial budgets and others include values and provisions related to sales that are generally
owed to clients, the counterpart of which the sales to such clients. Commercial budgets and agreements, when
negotiated with sales channels, aim primarily at additional exposure and promotion of products to consumers
and, as regards indirect channels, these are commercial benefits and/or clients’ loyalty incentives.



                                                                                                                48
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                     Corporate Law
ITR – QUARTERLY INFORMATION                                                          Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


20.      Notes payable
                                                                Controlling Entity              Consolidated
                                                          03/31/2010 12/31/2009       03/31/2010 12/31/2009

Acquisition of DM Indústria Farmacêutica Ltda. (i)          533,433       552,420        533,433     552,420
(-) Adjustment to present value                             (42,707)      (49,838)       (42,707)    (49,838)
                                                            490,726       502,582        490,726     502,582

Acquisition of Laboratório Neo Química Comércio e
Indústria S.A. (ii)                                         460,264       451,147        460,264     451,147
(-) Adjustment to present value                             (11,237)      (13,159)       (11,237)    (13,159)
                                                            449,027       437,988        449,027     437,988

Acquisition of Pom Pom Produtos Higiênicos Ltda. (ii)       185,028       181,363        185,028     181,363
(-) Adjustment to present value                              (9,432)      (10,083)        (9,432)    (10,083)
                                                            175,596       171,280        175,596     171,280

Acquisition of Ind. Nacional de Artefatos de Látex S.A.
(iv)                                                        132,079       133,714        132,079     133,714
(-) Adjustment to present value                             (15,762)      (16,769)       (15,762)    (16,769)
                                                            116,317       116,945        116,317     116,945

Acquisition of trademarks NY Looks (iii)                     48,535        48,099         48,535      48,099
(-) Adjustment to present value                              (4,055)       (4,472)        (4,055)     (4,472)
                                                             44,480        43,627         44,480      43,627

Acquisition of de Marcas Hydrogen (ii)                         9,086       12,723          9,086      12,723
(-) Adjustment to present value                                  (52)       (103)            (52)      (103)
                                                               9,034       12,620          9,034      12,620

Acquisition of Aprov Comércio de Cosméticos Ltda.             56,546       55,426         56,546      55,426
Acquisition of Niasi Indústria de Cosméticos Ltda.            50,995       49,985         50,995      49,985
Acquisition of Sul Química Ltda. (ii)                         13,729       13,463         13,729      13,463
Acquisition of FINN Administradora de
Marcas Ltda. (ii)                                                           1,726                      1,726
Acquisition of Marcas New Look                                              1,250                      1,250
Acquisition of ÉH Cosméticos S.A.(ii)                            974          955            974         955
Acquisition of Versoix Participações Ltda. (iv)                  890                         890
Acquisition of Quimivale Industrial Ltda. and
Distribuidora Clean Ltda.                                       389           378            389         378
Acquisition of CEIL Comércio e Distribuidora Ltda.              116           116            116         116
Acquisition of Right of Use                                   7,228         7,024          7,228       7,024
                                                            130,867       130,323        130,867     130,323

                                                           1,416,047    1,415,365      1,416,047    1,415,365

Current Liabilities                                         462,227       489,997        462,227     489,997

Non-Current Liabilities                                     953,820       925,368        953,820     925,368

(i)    Debt is secured by a Bank Surety Letter granted by a major bank, which is reduced annually according to
a schedule of repayments. The agreements has a clause providing for adjustment of the payment of the
installments according to the variation of the Real/US dollar exchange rate.
(ii)   Updating in accordance with financial market rates, basically the CDI rate.
(iii) The agreement providing for the Acquisition of trademarks (NY Looks, Bia Blanc, Radical, Aroma & Cor,
Day, Dois! Earth, Um!, Três!, Ski, Sun, and Eco) executed with Brasil Global Ltda. provides for a R$12 million
withholding from the price to guarantee eventual contingencies affecting the seller. Such amount is invested as
per the creditor’s instructions and, as of March 31, 2010, it is invested in shares, recorded under long-term


                                                                                                                49
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                  Corporate Law
ITR – QUARTERLY INFORMATION                                                       Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


receivables and, consequently, both the investment and the respective portion of the debt are valued at the market
price of such shares.
The remaining balance of the debt is updated in accordance with foreign exchange variation. The debt is secured
by a Letter of Surety
(iv) The agreement has a clause providing for adjustment of payments of the installments according to the
variation of the Real/US dollar exchange rate.


Long-term amounts have the following composition per year of maturity:

                                                                                 03/31/2010


           2011                                                                     480.263
           2012                                                                     267.270
           2013                                                                     144.859
           2014                                                                      61.428


                                                                                    953.820



21.     Other accounts payable
                                                       Controlling Entity              Consolidated
                                                 03/31/2010 12/31/2009       03/31/2010 12/31/2009

 Fomentar Loan(i)                                    11,821          3,510        11,821          3,510
 (-) adjustment to present value                   (10,602)        (2,972)      (10,602)        (2,972)

                                                      1,219           538          1,219           538

 Tax Recovery Program (Refis) (ii)                   30,899        31,220        30,899         31,220
 (-)adjustment to present value                      (2,506)       (2,595)       (2,506)        (2,595)

                                                     28,393        28,625         28,393        28,625

 INSS paid in installments                              607           684            607           684
 Others                                               2,332         4,164          2,332         4,164

                                                      2,939         4,848          2,939         4,848

                                                     32,551        34,011         32,551        34,011

 Current Liabilities
   Included in salaries and social security
   charges (INSS)                                       292           316            292           316
   Included in taxes payable (Refis) (ii)             3,268         4,132          3,268         4,132

                                                      3,560         4,448          3,560         4,448

 Non-Current Liabilities                             28,991        29,563         28,991        29,563

  (i)    The Fomentar loan is related to the ICMS tax incentive, whereby 70% of the ICMS as determined on a
  monthly basis is financed by the State of Goiás, with a payment term of 20 years and bearing interests at a rate
  of 2,4% per year, due and payable monthly. The State periodically auctions such credits subject to a discount
  of up to 89%, wherein the debtor (Hypermarcas) has also an acquisition right.

                                                                                                               50
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                               Corporate Law
ITR – QUARTERLY INFORMATION                                                    Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


(ii)     Tax Recovery Program (REFIS)

In November, 2009, the Company adhered to the REFIS Program, instituted by Law
No. 11,941/09 and by Provisional Measure No. 470/2009, aiming at equalizing and
regularizing its tax liabilities by means of a special payment system and payment of tax
and social security obligations in installments.

The general terms of such payment in installments may be summarized as follows:

(a)      Scope of the installment plan:


                                                                                    Balance as of
                                  Principal   Charges      Penalty   Interests     March 31, 2010
Balance of previous installment
plans REFIS, PAES, PAEX              4,001       2,917       3,696         6,887           17,501

Others                               4,616         303       2,024         6,455           13,398
                                     8,617       3,220       5,720        13,342           30,899




(b)    Calculation of the adjustment to present value was made by installment, taking
into account the loan raising rate prevailing in the period in which the financing was
granted (2% rate).

(c)    The values shall be consolidated by the Brazilian Federal Treasury (“Fazenda
Pública”) until June 30, 2010 in accordance with a joint instruction issued by the
General Counsel to the Federal Treasury and the Brazilian Federal Revenue Service
under No. 03/2010, whereupon the terms within which to pay the debts shall be
established.

22.      Composition of the income statement accounts

(a)      Sales and Marketing expenses

                                                    Controlling Entity                    Consolidated
                                              03/31/2010 03/31/2009         3103//2010      03/31/2009

Salaries, social charges and others             (29,637)       (16,066)        (30,281)        (16,085)
Freight                                         (22,217)       (10,924)        (22,329)        (10,934)
Expenditures with advertising, promotion
and the like                                    (45,226)       (28,902)        (44,840)        (28,902)
Agreements, commercial budgets and
others                                          (46,993)       (18,750)        (46,995)        (18,767)
Promotions, gifts and free samples               (1,748)        (5,010)         (1,748)         (5,010)
Medical appointments (i)                         (6,681)        (6,078)         (6,681)         (6,078)
Services rendered                                (7,701)        (5,447)         (8,384)         (5,465)


                                                                                                          51
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                     Corporate Law
ITR – QUARTERLY INFORMATION                                                          Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Travel and lodging                                     (2,141)          (1,671)        (2,142)          (1,671)
Car rental                                             (1,068)            (688)        (1,148)            (688)
Provision for doubtful accounts                          (482)          (2,721)          (482)          (2,721)
Depreciation and amortization                          (4,190)          (2,840)        (4,314)          (2,840)
Other expenses                                        (24,037)          (9,456)       (24,543)          (9,464)

                                                     (192,121)       (108,553)       (193,887)        (108,625)

(i) Substantially salaries and social security charges



(b)      Administrative, general and tax expenses

                                                          Controlling Entity                     Consolidated
                                                    03/31/2010 03/31/2009           3103//2010     03/31/2009

Salaries, social charges and others                   (24,444)          (9,422)       (25,694)          (9,894)
Travel and lodging                                     (1,164)            (470)        (1,185)            (476)
Lease payment and expenses                               (652)            (241)          (663)            (241)
Donations and contributions                              (919)            (230)          (919)            (230)
Services rendered                                     (12,934)          (6,441)       (13,971)          (6,576)
Contributions and taxes                                   (27)             (89)           (28)            (148)
Depreciation and amortization                          (2,291)          (1,355)        (2,607)          (1,355)
Other expenses                                         (5,111)          (2,640)        (5,311)          (2,791)

                                                      (47,542)         (20,888)       (50,378)         (21,711)



(c)      Financial expenses
                                                              Controlling Entity                 Consolidated
                                                     03/31/2010     03/31/2009      3103//2010     03/31/2009

Interests accrued on loans
      Working capital                                  (10,579)          (3,693)      (10,579)        (3,788)

                                                       (10,579)          (3,693)      (10,579)        (3,788)

Interests accrued on financings
      In Brazilian currency

      Financing Centro-Oeste – FCO                        (217)            (293)         (217)          (293)
      Financing FINEP                                                      (503)         (214)          (503)
      Financing BNDES                                   (1,276)            (954)       (1,502)          (954)
      FINAME – Financing of machinery and
      equipment                                            (70)             (75)         (124)          (108)

                                                        (1,563)          (1,825)       (2,057)        (1,858)

Interests accrued on foreign currency denominated
loans                                                   (2,302)          (4,394)       (2,414)        (4,394)
Interests on notes payable and others                  (17,911)          (4,860)      (17,992)        (4,131)
Interests and commissions on surety letters             (2,040)          (3,344)       (2,040)        (3,344)
Debentures                                              (4,222)                        (4,222)
Promissory notes                                        (2,779)                        (2,779)
Bank expenses, discounts granted and others             (4,341)          (2,780)       (4,297)        (2,795)
Foreign currency fluctuation on loans                     (599)          (2,318)         (657)        (2,318)
Foreign currency fluctuation on notes payable          (14,886)            3,133      (14,886)          3,133
Net foreign currency fluctuations, suppliers and          (542)               (9)        (752)            (68)


                                                                                                                  52
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                         Corporate Law
ITR – QUARTERLY INFORMATION                                              Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


clients

                                                (49,622)     (14,572)     (50,039)        (13,917)

Adjustment to present value                     (11,242)     (14,174)     (11,242)        (14,174)

                                                (73,006)     (34,264)     (73,917)        (33,737)




(d)       Financial revenues
                                                   Controlling Entity                Consolidated
                                             03/31/2010 03/31/2009      3103//2010     03/31/2009

Active interests                                    717         1,047          714           1,047
Remuneration of financial applications and
others                                           13,202         5,240       13,278           5,242

                                                 13,919         6,287       13,992           6,289



23.       Shareholders’ Equity

(a)       Capital Stock

According to provisions of the Company’s Articles of Incorporation and resolution of
the Board of Directors passed in the Shareholders Special Meeting (“AGE”) held on
March 11, 2010, the Company is authorized to increase its capital stock up to the limit
of R$4,500,000.

As of March 31, 2010, the Company’s capital stock, fully paid-in, was of R$2,555,552.
represented by 481,201,394 common shares.

In December, 2009, the capital stock was increased in R$681,625 upon a share
exchange within the scope of the incorporation of Hypernova (acquisition of Neo
Química).

In July, 2009, the capital stock was increased in R$281,750 as a result of a new
primary public distribution of common shares effected by the Company, generating a
premium in the subscription for shares in the amount of R$281,750, allocated to the
capital reserve.

(b)       Stock Option Plan

In Hypermarcas S.A.’s AGE held on March 24, 2008, the shareholders approved a
stock purchase option plan (“Plan I”) with a view to allowing Company’s managers
and employees to acquired shares of its issuance.



                                                                                                     53
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                Corporate Law
ITR – QUARTERLY INFORMATION                                     Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


In a Meeting of the Board of Directors held on May 30, 2008, lately ratified in the
Meeting of the Board of Directors held on December 29, 2008, 1,802,212 options
referring to fiscal year 2008 were granted (the “2008 Program”), to be granted to
managers and employees under a “Private Instrument of Grant of Stock Purchase
Options”. Such instruments were executed by the Company and the participants of
Plan I - Program 2008 as from February 02, 2009.

The main elements of Plan I - Program 2008 are the following:

         Exercise price of R$8.50;

         Vesting period of 3 years for 50% of the options granted and of 4 years for
          the remainder 50%.

In the AGE held on December 29, 2008, a new stock purchase option plan was
approved (“Plan II”), intended for Hypermarcas S.A.’s officers, with a view to
“attracting and retaining Company’s executive officers”.

In a Meeting of the Board of Directors held on December 29, 2008, lately
supplemented by the Meeting of the Board of Directors held on February 06, 2009,
8,800,000 options referring to fiscal year 2008 (“2008 Program”) were granted to be
extended to executive officers of the Company under an “Agreement for the Grant of
Stock Purchase Options”

The main elements of Plan II are the following:

         Exercise price of R$5.36;

         Vesting period of 1 year for up to 10% of the options granted, of 2 years for
          up to 20%, of 3 years for up to 40%, 4 years for up to 60%, 5 years for up to
          80% and 6 years for up to 100%;

         Mandatory allocation of 50% of the annual bonus received by executive
          officers participating in the plan to the purchase of Hypermarcas’ shares.

In a Meeting of the Board of Directors held on December 17, 2009, 2,800,000 options
referring to fiscal year 2009 (“2009 Program”) were granted to be extended to
executive officers of the Company under an “Agreement for the Grant of Stock
Purchase Options”.

The main elements of Plan II - 2009 Program are the following:

         Exercise price of R$17.06;


                                                                                         54
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                        Corporate Law
ITR – QUARTERLY INFORMATION                                                             Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


                   Vesting period of 1 year for up to 210% of the options granted, of 2 years
                    for up to 40%, of 3 years for up to 60%, 4 years for up to 80%, 5 years for
                    up to 100%;

                   Mandatory allocation of 50% of the annual bonus received by executive
                    officers participating in the plan to the purchase of Hypermarcas’ shares.

Total options granted:
                                                                             outstanding Fair value
                                                                                                      Estimated
                                        Exercise                             agreements as of the
 Plan             Program    Vesting                Granted      Exercised                            cost (in R$
                                         Price                                  as of     date of
                                                                                                      thousand)
                                                                             03/31/2010    grant
Plan I                2008   06/01/11       8.50      901,106            0       901,106       0.33         287.4
Plan I                2008   06/01/12       8.50      901,106            0       901,106       0.73         627.9


Plan II               2008   11/01/08       5.36      880,000            0       880,000       0.04          35.2
Plan II               2008   11/01/09       5.36      880,000            0       880,000       0.64         559.5
Plan II               2008   11/01/10       5.36     1,760,000           0      1,760,000      1.19        2,043.6
Plan II               2008   11/01/11       5.36     1,760,000           0      1,760,000      1.71        2,878.4
Plan II               2008   11/01/12       5.36     1,760,000           0      1,760,000      2.20        3,655.4
Plan II               2008   11/01/13       5.36     1,760,000           0      1,760,000      2.68        4,374.8


Plan II               2009   12/17/10      17.06      560,000            0       560,000       4.13        2,278.6
Plan II               2009   12/17/11      17.06      560,000            0       560,000       5.55        3,015.9
Plan II               2009   12/17/12      17.06      560,000            0       560,000       6.95        3,714.7
Plan II               2009   12/17/13      17.06      560,000            0       560,000       8.31        4,372.5
Plan II               2009   12/17/14      17.06      560,000            0       560,000       9.62        4,984.7


Total                                              13,402,212            0   13,402,212                 32,828.6




The percentage of dilution eventually affecting the existing shareholders in the event of
exercise of all outstanding options as of March 31, 2010 is of 2.79%.

Option Pricing Model

For purposes of determination of the fair value of the options granted, the Company
took into account the following assumptions:

                     the options will be exercised on the date of ending of each vesting period,
                      moreover in view of the mandatory allocation of the bonus received by the
                      Company’s executive officers to the purchase of shares;

                     inexistence of difference from distribution of dividends, as the exercise
                      price is adjusted by eventual distributions;



                                                                                                                     55
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                Corporate Law
ITR – QUARTERLY INFORMATION                                     Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


           valuation of the options in accordance with market parameters on the date
            of each agreement with the plan beneficiaries;

           attribution of a 1.5% reduction per year of options to be exercised, taking
            into account eventual dismissal of employees.

The valuation adopted was based on the Black & Scholes model for simple European
options, using the SELIC rate and the historical monthly volatility on the date of the
agreement with plan beneficiaries.

(c)    Legal reserve

Legal reserve is constituted annually from the allocation of 5% of the net profit of the
fiscal year and can not exceed 20% of the capital stock. Legal reserve has the purpose
of assuring the integrity of the capital stock, and may only be used to off-set losses and
to increase the capital stock. The amount of R$5,828 was constituted.

(d)    Tax incentive reserve

On March 26, 2010, as resolved by the AGO , the amount of R$38,726 was allocated
to this reserve, in accordance with the provisions of article 197 of the Corporations
Law (as amended by Law No. 11,638/2007). The portion of tax incentives recognized
in the fiscal year result is allocated to such reserve out of the accrued profit account.
Such incentives are not included in the tax base of the mandatory minimum dividend.

(e)    Realizable profit reserve

On March 26, 2010, as resolved by the AGO , the amount of R$27,685 was allocated
to this reserve, in accordance with the provisions of article 195-A of the Corporations
Law, seeing as the amount of mandatory dividends, as calculated pursuant to the
Company’s Articles of Incorporation, exceeds the realized portion of the net profit of
the fiscal year.

(f)    Expansion profit reserve

On March 26, 2010, as resolved by the AGO , the amount of R$44,327 was allocated
to this reserve, in accordance with the provisions of article 194 of the Corporations
Law and in article 39, sole paragraph, of the Company’s Articles of Incorporation.

(g)    Proposed dividends

Dividends proposed on December 31, 2009 in the amount of R$27,685 were reverted
to the Realizable Profit Reserve, as resolved by the AGO held on March 26, 2010,
pursuant to the provisions of article 197 of the Corporations Law.
                                                                                         56
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                        Corporate Law
ITR – QUARTERLY INFORMATION                                                             Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


24.        Passive Contingencies

(a)        Provision for contingencies

As of March 31, 2010, the Company had the following liabilities and the
corresponding prior deposits and/or court deposits related to such contingencies:
Controlling Entity                                          03/31/2010                                           12/31/2009

                                 Probable   Contingency       Possible                Probable   Contingency       Possible
                       Court         loss    net of court         loss     Court          loss    net of court         loss
                     Deposit   prognostic        deposit    prognostic   Deposit    prognostic        deposit    prognostic
Labor                   649          649                         6,804       682          682                         4,022
Civil                    39           39                         1,347        50           88              38         1,155
Tax and Fiscal
                        652          652                         2,565        94           94                         2,562
Administrative /
Others                   42          257             215          489         42          225             183           282
                      1,382        1,597             215       11,205        868        1,089             221         8,021
Provision -
Acquired
companies                         24,351         24,351                                24,195         24,195
                      1,382       25,948         24,566        11,205        868       25,284         24,416          8,021

Consolidated                                                03/31/2010                                           12/31/2009
                                 Probable   Contingency       Possible     Court      Probable   Contingency       Possible
                       Court         loss    net of court         loss   Deposit          loss    net of court         loss
                     Deposit   prognostic        deposit    prognostic   Judicial   prognostic        deposit    prognostic
Labor                   649          649                         7,353       682          682                         4,363
Civil                    39           39                         1,394        50           88              38         1,155
Tax and Fiscal
                        676          676                         2,565        94           94                         2,562
Administrative /
Others                   42          257             215          509         42          225             183           302
                      1,406        1,621             215       11,821        868        1,089             221         8,382
Provision -
Acquired
companies                         39,024         39,024                                38,868         38,868
                      1,406       40,645         39,239        11,821        868       39,957         39,089          8,382

(i)        The Company and its controlled entities have an estimated value of R$2,419 in court deposits
           exceeding probable loss prognostics, of which R$1,447 refer to labor court deposits, R$954 to
           tax court deposit and R$18 refer to civil court deposit.

(ii)       The Company has an estimated value of R$1,576 in court deposits related to contingencies
           resulting from the acquisition of Laboratório Americano de Farmacoterapia S.A. -
           FARMASA, for which an excess provisions was constituted.

(iii)      The Company has also an estimated value of R$935 in court deposits effected by virtue of
           legal provision and/or already registered in the acquired companies and partially related to a
           liability suit involving the selling members.

(b)        Possible contingencies

The Company and its controlled entities are involved in lawsuits addressing labor, civil
and tax matters. According to the current assessment of probability of success, which
is based upon legal counsel’s opinion and legal aspects, such lawsuits do not require

                                                                                                                       57
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                Corporate Law
ITR – QUARTERLY INFORMATION                                     Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


the constitution of provisions, either owing to the classification of the loss expectancy
as possible, or due to exclusion of liability resulting from contractual provision.

The amount of such lawsuits is estimated to be of R$11,821, of which R$7,353 refer to
labor suits, R$1,394 refer to civil suits, R$2,565 refer to tax suits and R$509 refer to
administrative and other suits.

The Company is currently involved in court litigation with competitors discussing
trademark use, which do not have a financial character.

i.    Labor

The Company and its controlled entities are involved in approximately seven hundred
seventy five (775) labor suits, involving liability of the Company and/or its controlled
entities and/or selling members of acquired and merged companies, in connection with
which the possible loss to be borne by the Company and/or its controlled entities is
estimated in R$7,353.

The matters discussed in such suits are basically overtime hours and reflexes, disregard
of the bank of hours, salary differences and reflexes, indemnifications resulting from
illness and/or occupational accidents, premium for unhealthy or dangerous work and
reflexes, among other claims.

Among these labor suits, one hundred and seventeen (117) result from the acquisition
of Laboratório Americano de Farmacoterapia S.A. - FARMASA, incorporated by the
Company, in connection with which the possible loss to be borne by the Company is of
R$3,870. These suits basically discuss, among other claims, indemnification resulting
from illness or occupational accident, recognition of employment relation and
consequent payment of social security charges, difference of salaries, overtime hours
and reflexes and provisional job security.

ii.   Tax

The Company is the defendant party in federal tax administrative proceedings (IPI,
PIS, and COFINS), the possible associated with which is estimated to be of R$404.
These are three notices of deficiency divided in two administrative proceedings, in
which the tax authority is challenging the evidence of actual exportation of sales made
to exporting commercial companies. Flaws have already been identified in such
notices of deficiency and the exports have been evidenced in connection with the
majority of the challenged sales.

Former in Laboratório Americano de Farmacoterapia S.A. - FARMASA requested to
the Federal Revenue Service the reimbursement of IPI credits to offset PIS and

                                                                                         58
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                Corporate Law
ITR – QUARTERLY INFORMATION                                     Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


COFINS debts. However, the requested reimbursement was only partially recognized
at administrative level and, therefore, since the Company has assumed such debt, it
currently owes an updated amount of R$1,942 as PIS and COFINS. A final decision is
still pending analysis at the administrative level.

iii.   Contingencies of acquired companies

The Company elected not to constitute provisions for contingencies the prognostic of
which is of possible and probable loss, and the liability of which lies with the selling
members. In the event of materialization of any loss for which the selling members are
liable, the Company has contractual mechanisms of reimbursement from the liable
selling members.

The main information regarding the proceedings followed-up by the Company, but
liability for which lies with the former managers of the acquired companies, are set
forth herein below:

       a)   DM Indústria Farmacêutica Ltda. ― contingencies whose prognostics
            are of possible and probable loss amount to R$27,440, of which R$18,884
            are of possible loss and R$8,556 are of probable loss. The Company
            elected to keep a R$1,000 provision registered.

       b)   Ceil Comércio e Distribuidora Ltda. ― contingencies whose prognostics
            are of possible and probable loss amount to R$36,516, of which R$38,754
            are of possible loss and R$2,238 are of probable loss. The Company
            elected to keep a R$809 provision registered.

       c)   Laboratório Americano de Farmacoterapia S.A. - FARMASA ―
            contingencies whose prognostics are of possible and probable loss amount
            to R$15,165, of which R$7,743 are of possible loss and R$7,422 are of
            probable loss. The Company elected to keep a R$2,563 excess provision
            registered.

            In addition, on August 17, 2006, Farmasa acquired Laboratório Barrenne,
            having executed with the selling members of such company an Agreement
            for the Assignment and Transfer of Quotas. Under such agreement, the
            selling members of Barrenne jointly agreed to indemnify and hold Farmasa
            harmless from and against any and all claim, liability or obligation, as well
            as any eventual tax, labor and civil liabilities of Barrenne, among others,
            the taxable event of which would have occurred prior to and until the date
            of acquisition of Barrenne by Farmasa.



                                                                                         59
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                              Corporate Law
ITR – QUARTERLY INFORMATION                                   Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


          As collateral to the performance of the indemnification obligations owed
          to Farmasa regarding the aforementioned liabilities, sufficient values were
          withheld from the installments of payment of the acquisition price of
          Barrenne due and payable to its former quota holders to guarantee the
          performance of such obligations by Barrenne’s former quota holders, as
          per an executed Withholding Agreement.

     d)   Niasi Indústria de Cosméticos Ltda. (former denomination of Cosmed
          Indústria de Cosméticos e Medicamentos S.A.) ― contingencies whose
          prognostics are of possible and probable loss amount to R$16,734, of
          which R$4,776 are of possible loss and R$11,958 are of probable loss.
          The Company elected to keep a R$14,673 provision registered.

     e)   Pom Pom Produtos Higiênicos Ltda. ― contingencies whose
          prognostics are of possible and probable loss amount to R$7,038, of which
          R$2,047 are of possible loss and R$4,991 are of probable loss. The
          Company elected to keep a R$10,421 provision registered.

     f)   Laboratório Neo Química Comércio e Indústria S.A. ― contingencies
          whose prognostics are of possible and probable loss amount to R$1,641, of
          which R$1,187 are of possible loss and R$454 are of probable loss. The
          Company elected to keep a R$1,769 provision registered.

     g)   Indústria Nacional de Artefatos de Látex Ltda. ― contingencies whose
          prognostics are of probable loss amount to R$11. The Company elected to
          keep a R$744 provision registered.

     h)   Employment Disputes filed by former employees transferred to the Etti
          Business after its acquisition by the Company under Law No. 11,101/2005
          without labor succession, pursuant to the understanding already evidenced
          by the Federal Supreme Court. Prognostics of possible and probable
          losses pertaining to the period preceding the acquisition, liability for which
          lies with the former shareholders, amount to R$1,831, of which R$1,310
          are of possible loss and R$521 are of probable loss.

     i)   A total of thirty-eight (38) Labor Disputes resulting from the acquisition
          of trademarks by the Company, the contended amount of which is
          estimated to be of R$3,822, filed by commercial representatives primarily
          discussing the existence of employment relationship and the consequent
          payment of salaries and social security charges. Possible losses, if
          materialized, shall be discounted from the price to be paid by the Company
          at the contractually established dates.

                                                                                       60
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                         Corporate Law
ITR – QUARTERLY INFORMATION                                              Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


25.        Adjustment to present value

Adjustment to present value was applied in accordance with Technical Pronouncement
CPC 12/08 and CVM Instruction No. 564/08 to the following liabilities:

           a)   Long-term notes payable - Resulting from the acquisition of companies
                and/or assets, updated by reference to the variation of the foreign exchange
                variation, without interests. For purposes of calculation of the initial
                adjustment, the average fund-raising rate as of the date of acquisition was
                used. Counterparts of the initial adjustments are accounted for as
                reductions of the costs of premium-assets, as follows:

                              Companies

                              DM                        7.25%
                              Neo Química               2.00%
                              NY Looks                  7.73%
                              Inal                      5.00%
                              Hydrogen                  2.00%
                              Pom Pom                   2.00%


           b)   Installment plans - calculation of the adjustment to present value was made
                per installment, taking into account the loan raising rate prevailing in the
                period of incurrence in the financing (2% rate).

           c)   Fomentar Loan - Long-term indebtedness, remunerated at an annual rate of
                2.4%, is discounted at present value using the estimate of discount at
                auctions (89%). Counterparts of the original adjustments are accounted for
                under line item ICMS incident upon sales/deductions from sales, since the
                financed value refers to the ICMS payable.

                                                                                    03/31/2010
                                          Federal tax
                                          installment                     Notes
                                                plans      Fomentar     payable          Total
      a)   Constitution:
           Expenses with ICMS                                   6,224                   6,224

      b)   Reversal of
           adjustment to present
           value - financial
           expense                               (96)             25    (11, 171)     (11,242)




                                                                                                  61
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                     Corporate Law
ITR – QUARTERLY INFORMATION                                                          Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES



                                                                                                     03/31/2009
                                           Federal tax
                                           installment                             Notes
                                                 plans       Fomentar            payable                  Total
       a) Constitution:
          Expenses with
          ICMS                                                     2,267                                 2,267

       b)    Reversal of
            adjustment to
            present value -
            financial expense                     (197)             (20)         (13,957)              (14,174)



26.      Operational lease arrangements

Minimum future payments under operational lease, in the aggregate and for each of the
following periods are set forth herein below:

                                                                                     Consolidated
                                                                    03/31/2010              12/31/2009

            Up to one year                                                  23,835               23,990
            More than one up to five years                                  52,233               55,389
            More than five years                                            26,835               27,829

                                                                           102,903             107,208

27.      Insurance Coverage

The Company’s insurance policy takes into account primarily the concentration of
risks, the relevance and the replacement value of the assets. Main information
regarding existing insurance coverage, according to the pertinent policies, is set forth
herein below:

                                                                       Neo       Pom                   Distribution
                       Cosmed    Goiânia     Itajaí   Araçatuba     Química      Pom          Inal         Centers

Fire, IDT, lightning
and explosion of
any nature              92,000    60,000    25,500        60,000    118,369     45,000      42,000         242,161
Maximum
compensation
value                   92,000    60,000    25,500        60,000    118,369     45,000      42,000         242,161
Cyclone / smoke         45,000    15,000    15,000        15,000      5,918        140         800          17,410
Electrical damages       3,000     1,000     1,000         1,000      5,918        100         300           3,397




28.      Financial instruments

Identification and valuation of financial instruments

                                                                                                                      62
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                               Corporate Law
ITR – QUARTERLY INFORMATION                                    Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


The Company operates with several financial instruments, specially cash equivalents,
including financial applications, accounts receivable from clients, accounts payable to
suppliers, loans and financings and notes payable, in view of the acquisitions of
controlled entities under financing arrangements (Note 20). In addition, the Company
also operates with derivatives financial instruments, mainly forwards and swap
transactions, both without speculative purposes.

The values recorded under current assets and current liabilities have immediate
liquidity or maturity, in the majority of cases, within less than three months. Taking
into account the term and elements of such instruments, which are systematically
renegotiated, their book values are close to their fair values.

(b)   Cash and cash equivalents, financial applications, accounts receivable,
other current assets and accounts payable

The recorded values are close to their realization values.

(c)    Investments

These consist primarily of investments in closely-held controlled entities, registered
pursuant to the equity method, in which the Company has a strategic interest.
Considerations on market value of the shares held are not applicable.

(d)    Loans and financings, notes payable and other accounts payable

These financial instruments are recorded based upon their respective indexes and
contractual interests accrued to each transaction (amortized cost method), as per Notes
15, 20 and 21. In view of the adoption of such method, considerations on fair value are
not applicable.

(e)    Financial risk management policy

The Company has and follows a risk management policy directed to transactions and
requires the diversification of transactions and counterparts. According to such policy,
the nature and general position of financial risks is regularly monitored and managed
to assess the results and the financial impact to the cash flows. Credit limits and the
quality of hedging transactions related to counterparts are also periodically reviewed.

The Company’s risk management policy was established by its Board of Directors, and
provides for the existence of a risk management committee. According to such policy,
market risks are protected whenever it is deemed necessary for purposes of supporting
the corporate strategy or when it is necessary to maintain the level of financial
flexibility. The Risk Management Committee assists the Financial Department in the

                                                                                        63
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                Corporate Law
ITR – QUARTERLY INFORMATION                                     Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


examination and review of information related to risk management, including
significant policies, procedures and practices applied to risk management.

According to the conditions set forth in the risk management policy, the Company
manages some of the risks by means of the use of derivative instruments that prohibit
speculative trading and short sales

(f)    Credit Risk

The Company’s sales policy takes into consideration the level of credit risk that the
Company is willing to be exposed to in the course of its activities. Diversification of
its receivables portfolio, selectivity of its clients, as well as a close follow-up of the
terms of sales financing by segment of business and individual position limits are
procedures adopted with a view to minimizing eventual defaults in its accounts
receivables.

Regarding financial applications and other investments, the Company’s policy is to
deal solely with first line institutions.

(g)    Liquidity Risk

Means the risk that the Company does not have sufficient available funds to comply
with its financial obligations, as a result of any unmatching of term or volume of
foreseen receivables and payables.

In order to manage Brazilian and foreign currency cash liquidity, future disbursement
and income premises are established and monitored on a daily basis by the Company’s
treasury area.

(h)    Market Risk

Interest rate risk

The associated risk derives from the possibility that the Company incur in losses owing
to interest rate variations that increase financial expenses related with loans and
financings raised in the market. As of March 31, 2010, we had interest rate swaps with
a notional value of R$31,762 thousand, in which we are active in prefixed rate and
passive in post-fixed rate plus a spread.

Exchange rate risk

The associated risk derives from the possibility that the Company incur in losses owing
to exchange rate variations that increase amounts raised in the market.


                                                                                         64
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                              Corporate Law
ITR – QUARTERLY INFORMATION                                   Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


As of March 31, 2010 and December 31, 2009, assets and liabilities denominated in
foreign currency and financial instruments aimed at mitigating foreign exchange risks
are as follows:

                                        mar/10                    dec/09
                               US$                     US$
                          thousand       Reais    thousand         Reais
  Assets
  Accounts receivable        1,754       3,123         709         1,234
  Liabilities
  Suppliers                  6,245      11,123       3,429         5,971
  Loans and
  Financings                61,393     109,341     100,721       179,376
  Notes payable            361,879     644,506     361,879       630,103



  Risk mitigating
  financial instruments   (152,681)   (271,924)   (188,229)     (327,744)

  Net exposure             278,590     496,169     278,509       488,940


Notes 15 and 20 show the maturities of the transactions and future commitments listed
above, indicating the respective terms of financial impacts of the eventual foreign
exchange risks.

(i)    Derivatives

During the three-month period ended March 31, 2010, the Company carried out
transactions involving derivative financial instruments: new currency terms (US Dollar
x Real) and foreign exchange swaps (US Dollar x Real and Yen x Real). We have
other positions of outstanding derivative instruments.

The aforementioned transactions were carried out with a view to protecting
fluctuations in short-term liabilities denominated in foreign currency under line items
Loans and Financings and Notes Payable. They are not used for speculative purposes
and are financial instruments highly connected to liabilities to which they refer (see
sensitivity analysis below).

As defined by the Board of Directors, the Company’s guideline is to protect itself from
foreign currency exposure for at least the next 12 months, always with major banks
with a strong presence in the foreign exchange market and offering competitive rates.
Other risk factors and the possibility of entering into transactions to protect against
them (for instance, interest rates) are also taken into account.



                                                                                       65
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                                             Corporate Law
ITR – QUARTERLY INFORMATION                                                                                  Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


As of March 31, 2010, transactions involving foreign currency derivative instruments
entered into by the Company amounted to US$152,681 thousand (12/31/2009 -
US$188,229 thousand), and the results of transactions not yet settled represented losses
of R$21,802 thousand (12/31/2009 - losses of R$92,634 thousand). As of March 31,
2010, transactions involving interest rate derivative instruments entered into by the
Company amounted to R$26,879 thousand (12/31/2009 - R$26,107 thousand), and the
results of transactions not yet settled represented gains of R$221.0 thousand
(12/31/2009 - losses of R$23.0 thousand).

Adjustments to fair value are registered in the line items corresponding to each
transaction, that is, Loans and Financings (Note 15) and Notes Payable (Note 20). As
of March 31, 2010 and December 31, 2009, such transactions can be summarized as
follows:

                                        Reference Value                             Values receivable /     Realized gains /   Non-realized gains
Type                    Counterparts       (notional)            Fair Value              payable                 losses             / losses
(in R$ thousand)                        Mar. 31 Dec. 31       Mar. 31 Dec. 31       Mar. 31    Dec. 31      Mar. 31 Dec.31     Mar. 31    Dec. 31

Foreign currency
Forward contracts                       161,602    313,324    146,500    231,735    (15,102)    (81,589)    (63,500)      0    (15,616)    (81,589)
                        HSBC, BTG
                        Pactual and
Long position           Deutsche Bank   161,602    313,324    146,500    231,735     (15,102)    (81,589)    (63,500)      0    (15,616)    (81,589)
Short position                                0          0          0          0            0           0           0      0           0           0

Swap Contracts                          132,124    107,054    125,424     96,009     (6,700)    (11,045)     (5,902)    (39)    (3,876)    (11,045)
                        Itaú BBA,
                        Bradesco,
Long position           Safra and BB    132,124    107,054    125,424     96,009      (6,700)    (11,045)     (5,902)   (39)     (3,876)    (11,045)
Short position                                0          0          0          0            0           0           0      0           0           0

Interest Rate
Swap Contracts                           31,763     31,763     26,879     26,107         221        (23)           0      0         221        (23)

Active Position - Pre                     31,763     31,763     26,879     26,107
Passive Position Post    BTG Pactual    (31,763)   (31,763)   (26,659)   (26,131)        221         (23)          0       0        221         (23)

Total                                   325,489    452,141    298,803    353,851    (21,581)    (92,657)    (69,402)    (39)   (19,271)    (92,657)




The aforementioned contracts have the following maturity dates:
               Maturity                                                    Reference Value (notional)
        Foreign Currency - USD                             Mar. 31            Rate           Dec. 31                               Rate
               01/20/10                                    0                  0.000            28,358                              2.499
               02/17/10                                    0                  0.000            72,006                              2.453
               03/08/10                                    0                  0.000            28,984                              2.419
               04/26/10                                  3,330                2.372             3,330                              2.372
               06/01/10                                153,358                2.005           184,420                              2.411
               06/07/10                                   461                 1.919              461                               1.919
               07/30/10                                  8,244                1.803               0                                0.000
               09/03/10                                   505                 1.951              505                               1.951
               12/02/10                                   509                 1.984              509                               1.984
               03/02/11                                   580                 2.028              580                               2.028
               05/31/11                                   551                 2.071              551                               2.071
               08/24/11                                 21,008                2.260            84,032                              2.260

                                                                                                                                                66
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                     Corporate Law
ITR – QUARTERLY INFORMATION                                          Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


              08/29/11              16,642        2.119              16,642         2.119
              02/07/12              63,020        2.146
             Total USD             268,208        2.058              420,378        2.376
    Foreign Currency - Yen
           20/01/10                 25,518       0.02244               0            0.000
          Total Yen                 25,518       0.02244               0            0.000


               TOTAL               293,726                           420,378



   Maturity                            Reference Value (notional)
    Interest                                                          CDI+Passive
      Rate               Mar. 31   CDI+Passive Rate        Dec. 31       Rate
   11/16/2010            1,473          1.25%              1,473         1.25%
   12/15/2010            1,434          1.25%              1,434         1.25%
   1/17/2011             1,457          1.25%              1,457         1.25%
   2/15/2011             1,412          1.25%              1,412         1.25%
   3/15/2011             1,393          1.25%              1,393         1.25%
   4/15/2011             1,404          1.25%              1,404         1.25%
   5/16/2011             1,392          1.25%              1,392         1.25%
   6/15/2011             1,373          1.25%              1,373         1.25%
   7/15/2011             1,362          1.25%              1,362         1.25%
   8/15/2011             1,356          1.25%              1,356         1.25%
   9/15/2011             1,344          1.25%              1,344         1.25%
   10/17/2011            1,337          1.25%              1,337         1.25%
   11/16/2011            1,315          1.25%              1,315         1.25%
   12/15/2011            1,299          1.25%              1,299         1.25%
   1/16/2012             1,300          1.25%              1,300         1.25%
   2/15/2012             1,281          1.25%              1,281         1.25%
   3/15/2012             1,266          1.25%              1,266         1.25%
   4/16/2012             1,263          1.25%              1,263         1.25%
   5/15/2012             1,243          1.25%              1,243         1.25%
   156//2012             1,236          1.25%              1,236         1.25%
   7/16/2012             1,224          1.25%              1,224         1.25%
   8/15/2012             1,211          1.25%              1,210         1.25%
   9/17/2012             1,202          1.25%              1,202         1.25%
   10/15/2012            1,187          1.25%              1,187         1.25%
     Total               31,763         1.25%              31,763        1.25%



Calculation method of the fair value of derivatives



                                                                                              67
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                   Corporate Law
ITR – QUARTERLY INFORMATION                                                        Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


                   Foreign currency forward contracts - these are valued using interpolation
                    of market rates applicable to US dollar futures contracts at each base date,
                    as informed by the BM&F;

                   Swap contracts - these are valued using interpolation of market rates
                    applicable to foreign exchange coupons and future DI for each base date,
                    as informed by the BM&F.

Sensitivity analysis

We present herein below a table demonstrating a sensitivity analysis of financial
instruments, including derivatives, describing the risks that may cause material loss to
the Company, within a most favorable scenario (scenario I, of approximately 3.9% of
fluctuation, taking into account 3 standard deviations of the fluctuation of the US
Dollar during the three months of the fourth quarter of the year), according to the
evaluation made by the Company’s management for a period of three months, when
the next financial information containing such analysis shall be disclosed. In addition,
two other scenarios are demonstrated, as determined by the CVM under Instruction
No. 475/08, so as to present a 25% and a 50% deterioration of Real x US Dollar
exchange rate, respectively (scenarios II and III):
Risk                                 Scenario I                Scenario II                 Scenario III
(in R$ thousand)                                            25% fluctuation              50% fluctuation
                               Valuation   Devaluation   Valuation   Devaluation     Valuation    Devaluation
US Dollar quotation             1.657        1.905        1.336         2.226          0.891         2.672
Real quotation                 0.01719      0.02093      0.01430      0.02383         0.00953       0.02859


Foreign currency
Hedge                          -41,392      -2,213       -89,783       46,179        -157,764       114,160
Forward Contracts              -25,284       -4,921      -51,727       21,523         -88,352        58,148
Swap                           -16,108       2,708       -38,056       24,656         -69,412        56,012


Object of hedge                39,308        2,808       84,491       -42,375        147,924       -105,808

Loans and Financings and
Notes Payable subject to
short-term foreign exchange
variations                      39,308       2,808        84,491       -42,375        147,924       -105,808


Net Effect                     -2,084         595        -5,292        3,804          -9,840         8,352


Other liabilities              67,575       -1,941       157,846      -92,211        282,875       -217,240

Other Loans and Financings
and Notes Payable subject to
foreign exchange variations     67,575       -1,941      157,846       -92,211        282,875       -217,240


The foregoing sensitivity analysis takes into account changes regarding the US Dollar quotation,
keeping constant all other variables, associated to other risks.


                                                                                                                68
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                Corporate Law
ITR – QUARTERLY INFORMATION                                     Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


29.   Subsequent events

a)    Acquisition of new businesses

      (i)     Pursuant to a material fact disclosed on April 16, 2010, Hypermarcas
              S.A. acquired for R$52,161 the entirety of the quotas representing the
              capital stock of Luper Indústria Farmacêutica Ltda. The business
              consists of the manufacture and distribution of medicaments under
              trademarks Gastrol, Virilon, Dramavit, Blumel and Senareti, among
              others.

      (ii)    Pursuant to a material fact disclosed on May 04, 2010, Hypermarcas S.A.
              acquired for R$225,000 the entirety of the quotas representing the capital
              stock of Sapeka - Indústria e Comércio e Fraldas Descartáveis Ltda. and
              its subsidiaries. By virtue of the incorporation of the shares, the
              Company shall issue 6,784,922 shares to be subscribed for by the current
              shareholders of Sapeka. Shares issued by the Company as a consequence
              of the incorporation of shares shall be subject to a lock-up period of up to
              five years, as provided for in the agreement for the purchase and sale of
              shares, incorporation of shares and other covenants. The business
              consists of the manufacture and sale of disposable diapers, mainly under
              trademarks Sapeka, Flutty, Maturidade, Única and Leve.

      (iii)   Until May, 2010, Hypermarcas is expected to conclude the full
              acquisition of the quotas representing the capital stock of Facilit
              Odontológica e Perfumaria Ltda. for an estimated value of R$79,000, as
              per a binding Memorandum of Understanding. The business consists of
              the manufacture and sale of toothbrushes, dental floss and tape and
              mouthwashes, among others, distributed under trademark Sanifil, among
              others.

      (iv)    Until May, 2010, Hypermarcas is expected to conclude the full
              acquisition of up to 100% of the capital stock of York S.A. Indústria e
              Comércio for an estimated value of R$100,000, as per a binding
              Memorandum of Understanding.           The business consists of the
              manufacture and sale of flexible shafts, bandages, dressing material,
              hygienic pads and cotton, among others, which are distributed under
              trademarks York, Palinetes and Silhouette, among others.

(b)




                                                                                         69
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                            Corporate Law
ITR – QUARTERLY INFORMATION                                 Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


      (i)   In April, 2010 the Company completed the primary distribution of
            58,696,000 common shares of its issuance at a subscription price of
            R$21.00 (twenty-one Reais) per share, which resulted in a total of
            R$1,232,616. Of this total, the amount of R$606,078 was allocated to a
            capital increase and the remaining R$626,538 were allocated to the
            capital reserve.

            The proceeds obtained from the offering shall be used in the acquisition
            of new companies, assets and trademarks.

      (ii) The Company’s paid-in capital stock, which was of R$2,555,552,
           represented by 481,201,394 common shares was increased in April, 2010
           to R$3,168,195, represented by 547,061,447 common shares.
           R$606,078 came from the proceeds obtained from the primary
           distribution of 58,696,000 common shares and R$6,565 came from
           proceeds obtained from the issuance of 1,164,056 shares granted by the
           Company within the scope of the 2008 Stock Option Plan.



                                 *      *      *




                                                                                     70
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                       Corporate Law
ITR – QUARTERLY INFORMATION                            Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


________________________________________________________________________
02143-1                  HYPERMARCAS S.A.              02.932.074/0001-91
________________________________________________________________________
________________________________________________________________________
07.01 ― COMMENTS ON THE COMPANY’S PERFORMANCE IN THE THREE-
MONTH PERIOD
________________________________________________________________________
See Comments on Consolidated Performance.




                                                                                71
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                                                Corporate Law
ITR – QUARTERLY INFORMATION                                                                                     Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


________________________________________________________________________
02143-1                  HYPERMARCAS S.A.              02.932.074/0001-91
________________________________________________________________________
________________________________________________________________________
12.01 ― COMMENTS ON THE COMPANY’S CONSOLIDATED PERFORMANCE
IN THE THREE-MONTH PERIOD
________________________________________________________________________
              Hypermarcas reports Sales growth of 68%,
            EBITDA of R$178.8 million and Cash Earnings of
                     R$132.4 million in the 1Q10
São Paulo, May 10, 2010 – Hypermarcas S.A. (BM&FBovespa: HYPE3; Reuters: HYPE3.SA;
Bloomberg: HYPE3 BZ) announces today its results for the first quarter of 2010 (1Q10). All the
financial and operating information herein is presented on a consolidated basis, in accordance with
Brazilian Corporate Law.
            Highlights

           Gross Revenue of R$820.5 million, 68% up on 1Q09
           Net Revenue of R$656.8 million, 71% higher than 1Q09
           EBITDA(1) of R$178.8 million, or 27.2% of Net Revenue
           Cash Earnings(2) of R$132.4 million, or 20.2% of Net Revenue


       (R$ million)                                                2009              4Q09               1Q09               1Q10            ∆
       Gross Revenue                                            2,631.6              945.3              489.5              820.5             67.6%
       Net Revenue                                              2,025.3              719.4              384.7              656.8             70.7%
       Gross Profit                                             1,182.3              407.2              221.0              382.5             73.1%
       Gross Profit Margin                                       58.4%              56.6%              57.4%              58.2%            0.8 p.p.
       EBITDA (1)                                                 511.7              159.3              102.1              178.8             75.1%
       EBITDA Margin                                             25.3%              22.1%              26.5%              27.2%            0.7 p.p.
       Cash Earnings (2)                                          444.4              140.2               79.3              132.4             67.0%
       Cash Earnings Margin                                      21.9%              19.5%              20.6%              20.2%           -0.5 p.p.
       Net Income                                                 313.4              101.0               76.3               62.1            -18.7%
       Cash Earnings per Share (3)                                 1.02               0.29               0.20               0.28               0.08
       Net Debt (4)                                             1,711.9            1,711.9            1,073.0            1,823.6
       Cash & Equivalents                                         499.3              499.3              255.6              641.9




                  Results of 1Q10 do not incorporate Sapeka, Luper, Sanifill or York.

  Results of 4Q09 and 2009 consolidate the results of the last 2 months of the year for the
             companies acquired Neo Química, Pom Pom, Olla and Hydrogen.

(1) EBITDA before non-recurring expenses amounting R$4.1 million. Refer to EBITDA Reconciliation table on page 6.
(2) Cash Earnings = Net Income (62.1 million) + non-recurring expenses (R$4.1 million) + fx gains (losses) (R$16.3 million) + Non-cash Income Tax and Social
    Contribution (R$38.7 million) + NPV Reversion (R$11.2 million).
(3) Already adjusted for the stock split and before the equity offering closed on April 9.
(4) Refer to Net Debt table on page 8.



                                                                                                                                                        72
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                        Corporate Law
ITR – QUARTERLY INFORMATION                                                             Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES



                                             Operating Scenario

Net revenue totaled R$656.8 million on 1Q10, representing 71% of growth in comparison
with the same period in 2009. EBITDA was R$178.8 million, representing 75% of growth and
profitability of 27.2%. Cash Earnings were R$132.4 million, which results in 67% growth vs
1Q09.
The organic growth (same brand sales) was 25%, 8% higher than the 17% observed in 1Q09.
This growth has been stronger in the last quarters due to:
      i) Growth acceleration of the sectors in which Hypermarcas operates, including new segments
            with high potential from the strategic acquisitions made in 2008;
      ii) Heated retail market, contributing to greater acceptance of several launches made at the
            end of 2009, mainly in the segments of Beauty and Personal Care and Foods; and
      iii)   Anticipation of inventory building by customers relating to the Pharma Business Unit, due to expected increase
             in prices that can occur after March 31, 2010, as authorized by Anvisa, expressed on March 8, 2010, which
             allows a readjustment of up to 4.83% on the price of the drugs being sold.


For the current year, the pipeline of launchings is quite extensive, with innovations in several business
lines. Already in the first quarter of 2010, the launchings made throughout 2009, mainly the Monange
hair line and the renewal of male line Bozzano (including blade, razor, foam and shaving gel, and after
shaving lotion), are being well received by the market, being partially responsible for the organic
growth.
On March 4, Hypermarcas completed the acquisition of Jontex, the market leader in male condoms.
Additionally, based on the Company's strategy to accelerate growth, four new acquisitions were
announced which will complement its portfolio of disposable products and drugs:
       Luper: traditional company in the OTC market, owner of the brands “Gastrol”, “Virilon”,
          “Dramavit” and “Senareti”, among others;
       Sapeka: leader company in the baby diapers market in Northeast;
       Sanifill: traditional company in oral care market; and
       York: traditional company in the market of swabs, bandages, cotton and others products for
          children.
Accordingly, the Company made a total of nine acquisitions in the last 2 quarters in the
strategic markets of health, beauty and personal care, that further strengthened its market
positioning and will enable the capture of multiple synergies in several areas in the next 2 to 3
years.




                                                                                                                       73
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                   Corporate Law
ITR – QUARTERLY INFORMATION                                                        Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES




                                                   Financial Indicators

                                                                   Net Revenue was R$656.8 million in the
                    Net Revenue (R$ mm)                            1Q10, 71% higher in comparison with
                                                                   the same period in the previous year,
           719.4                                                   25% explained by additional revenue
                                                       656.8
                                                                   from the businesses previously owned by
                            384.7                                  Hypermarcas (organic growth or same
                                             71%
                                                                   brand sales) and 46% derived from the
                                                                   acquisitions made throughout 2009.

           4Q09             1Q09                       1Q10        EBITDA (1) stood at R$178.8 million in
                                                                   the 1Q10, 75% higher than 1Q09
                                                                   EBITDA (1), with 27.2% margin.


                   EBITDA (R$ mm)                                              EBITDA Margin (%)
                                                   178.8                             26.5%               27.2%
   159.3
                                                                    22.1%
                        102.1                                                                  0.7 pp
                                       75%




   4Q09                 1Q09                       1Q10             4Q09              1Q09               1Q10




Cash Earnings in 1Q10 were R$132.4 million, 67% higher than in the 1Q09, representing a
profitability of 20.2% compared to Net Revenue

                   Cash Earnings (R$ mm)                                     Cash Earnings Margin (%)
      140.2                                                132.4                      20.6%
                                                                                               -0.5 pp   20.2%
                                79.3         67%
                                                                     19.5%




       4Q09                 1Q09                           1Q10      4Q09             1Q09                1Q10




                                                                                                                 74
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                           Corporate Law
ITR – QUARTERLY INFORMATION                                                                Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES




Net Income in 1Q10 was R$62.1 million,                                             Net Income (R$ mm)
R$14.2 million or 19% below the values
                                                                       101.0
observed in 1Q09, due to changes in                                                          76.3
accounting rules (Technical Pronouncement                                                                -19%        62.1
CPC32) that have required, since 3Q09, the
recognition of non-cash Income Taxes
worth R$38.7 million, and to exchange rate
variation and NPV adjustment realization                               4Q09                 1Q09                    1Q10
totaling R$27.5 million.




       Financial Indicators

The main items of Hypermarcas’ 1Q10 income statement are shown below:
       INCOME STATEMENT (R$ million)                       4Q09       % NR     1Q09       % NR        1Q10        % NR
       Gross Revenue                                         945.3    131.4%    489.5     127.2%        820.5     124.9%
       Net Revenue                                           719.4    100.0%    384.7     100.0%        656.8     100.0%
       Gross Profit                                          407.2     56.6%    221.0      57.4%        382.5      58.2%
         Sales Expenses                                      (91.3)   -12.7%     (49.9)   -13.0%        (93.6)    -14.3%
         Marketing                                          (147.0)   -20.4%     (58.8)   -15.3%       (100.3)    -15.3%
         General, Fiscal and Administrative Expenses         (54.6)    -7.6%     (21.7)    -5.6%        (50.4)     -7.7%
         Other Operational Net Expenses                       31.4      4.4%       0.2      0.1%         22.5       3.4%
       EBIT                                                  145.7     20.2%      90.8     23.6%        160.7      24.5%
         Financial Expensses                                 (35.0)    -4.9%     (33.7)    -8.8%        (73.9)    -11.3%
         Financial Income                                     19.1      2.6%       6.3      1.6%         14.0       2.1%
       Income Tax and CSLL                                   (28.7)    -4.0%      12.9      3.4%        (38.7)     -5.9%
       Net Income (loss)                                     101.0     14.0%      76.3     19.8%         62.1       9.5%
       EBITDA (1)                                            159.3     22.1%    102.1      26.5%        178.8      27.2%
       Cash Earnings                                         140.2     19.5%      79.3     20.6%        132.4      20.2%
       Cash Earnings per Share                                0.29                0.20                   0.28

The main costs involved in Hypermarcas´ activities are related to raw materials, packaging
and industrialization. The most relevant expenses, as a part of the Company´s strategy in
investing in its brands, are related to marketing expenses.


Net Revenue
According to the table below, Net Revenue in 1Q10 was R$656.8 million, 71% higher than
1Q09. Of this total amount, R$481.0 million derived from the businesses already owned by
Hypermarcas (5) (pre-2009 acquisitions), representing growth of 25% (same brand sales), and
the remaining came from the inorganic component of the acquisitions made in 2009.
               R$ million                        4Q09                1Q09               1Q10              ∆
               Hypermarcas SBS (5)           614.3     85.4%     384.7    100.0%    481.0     73.2%       25.0%
               Neo Química (6)                62.7      8.7%       0.0       -      105.2     16.0%         -
               Pom Pom + Hydrogen (6)         33.8      4.7%       0.0       -       50.6      7.7%         -
               Inal + Jontex (6)               8.6      1.2%       0.0       -       20.0      3.0%         -
               Total                         719.4    100.0%     384.7    100.0%    656.8    100.0%       70.7%



                                                                                                                            75
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                                             Corporate Law
ITR – QUARTERLY INFORMATION                                                                                  Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


(5) SBS" or "same brand sales" refers to the organic component of the Company's sales, its original brand portfolio. To calculate the effect of "SBS" is
considered the revenue of Hypermarcas´ brands before 2009 acquisitions.
(6) Acquisitions made in the year of 2009: Neo Química, Pom Pom, Inal, Hydrogen and Jontex.



Net Revenue´s breakdown by business unit is presented in the table below. The Personal Care
division was responsible for 34% of 1Q10 Net Revenue, 48% came from Pharma, 8% from Home Care
and 9% from Food, whereas in 1Q09, 32% of Net Revenue derived from Personal Care products, 41%
from Pharma, and 15% and 12% from Home Care and Food, respectively.


                 R$ million                              4Q09                     1Q09                     1Q10                ∆
                 Personal Care                       280.6       39.0%        122.8       31.9%        225.9     34.4%         83.9%
                 Pharma                              248.8       34.6%        157.8       41.0%        318.4     48.5%        101.8%
                 Home Care                            99.8       13.9%         57.1       14.8%         54.9      8.4%         -3.9%
                 Food                                 90.1       12.5%         46.6       12.1%         57.6      8.8%         23.7%
                 Total                               719.4      100.0%        384.7      100.0%        656.8    100.0%         70.7%




Of the R$225.9 million of Personal Care’s Net Revenue in 1Q10 of, R$70.6 million derived from the
acquisitions made in 2009 and the remaining by Hypermarcas´ portfolio of original brands; which
represented 26% growth (“SBS”). In Pharma, R$105.2 million out of the R$318.4 million of Net
Revenue came from Neo Química’s brands and the remaining from Hypermarcas´ original businesses,
which represented 35% growth (“SBS”). Food and Home Care divisions growth were not affected by
the acquisitions.


           Gross Profit

Hypermarcas´ Gross Profit was R$382.5 million in 1Q10, representing a margin of 58.2% of Net
Revenue, 81 basis points above 1Q09 figures.


           Marketing Expenses

Marketing Expenses totaled R$100.3 million in 1Q10, or 15.3% of Net Revenue, in line with the
percentage observed in the same period in the previous year. Of this amount, R$44.8 million, or 6.8%
of Net Revenue, were spent on advertising and promotions, while the remaining were spent on Trade
deals and promotions for points of sale and on Medical Visits, as shown by the table below:
         MARKETING EXPENSES (R$ million)                                 4Q09        % NR         1Q09       % NR         1Q10        % NR
         Marketing Expenses                                               (147.0)    -20.4%        (58.8)    -15.3%        (100.3)    -15.3%
          Advertisements and consumer promotion                            (75.4)    -10.5%        (28.9)     -7.5%         (44.8)     -6.8%
          Medical visits                                                    (5.7)     -0.8%         (6.1)     -1.6%          (6.7)     -1.0%
          Trade deals and promotions for points of sale                    (65.9)     -9.2%        (23.8)     -6.2%         (48.7)     -7.4%




Selling Expenses


                                                                                                                                                    76
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                    Corporate Law
ITR – QUARTERLY INFORMATION                                                         Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Selling Expenses totaled R$93.6 million in 1Q10, or 14.3% of Net Revenue, 129 basis points
higher than 1Q09. The detailed breakdown of these expenses is shown below:


     SALES EXPENSES (R$ million)                     4Q09       % NR     1Q09       % NR      1Q10         % NR
     Sales Expenses                                    (91.3)   -12.7%    (49.9)    -13.0%      (93.6)     -14.3%
       Comercial Expenses                              (65.1)    -9.1%    (36.2)     -9.4%      (70.8)     -10.8%
       Freights                                        (24.8)    -3.5%    (10.9)     -2.8%      (22.3)      -3.4%
       Delinquency                                      (1.4)    -0.2%     (2.7)     -0.7%       (0.5)      -0.1%

The synergies of the companies acquired at the end of 2009 have not yet been entirely
captured as of the 1Q10, resulting in the 129 basis points above the same period in the
previous year.


General, Administrative and Tax Expenses
General, Administrative and Tax expenses were R$50.4 million in 1Q10, or 7.7% of Net
Revenue, and R$21.7 million in 1Q09 or 5.6% of Net Revenue, as shown in the table below. It
is important to highlight that in 1Q10, there was a non-cash expense with stock option plan of
approximately R$2.9 million, or 0.4% of Net Revenue, and restructuring expenses which
totaled R$4.1 million, or 0,6% of Net Revenue. Consequently, the net value would be 6.6% of
Net Revenue.
     ADMINISTRATIVE EXPENSES (R$ million)            4Q09       % NR     1Q09       % NR       1Q10         % NR
     General, Administrative and Tax Expenses          (54.6)    -7.6%    (21.7)     -5.6%       (50.4)      -7.7%

When compared to the same period of the previous year, such expenses were 96 basis points
above 1Q10 due to the strengthening of the Company’s executive team throughout the year of
2009, and synergies that have not yet been captured of the companies acquired at the end of
2009.


Operating Income
1Q10 EBITDA (1) was R$178.8 million or 27.2% of Net Revenue, as shown in the
reconciliation below:
        EBITDA RECONCILIATION (R$ million)           4Q09       % NR     1Q09      % NR      1Q10         % NR
        Gross Profit                                   407.2     56.6%    221.0     57.4%      382.5       58.2%
          Sales Expenses                               (91.3)   -12.7%    (49.9)   -13.0%      (93.6)     -14.3%
          Marketing                                   (147.0)   -20.4%    (58.8)   -15.3%     (100.3)     -15.3%
          General, Administrative and Tax Expenses     (54.6)    -7.6%    (21.7)    -5.6%      (50.4)      -7.7%
          Other Operational Net Expenses                31.4      4.4%      0.2      0.1%       22.5        3.4%
        EBIT                                           145.7     20.2%     90.8     23.6%      160.7       24.5%
          (+) Depreciations                              7.4      1.0%      5.3      1.4%        8.7        1.3%
          (+) Other Amortizations                        5.0      0.7%      3.5      0.9%        5.3        0.8%
          (+) Restructuring expenses                     1.2      0.2%      2.5      0.7%        4.1        0.6%
        EBITDA (1)                                     159.3     22.1%    102.1     26.5%      178.8       27.2%

The quarter’s non-recurring expenses were mainly related to costs with corporate
restructurings due to the last acquisitions.

                                                                                                                     77
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                 Corporate Law
ITR – QUARTERLY INFORMATION                                                      Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES




Financial Income and Expenses
Net interest expenses totaled R$32.4 million in 1Q10, which represented an increase of
R$18.4 million in comparison with the same period in the previous year, mainly due to a
higher level of debt derived from the acquisitions made at the end of 2009. Non-cash expenses
with the adjustment to present value realization, related to the change in the period of Notes
Payable, totaled R$11.2 million and the exchange rate expenses were R$16.3 million, as
shown in the reconciliation below:
     FINANC. INCOME AND EXPENSES (R$ million)      4Q09       % NR     1Q09      % NR      1Q10        % NR
     Net Interest Expenses                            (6.7)    -0.9%    (14.0)    -3.6%      (32.4)     -4.9%
     FX Gains (Losses)                                 6.9      1.0%      0.7      0.2%      (16.3)     -2.5%
     NPV Adjustment Realization                      (16.2)    -2.3%    (14.2)    -3.7%      (11.2)     -1.7%




Net Income
Net Income totaled R$62.1 million in 1Q10, or 9.5% of Net Sales, R$14.2 million below the
same period in the previous year. Net Income before non-recurring expenses and non-cash
expenses (Cash Earnings) totaled R$132.4 million in 1Q10, an increase of 67% against 1Q09,
and the equivalent to 20.2% of Net Revenue, as shown in the table below:
       CASH EARNINGS RECONCILIATION (R$ million)    4Q09      % NR     1Q09      % NR     1Q10        % NR
       Net Income (loss)                             101.0     14.0%     76.3     19.8%     62.1        9.5%
       (+) Goodwill amortizations                      0.0      0.0%      0.0      0.0%      0.0        0.0%
       (+) Restructuring expenses                      1.2      0.2%      2.5      0.7%      4.1        0.6%
       (-) FX (Gain) losses                           (6.9)    -1.0%     (0.7)    -0.2%     16.3        2.5%
       (-) Non-cash Income Tax                        28.7      4.0%    (12.9)    -3.4%     38.7        5.9%
       (+) NPV Adjustment Realization                 16.2      2.3%     14.2      3.7%     11.2        1.7%
       Cash Earnings                                 140.2     19.5%     79.3     20.6%    132.4       20.2%
       Cash Earnings per Share                        0.29               0.20               0.28

It is important to mention that Technical Pronouncement CPC 32, which requires the
recognition of deferred tax liabilities for all temporary differences, came into force on July 17,
2009. As a result, as of 3Q09, income tax and social contribution began to be recognized on a
year-to-date basis at the rate of 34% applicable on the amount of goodwill amortization. This
amount, nevertheless, is recognized as a deferred tax obligation under non-current liabilities,
and therefore does not impact the Company’s cash position.


Cash Flow
Cash Flow recorded a net increase in 1Q10 of R$142.6 million. Of this amount, the Company
generated an operational cash flow of R$136.2 million, and invested R$8.8 million on
CAPEX and R$170.0 million in acquisitions, which were funded by new net financings of
R$185.2 million, as shown in the reconciliation below:




                                                                                                                78
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                                             Corporate Law
ITR – QUARTERLY INFORMATION                                                                                  Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


                      CASH FLOW (R$ million)                                         4Q09              1Q09          1Q10
                      Cash Balance at beginning of period                               874.5            149.8          499.3
                      Cash Flow from Operating Activities                              (151.5)           126.0          136.2
                        EBITDA                                                          163.3              99.6         177.6
                        Delta Working Capital                                          (314.8)             26.4         (41.3)
                      Cash Flow from Investment Activities                             (378.7)              1.7        (178.7)
                        CAPEX                                                           (15.8)             (3.2)         (8.8)
                        Acquisitions and Others                                        (362.8)              4.9        (170.0)
                      Cash Flow from Financing Activities                               154.9             (21.9)        185.2
                        Share Issuance                                                   (7.9)              0.0           0.0
                        Financing (Loans and Notes Payable)                             162.8             (21.9)        185.2
                      Cash Balance Increase                                            (375.2)           105.8          142.6
                      Cash Balance at end of period                                     499.3            255.6          641.9




Net Debt
Hypermarcas´ Net Debt as of March, 2010 was R$1,823.6 million, composed of R$641.9
million in cash and cash equivalents, R$1,049.5 million in bank loans and financings
(including promissory notes and debentures) and R$1,416.0 million in accounts payable
related to acquisition installments, as shown below:
DEBT PROFILE (R$ million)                               Balance on    Balance on                                 Payment Schedule
                                                                                                                                                2014 and
                                                          4Q09          1Q10              2010            2011         2012         2013
                                                                                                                                                 Others
Loans and Financing                                           795.8       1,049.5            366.6           141.7        95.1        359.8          86.2
Notes Payable                                               1,415.4       1,416.0            462.2           480.3       267.3        144.9          61.4
Gross Debt                                                  2,211.2       2,465.5            828.9           621.9       362.4        504.7         147.7
Cash and Cash Equivalents                                     499.3         641.9            499.3
Net Debt                                                    1,711.9       1,823.6            329.6
                                (7)
% of Gross Debt subject to fx                                                  21%               3%           26%         74%              7%        20%
% of Gross Debt w/ no interest bearing                                         26%               21%          33%         57%              7%        18%
                                      (8)
Leverage (Net Debt / EBITDA LTM )                             3.3 x         3.1 x



 (7) Including hedges.
(8) “EBITDA LTM” refers to last twelve months EBITDA.




                                                                                                                                                  79
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                              Corporate Law
ITR – QUARTERLY INFORMATION                                                   Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES




                                           IR Schedule

                                       1Q10 Conference
                                  English                          Portuguese
                             Date: 11/05/2010                   Date: 11/05/2010
                          Time: 1:00 pm (Brasília)          Time: 11:30 am (Brasília)
                         Phone: +1 (973) 935-8893          Phone: +55 (11) 4003-9004
                         Replay: +1 (706) 645-9291         Replay: +55 (11) 4003-9004
                              Code: 71747442                  Code: Hypermarcas


                                            IR Contact
                                        Martim Prado Mattos
                                                IRO
                                           Patrícia Salem
                                             IR Manager
                                             Guy Houly
                                              IR Intern
                                      Phone: +55 (11) 3627-4251
                                        ri@hypermarcas.com.br
                                       www.hypermarcas.com.br/ri


Date                                                    Event                                     Place

         13/may          Goldman Sachs Consumer Products Symposium                              New York
   12/may and 14/may     Non-deal roadshow in USA (to be confirmed)                             New York
     15/jun - 16/jun     Deutsche Bank Global Consumer and Food Retail Conference                 Paris
     17/jun - 18/jun     Non-deal roadshow in Europe (to be confirmed)                           London
     23/jun - 25/jun     Citi Brazil Equity Conference 2010                                     Sao Paulo
      19/jul - 23/jul    Non-deal roadshow in Asia (to be confirmed)                               Asia
     03/aug - 05/aug     Credit Suisse 2010 Mid Summer LatAm Conference                         New York
     26/jul - 09/aug     Quiet Period
         09/aug          2T10 Earnings Release




                                      Subsequent Events

As material subsequent events, please find below detailed information:
    Acquisition of new businesses
          i.    According to a material fact released on April 16, 2010, Hypermarcas acquired
                Luper Indústria Farmacêutica Ltda. for R$52.1 million, which operates in the
                manufacturing and distribution of drugs sold under the brands Gastrol, Virilon,
                Dramavit, Blumel and Senareti, among others.


                                                                                                       80
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                   Corporate Law
ITR – QUARTERLY INFORMATION                                        Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


         ii.   According to the material fact released on May 4, 2010, Hypermarcas acquired
               Sapeka for R$225 million, which manufactures and distributes disposable
               diapers, mainly under the brands: Sapeka, Flutty, Maturidade, Única e Leve.
               Due to the merger of shares it shall be issued, by the Company, 6,784,922
               shares, which will be subscribed by the current shareholders of Sapeka and that
               will be locked-up for a period up to 5 years.

        iii.   Until May 2010, the acquisition of Facilit Odontológica e Perfumaria Ltda. is
               expected to be completed for the estimated value of R$79 million, which
               manufactures and distributes toothbrushes, dental floss and mouthwash, among
               others, which are sold under the brand Sanifill, among others.

        iv.    By May 2010, the acquisition of York S.A. Indústria e Comércio is expected to
               be completed for the estimated value of R$100 million, which business consists
               of the manufacturing and distribution of cotton swabs, bandages products,
               feminine pads and cottons, among others, which are sold under the brands
               York, Palinetes, Silhouette, among others.

    Public Offering
     In April 2010 was completed the primary distribution of 58,696,000 common shares
     issued by the Company at the subscription price of R$21.00 per share, which totaled
     R$1,232.6 million. Of this total amount, the value of R$606.1 million increased the
     capital stock and the remainder, amounting R$626.5 million, was allocated to the
     capital reserve account.
     The capital raised in the offering will be disbursed in the acquisition of new business,
     assets and brands.

    Capital Increase

       The Company’s capital stock, which was R$ 2,555.6 million, represented by
       481,201,394 common shares on December 31, 2009, increased to R$ 3,168.2 billion in
       April 2010, represented by 541,061,447 common shares. Of this total, R$606.1 million
       derived from the proceeds of the primary distribution of 58,696,000 common shares
       and R$6.6 million derived from the proceeds from the issuance of 1,164,056 shares
       granted by the Company under the Stock Option Program of 2008 .

                                        Disclaimer

This release contains forward-looking statements relating to the prospects of the business and
estimates of operating and financial results, as well as the Company’s growth prospects. These
are merely projections and as such are based exclusively on the expectations of the
Company’s management concerning the future of the business and its continued access to
capital to fund its business plan. These forward-looking statements depend substantially on
changes in market conditions, government regulations, competitive pressures, the performance

                                                                                            81
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                   Corporate Law
ITR – QUARTERLY INFORMATION                                        Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


of the Brazilian economy and the industry, among other factors, as well as the risks described
in the Company’s filed disclosure documents, and therefore are subject to change without
prior notice.




                                                                                            82
 FEDERAL PUBLIC SERVICE
 CVM – SECURITIES AND EXCHANGE COMMISSION                                                           Corporate Law
 ITR – QUARTERLY INFORMATION                                                                Base-Date – 03/31/2010
 COMMERCIAL, MANUFACTURING AND OTHER COMPANIES



                                             Income Statement (R$ thousand)

                                                                  Consolidated                           Consolidated
                                                          2009                   4Q09             1Q09                  1Q10


Gross sales revenues
  Local market                                             2,613,838               937,844           486,016              813,801
  Foreign market                                                 17,713                 7,457            3,522                 6,688
  Sales deductions                                          -606,279               -225,866         -104,807              -163,706


Net sales revenue                                          2,025,272               719,435           384,731              656,783
  Cost of sales                                             -842,938               -312,238         -163,761              -274,253


Gross profit                                               1,182,334               407,197           220,970              382,530


Operating income (expenses)
  Selling and marketing expenses                            -663,701               -238,314         -108,625              -193,887
  Administrative, general and tax expenses                  -128,071                -54,614          -21,711               -50,378
  Other operating income (expenses), net                         73,969             31,398                213              22,474


Operating income before equity income and financial
                                                             464,531               145,667            90,847              160,739
reuslt


Financial Result                                                 14,584             -15,968          -27,448               -59,925
  Finacial Costs                                             -35,596                -35,022          -33,737               -73,917
  Financial Income                                               50,180             19,054               6,289             13,992




Profit before income tax and social contribution             479,115               129,699            63,399              100,814


Income tax and social contribution                          -165,742                -28,737           12,909               -38,748
  Current s                                                      71,992             39,278            34,536               53,612
  Deferred                                                  -237,734                -68,015          -21,627               -92,360


Profit (loss) before minority interest                       313,373               100,962            76,308               62,066
  Minority interest in subsidiaries                                   -                     -                0                    0


Net Profit/ Loss                                             313,373               100,962            76,308               62,066


Earnings per share – R$                                            0.74                  0.21             0.19                  0.13




                                                                                                                           83
 FEDERAL PUBLIC SERVICE
 CVM – SECURITIES AND EXCHANGE COMMISSION                                                      Corporate Law
 ITR – QUARTERLY INFORMATION                                                           Base-Date – 03/31/2010
 COMMERCIAL, MANUFACTURING AND OTHER COMPANIES



                                    Balance Sheet (R$ thousand)

                                      Consolidated                                                             Consolidated

Assets                           03/31/2010   12/31/2009     Liabilities and Shareholders Equity          03/31/2010   12/31/2009


Short-term assets                2.050.758    1.836.317      Short-term                                   1.210.127    1.291.781
  Cash and banks                   641.922      499.279        Suppliers                                    141.120      120.477
  Trade accounts receivable        633.260      724.630        Loans and financing                          366.647      398.885
  Inventories                      328.971      319.492        Payroll and social charges                    49.590       46.158
  Sundry advances                   26.975       20.132        Income tax and social contribution              2.831          4.931
  Tax recoverable                  271.613      206.499        Taxes payable                                 62.498       73.769
  Fiscal credits                    59.529       27.916        Proposed Dividends                                  -      27.685
  Other credit                        7.290          5.844     Accounts payable                             125.214      129.879
  Prepaid expenses                  81.198       32.525        Notes payable                                462.227      489.997


Non-current assets               4.620.903    4.441.835      Non-current liabilites                       5.461.534    4.986.371


Long term assets                   312.480      310.407      Long term liabilities                        1.931.588    1.549.061
  Related companies                       -              -     Loans and financing                          682.821      396.937
  Tax credits                      279.925      279.378        Income tax and social contribution           225.311      157.236
  Tax recoverable                     1.218          1.280     Notes payable                                953.820      925.368
  Judicial deposits and others      14.011       12.503        Other accounts payable                        28.991       29.563
  Prepaid expenses                    1.431          1.059     Allowance for contingencies                   40.645       39.957
  Temporary Investments                   0      16.187

Investments                      4.308.423    4.131.428      Shareholders equity                          3.529.946    3.437.310
  Other investments                    287            287    Capital                                      2.555.552    2.555.552
  Fixed assets                     296.732      295.539         Capital reserve                             795.762      792.877
  Intangible                     4.010.946    3.835.052         Profit reserve                              116.566       88.881
  Deferred charges                     458            550    Accumulated profit/loss                         62.066               -


Total Assets                     6.671.661    6.278.152      Total liabilities and shareholders' equity   6.671.661    6.278.152




                                                                                                                        84
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                         Corporate Law
ITR – QUARTERLY INFORMATION                                                              Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES



                                             Cash Flow Statement (R$ thousand)
                                                                      Consolidated                 Consolidated
                                                                      2009       4Q09           1Q09          1Q10

 Cash flows from operating activities

 Income (loss) before income taxes                                  479,115          129,699      63,399          100,814
 Adjustments:
 Depreciation and amortization                                       38,506           12,386       8,766           13,934
 Amortization of goodwill                                                 -                 -             -              -
 Gain on permanent asset disposals                                     -517             -493            -18          -143
 Foreign exchange losses                                           -114,675            -6,893          -747        16,295
 Interest expense                                                   100,091           22,861      28,194           43,629
 Stock option expense                                                 5,240            5,240              -         2,884
 Adjusted results                                                   507,760          162,800      99,594          177,413

 Decrease (increase) in assets                                     -298,732          -249,066     80,706           -41,187
 Trade accounts receivable                                         -119,411          -153,748     65,773           91,370
 Inventories                                                        -31,986           -13,967      3,635            -8,739
 Taxes recoverable                                                 -117,852           -73,854     18,175           -64,976
 Judicial deposits                                                     -812             -811           -179         -1,508
 Other accounts receivable                                          -28,671            -6,686      -6,698          -57,334

 Increase (decrease) in liabilities                                 -15,524           -65,230     -54,253               -9
 Suppliers                                                            3,713           -51,062     -25,725          20,643
 Income tax and social contribution paid                            -12,912            -2,780      -2,265           -4,931
 Taxes payable                                                       37,558           24,809           420         -11,264
 Salaries and payroll charges                                         1,987            -8,594          -836         3,457
 Accounts payable                                                    -7,397            7,329      -24,746           -4,668
 Interest paid                                                         668               760           -574         -3,836
 Other accounts payable                                             -39,141           -35,692          -527           590

 Net cash provided by operating activities                          193,504          -151,496    126,047          136,217

 Cash flows from investing activities

 Acquisitions of subsidiaries, net of cash acquired                -369,330          -369,330             -       -181,256

 Acquisitions of property, plant and equipment                      -29,980           -15,806      -3,194           -8,785
 Deferred charges                                                         -                 -             -              -
 Intangible assets                                                  -14,810           -11,876          -439         -1,884
 Proceeds from the sale of equipments                                 1,448            1,024           251            325
 Interest received                                                   46,352           17,338       5,085           12,858

 Net cash provided by (used in) investing activities               -366,320          -378,650      1,703          -178,742

 Cash flows from financing activities

 Proceeds from shares distribution                                  540,362            -7,867             -              -
 Capital integralização                                                   -                 -             -              -
 Borrowings                                                         339,778          234,557      53,757          400,556

 Repayment of loans                                                -331,578           -58,731     -66,745         -219,436
 Interest received                                                        -                 -             -              -
 Interest paid on loans                                             -26,226           -13,061      -8,918           4,048

 Net cash provided by (used in) financing activities                522,336          154,898      -21,906         185,168

 Increase in cash and cash equivalents, net                         349,520          -375,248    105,844          142,643

 Statement of increase in cash and cash equivalents, net
 At the beginning of the period                                     149,759          874,527     149,759          499,279
 At the end of the period                                           499,279          499,279     255,603          641,922
 Increase in cash and cash equivalents, net                         349,520          -375,248    105,844          142,643



                                                                                                                         85
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                               Corporate Law
ITR – QUARTERLY INFORMATION                                                    Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES




                                Other Operating Data

Gross Revenue
       R$ million                   4Q09                1Q09                1Q10           ∆
       Hypermarcas SBS (5)      818.2     86.6%     489.5    100.0%     607.8     74.1%    24.2%
       Neo Química (6)           72.9      7.7%       0.0       -       121.4     14.8%      -
       Pom Pom + Hydrogen (6)    45.2      4.8%       0.0       -        69.0      8.4%      -
       Inal + Jontex (6)          9.0      1.0%       0.0       -        22.4      2.7%      -
       Total                    945.3    100.0%     489.5    100.0%     820.5    100.0%    67.6%

       R$ million                   4Q09                1Q09                1Q10           ∆
       Personal Care            388.4       41.1%   137.5       28.1%   305.1     37.2%   121.9%
       Pharma                   295.7       31.3%   219.0       44.7%   364.9     44.5%    66.6%
       Home Care                136.0       14.4%    72.8       14.9%    73.0      8.9%     0.3%
       Food                     125.1       13.2%    59.6       12.2%    77.5      9.4%    30.1%
       Total                    945.3      100.0%   489.5      100.0%   820.5    100.0%    67.6%




                                                                                                        86
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                  Corporate Law
ITR – QUARTERLY INFORMATION                                       Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES




01.01 – IDENTIFICATION
1. CVM CODE              2. CORPORATE NAME                                                               3. CNPJ
02143-1                  HYPERMARCAS S.A.                                                                02.932.074/0001-91



09.01 – INTERESTS HELD IN CONTROLLED COMPANIES AND/OR AFFILIATED ENTITIES
1- ITEM 2 – CORPORATE NAME OF THE       3 – CNPJ                  4 – CLASSIFICATION           5 - % INTEREST IN  6 - % OF THE
        CONTROLLED / AFFILIATED COMPANY                                                        THE INVESTED       INVESTING
                                                                                               COMPANY’S          COMPANY’S NET
                                                                                               CAPITAL STOCK      EQUITY
7 – TYPE OF COMPANY                          8 – NUMBER OF SHARES HELD IN THE                  9 – NUMBER OF SHARES HELD IN THE
                                             CURRENT QUARTER (Thousand)                        PRECEDENT QUARTER (Thousand)

   01    COSMED IND.DE COSM.E MED. S/A       61.082.426/0001-26   CLOSELY-HELD                              100,00             100,00
                                                                  SUBSIDIARY
COMMERCIAL, INDUSTRIAL AND OTHERS                                                   142,894                                   117.894

   02    VERSOIX PARTICIPAÇÕES LTDA          11.218.371/0001-05   CLOSELY-HELD                                99,99             99,99
                                                                  SUBSIDIARY
COMMERCIAL, INDUSTRIAL AND OTHERS                                                      2.405                                       0

   03    MY AGÊNCIA DE PROPAGANDA LTDA. 03.532.177/0001-27        CLOSELY-HELD                                99,99             99,00
                                                                  SUBSIDIARY
COMMERCIAL, INDUSTRIAL AND OTHERS                                                          9                                      10




                                                                                                                                        87
            FEDERAL PUBLIC SERVICE
            CVM – SECURITIES AND EXCHANGE COMMISSION                                                 Corporate Law
            ITR – QUARTERLY INFORMATION                                                      Base-Date – 03/31/2010
            COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


            ________________________________________________________________________
            02143-1                  HYPERMARCAS S.A.              02.932.074/0001-91
            ________________________________________________________________________
            ________________________________________________________________________
            20.01 ― OTHER INFORMATION DEEMED RELEVANT BY THE COMPANY
            ________________________________________________________________________
                                                SHARE OWNERSHIP

SHARE OWNERSHIP OF HOLDERS OF MORE THAN 5% OF THE COMPANY’S SHARES OF EACH TYPE AND CLASS, UNTIL THE NATURAL
PERSON LEVEL
Company: Hypermarcas S.A.

                                                                                                              Position as of 03/31/2010
                                                                                                                     (In Shares)
                                                 Common Shares                  Preferred Shares                        Total
Shareholder                                      Number              %         Number             %               Number                 %
Igarapava Participações S.A.                      142,776,510         29.7                   -           -         142,776,510            29.7
Maiorem S.A. de C.V                                93,371,780         19.4                   -           -          93,371,780            19.4
Marcelo Henrique Limírio Gonçalves                 34,641,026            7.2                 -           -          34,641,026               7.2
Cleonice Barbosa Limírio Gonçalves                   350,000             0.1                 -           -             350,000               0.1
Marcelo Henrique Limírio Gonçalves Filho                  16             0.0                 -           -                     16            0.0
 Luana Barbosa Limírio Gonçalves de Sant’Anna
                                                        9,136            0.0                                             9,136               0.0
Braga
                                                                                             -           -
Treasury shares                                                -           -                 -           -                         -           -
Others                                            210,052,926         46.7                   -           -         210,052,926            46.7
Total                                            481,201,394        100.0                    -           -        481,201,394           100.0




DISTRIBUTION OF THE LEGAL PERSON’S CAPITAL STOCK (SHAREHOLDER OF THE COMPANY) UNTIL THE NATURAL PERSON LEVEL
Corporate Name: Igarapava Participações S.A.

                                                                                                             Position as of 03/31/2010
                                                                                                                    (In Shares)
                                                Common Shares                  Preferred Shares                        Total
Shareholder                                     Number             %           Number            %              Number                 %
Monte Cristalina Ltda                               280,944        63.5                  -           -              280,944            57.0
João Alves de Queiroz Filho                         115,504         26.1            50,000         11.                165,504           33.6
Maria Esmeralda Alves de Q. Bertucelli               41,013          9.3                 -           -                 41,013            8.3
Others                                                2,539          0.6                 -           -                  2,539            0.5
                                                                                                                               -          -
                                                                                                                               -          -
Treasury shares                                            -          -                  -           -                         -          -
Others                                                2,539          0.6                 -           -                  2,539            0.5
Total                                              440,000         100.0           50,000         11.                490,000           100.0




                                                                                                                           88
             FEDERAL PUBLIC SERVICE
             CVM – SECURITIES AND EXCHANGE COMMISSION                                  Corporate Law
             ITR – QUARTERLY INFORMATION                                       Base-Date – 03/31/2010
             COMMERCIAL, MANUFACTURING AND OTHER COMPANIES




DISTRIBUTION OF THE LEGAL PERSON’S CAPITAL STOCK (SHAREHOLDER OF THE COMPANY) UNTIL THE NATURAL PERSON LEVEL
Corporate Name: Monte Cristalina Ltda

                                                                                          Position as of 03/31/2010
                                                                                                 (In Shares)
                                         Common Shares           Preferred Shares                   Total
Shareholder                              Number          %       Number           %          Number             %
João Alves de Queiroz Filho               169,929,698    76.8              -          -       169,929,698       76.8
Cirillo Marcos Alves                       51,390,564    23.2              -          -         51,390,564       23.2
                                                                                                            -      -
                                                                                                            -      -
Treasury shares                                     -      -               -          -                     -      -
Others                                              -      -               -          -                     -      -
Total                                    221,320,262    100.0              -          -       221,320,262       100.0




DISTRIBUTION OF THE LEGAL PERSON’S CAPITAL STOCK (SHAREHOLDER OF THE COMPANY) UNTIL THE NATURAL PERSON LEVEL
Corporate Name: Maiorem S.A. de C.V

                                                                                          Position as of 03/31/2010
                                                                                                 (In Shares)
                                         Common Shares           Preferred Shares                   Total
Shareholder                              Number          %       Number           %          Number             %
Roberto Hernández Ramírez                    901,920     39.7              -          -          901,920        39.7
Alfredo Harp Helú                             541,152    23.8              -          -            541,152       23.8
José G. Aguilera Medrano                      541,152    23.8              -          -            541,152       23.8
Esteban Malpica Fomperosa                     270,609    11.9                                      270,609       11.9
Others                                         14,463     0.6                                       14,463        0.6
                                                                                                            -      -
                                                                                                            -      -
                                                                                                            -      -
Treasury shares                                     -      -               -          -                     -      -
Others                                              -      -               -          -                     -      -
Total                                      2,269,296    100.0              -          -         2,269,296       100.0




                                                                                                       89
         FEDERAL PUBLIC SERVICE
         CVM – SECURITIES AND EXCHANGE COMMISSION                                      Corporate Law
         ITR – QUARTERLY INFORMATION                                           Base-Date – 03/31/2010
         COMMERCIAL, MANUFACTURING AND OTHER COMPANIES




                     CONSOLIDATED SHARE OWNERSHIP OF CONTROLLING PERSONS AND MANAGERS
                                          AND OUTSTANDING SHARES
                                           Position as of 03/31/2010
                                         Common Shares                  Preferred Shares                Total
Shareholder                           Number             %               Number            %       Number          %
Controlling person                   271,148,468        56.3                               0.0    271,148,468     56.3


Managers                               3,049,430         0.6                               0.0      3,049,430      0.6
Board of Directors                      1,523,472        0.3                               0.0       1,523,472     0.3
Senior Management                        1,525,958       0.3                               0.0        1,525,958    0.3


Fiscal Council 1                               -         0.0                               0.0               -     0.0
Treasury shares                                -         0.0                               0.0               -     0.0


Other Shareholders                   207,003,496        43.0                               0.0    207,003,496     43.0


Total                                481,201,394        100.0                              0.0    481,201,394     100.0



                                    207,003,496         43.0                               0.0   207,003,496      43.0
Outstanding Shares




                     CONSOLIDATED SHARE OWNERSHIP OF CONTROLLING PERSONS AND MANAGERS
                                          AND OUTSTANDING SHARES
                                           Position as of 03/31//2009
                                         Common Shares                  Preferred Shares                Total
Shareholder                           Number             %               Number            %       Number          %
Controlling person                   161,054,286        81.1                               0.0   161,054,286      81.1


Managers                               1,525,164         0.8                               0.0      1,525,164      0.8
Board of Directors                       761,835         0.4                               0.0        761,835      0.4
Senior Management                        763,329         0.4                               0.0        761,729      0.4
                                               -         0,0                                                 -     0,0
Fiscal Council 1                                                                           0.0
Treasury shares                                -         0,0                               0.0               -     0,0


Other Shareholders                    36,021,247        18.1                               0.0    36,021,247      18.1


Total                                198,600,697        100,0                              0.0   198,600,697      100,0


Outstanding Shares                   36,021,247         18.1                               0.0   36,021,247       18.1




                                                                                                        90
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                Corporate Law
ITR – QUARTERLY INFORMATION                                     Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


________________________________________________________________________
02143-1                  HYPERMARCAS S.A.              02.932.074/0001-91
________________________________________________________________________
___________________________________________________________________
20.01 ― OTHER INFORMATION DEEMED RELEVANT BY THE
COMPANY
___________________________________________________________________
                           ARBITRATION CHAMBER

In accordance with the Company’s Articles of Incorporation, any disputes and
controversies arising out of or related with these Articles of Incorporation, the Novo
Mercado Rules, the provisions of Law No. 6,404/76, the rules enacted by the
Brazilian National Monetary Council, by the Central Bank of Brazil, by the Brazilian
Securities and Exchange Commission (CVM), the BM&FBOVESPA Rules and any
other rules and regulations applicable to the capital market in general shall be settled
by arbitration, to be conducted pursuant to the Rules of the Market Arbitration
Chamber instituted by the BM&FBOVESPA.




                                                                                     91
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                       Corporate Law
ITR – QUARTERLY INFORMATION                            Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


________________________________________________________________________
02143-1                  HYPERMARCAS S.A.              02.932.074/0001-91
________________________________________________________________________
________________________________________________________________________
21.01    ―     SPECIAL      REVIEW      REPORT       -    UNQUALIFIED
________________________________________________________________________



Hypermarcas S.A. and
Subsidiaries
Quarterly Information (ITR)
as of March 31, 2010 and
Report of Independent Accountants
on Limited Review




                                                                            92
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                               Corporate Law
ITR – QUARTERLY INFORMATION                                    Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES




Report of Independent Accountants

on Limited Review



To the Shareholders and Board of Directors of

Hypermarcas S.A. and Hypermarcas S.A. Subsidiaries



1     We have reviewed the accounting information included in the Quarterly
Information (ITR) of Hypermarcas S.A. (“Company”) and subsidiaries (parent
company and consolidated) for the quarter ended March 31, 2010, comprising the
balance sheets and the statements of income, of changes in stockholders’ equity
and of cash flows, and explanatory notes. This Quarterly Information is the
responsibility of the Company’s management.

2      Our review was carried out in accordance with specific standards
established by the Institute of Independent Auditors of Brazil (IBRACON), in
conjunction with the Federal Accounting Council (CFC), and mainly comprised:
(a) inquiries of and discussions with management responsible for the accounting,
financial and operating areas of the Company with regard to the main criteria
adopted for the preparation of the Quarterly Information; and (b) a review of
information and of subsequent events which have, or could have, significant
effects on the financial position and operations of the Company and its
subsidiaries.

3      Based on our limited review, we are not aware of any material
modifications that should be made to the quarterly information referred to above in
order that it be stated in accordance with the accounting practices adopted in
Brazil applicable to the preparation of the Quarterly Information, consistent with
the standards issued by the Brazilian Securities Commission (CVM).

4      As mentioned in Note 3, the CVM has approved several Pronouncements,
Interpretations and Technical Guidance issued by the Brazilian Accounting
Pronouncements Committee (CPC) to be effective as from 2010, which altered the
accounting practices adopted in Brazil. As permitted by CVM Resolution 603/09,
the Company’s management has opted to present its Quarterly Information by
using the accounting standards adopted in Brazil until December 31, 2009. As

                                                                                      93
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                               Corporate Law
ITR – QUARTERLY INFORMATION                                    Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


required by said Resolution, Note 3 to the Quarterly Information discloses this fact
and also provides a description of the main changes that may have an impact on
the Company's year-end financial statements, as well as explanations of the
reasons that make it impractical to present an estimate of their possible effects on
stockholders' equity and results of operations.



São Paulo, May 7, 2010



PricewaterhouseCoopers

Auditores Independentes

CRC 2SP000160/O-5



Douglas Souza de Oliveira

Accountant CRC 1SP191325/O-0




                                                                                       94
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                           Corporate Law
ITR – QUARTERLY INFORMATION                                                                Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission

01 – IDENTIFICATION
1. CVM CODE                         2. CORPORATE NAME                                                                                              3. CNPJ
02143-1                             HYPERMARCAS S.A.                                                                                               02.932.074/0001-91


CONTROLLED/AFFILIATED ENTITY
CORPORATE NAME
COSMED IND. DE COSM. E MED. S/A/


22.01 – STATEMENT OF INCOME OF CONTROLLED/AFFILIATED ENTITY (Reais Thousand)
1 – CODE       2 – DESCRIPTION                                    03 – 01/01/2010 to 03/31/2010   4 – 01/01/2010 to 03/31/2010   5 – 01/01/2009 to 03/31/2009   6 – 01/01/2009 to 03/31/2009
3.01           Gross Revenue of Sales and/or Services                                  220,853                        220,853                         24,804                         24,804
3.02           Deductions from Gross Revenue                                          (97,765)                       (97,765)                       (11,589)                       (11,589)
3.03           Net Revenue of Sales and/or Services                                    123,088                        123,088                         13,215                         13,215
3.04           Cost of Products and/or Services Sold                                 (106,414)                      (106,414)                       (15,443)                       (15,443)
3.05           Gross Income                                                             16,674                         16,674                         (2,228)                        (2,228)
3.06           Operational Expenses/Revenue                                             (5,591)                        (5,591)                         (284)                          (284)
3.06.01        With Sales                                                               (2,152)                        (2,152)                           (72)                           (72)
3.06.02        General and Administrative                                               (2,604)                        (2,604)                         (823)                          (823)
3.06.03        Financial                                                                 (839)                          (839)                            529                            529
3.06.03.01     Financial Revenue                                                            96                             96                            788                            788
3.06.03.02     Financial Expenses                                                        (935)                          (935)                          (259)                          (259)
3.06.04        Other Operational Revenue                                                   257                            257                             82                             82
3.06.05        Other Operational Expenses                                                (253)                          (253)                              0                              0
3.06.05.01     Premium Amortization/Net Discounts                                            0                              0                              0                              0
3.06.05.02     Other Expenses                                                                0                              0                              0                              0
3.06.06        Equity Method Result                                                          0                              0                              0                              0
3.07           Operational Income                                                       11,083                         11,083                         (2,512)                        (2,512)
3.08           Non-Operational Income                                                        0                              0                              0                              0
3.08.01        Revenues                                                                      0                              0                              0                              0
3.08.02        Expenses                                                                      0                              0                              0                              0
3.09           Income Before Tax / Equity Interests                                     11,083                         11,083                         (2,512)                        (2,512)
3.10           Provision for Income Tax and Social Contribution                         (2,766)                        (2,766)                             0                              0


                                                                                                                                                                                               95
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                           Corporate Law
ITR – QUARTERLY INFORMATION                                                                Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01 – IDENTIFICATION
1. CVM CODE                            2. CORPORATE NAME                                                                                           3. CNPJ
02143-1                                HYPERMARCAS S.A.                                                                                            02.932.074/0001-91



CONTROLLED/AFFILIATED ENTITY
CORPORATE NAME
COSMED IND. DE COSM. E MED. S/A/


22.01 – STATEMENT OF INCOME OF CONTROLLED/AFFILIATED ENTITY (Reais Thousand)
       1 – CODE                      2 – DESCRIPTION              03 – 01/01/2010 to 03/31/2010 4 – 01/01/2010 to 03/31/2010    5 – 01/01/2009 to 03/31/2009    6 – 01/01/2009 to 03/31/2009
3.11              Deferred Income Tax                                                   (1,110)                       (1,110)                            (96)                            (96)
3.12              Equity Interests/Statutory Contributions                                   0                             0                               0                               0
3.12.01           Equity Interests                                                           0                             0                               0                               0
3.12.02           Contributions                                                              0                             0                               0                               0
3.13              Reversal of Interests on Shareholders’ Equity                              0                             0                               0                               0
3.15              Profit/Loss of the Period                                              7,207                         7,207                          (2,608)                         (2,608)
                  NUMBER OF SHARES, EXCLUDING                                          142,894                       142,894                         117,894                         117,894
                  TREASURY (Thousand)
                  PROFIT PER SHARE (Reais)                                             0,05044                       0,05044
                  LOSS PER SHARE (Reais)                                                                                                           (0,02212)                       (0,02212)




                                                                                                                                                                                                96
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                           Corporate Law
ITR – QUARTERLY INFORMATION                                                                Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission

01 – IDENTIFICATION
1. CVM CODE                         2. CORPORATE NAME                                                                                              3. CNPJ
02143-1                             HYPERMARCAS S.A.                                                                                               02.932.074/0001-91


CONTROLLED/AFFILIATED ENTITY
CORPORATE NAME
VERSOIX PARTICIPAÇÕES LTDA.


22.01 – STATEMENT OF INCOME OF CONTROLLED/AFFILIATED ENTITY (Reais Thousand)
    1 – CODE                   2 – DESCRIPTION                    03 – 01/01/2010 to 03/31/2010 4 – 01/01/2010 to 03/31/2010    5 – 01/01/2009 to 03/31/2009   6 – 01/01/2009 to 03/31/2009
3.01           Gross Revenue of Sales and/or Services                                        0                             0                               0                              0
3.02           Deductions from Gross Revenue                                                 0                             0                               0                              0
3.03           Net Revenue of Sales and/or Services                                          0                             0                               0                              0
3.04           Cost of Products and/or Services Sold                                         0                             0                               0                              0
3.05           Gross Income                                                                  0                             0                               0                              0
3.06           Operational Expenses/Revenue                                               (53)                           (53)                              0                              0
3.06.01        With Sales                                                                    0                             0                               0                              0
3.06.02        General and Administrative                                                 (53)                           (53)                              0                              0
3.06.03        Financial                                                                     0                             0                               0                              0
3.06.03.01     Financial Revenue                                                             0                             0                               0                              0
3.06.03.02     Financial Expenses                                                            0                             0                               0                              0
3.06.04        Other Operational Revenue                                                     0                             0                               0                              0
3.06.05        Other Operational Expenses                                                    0                             0                               0                              0
3.06.06        Equity Method Result                                                          0                             0                               0                              0
3.07           Operational Income                                                         (53)                           (53)                              0                              0
3.08           Non-Operational Income                                                        0                             0                               0                              0
3.08.01        Revenues                                                                      0                             0                               0                              0
3.08.02        Expenses                                                                      0                             0                               0                              0
3.09           Income Before Tax / Equity Interests                                       (53)                           (53)                              0                              0
3.10           Provision for Income Tax and Social Contribution                              0                             0                               0                              0
3.11           Deferred Income Tax                                                           0                             0                               0                              0
3.12           Equity Interests/Statutory Contributions                                      0                             0                               0                              0


                                                                                                                                                                                              97
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                           Corporate Law
ITR – QUARTERLY INFORMATION                                                                Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01 – IDENTIFICATION
1. CVM CODE                            2. CORPORATE NAME                                                                                           3. CNPJ
02143-1                                HYPERMARCAS S.A.                                                                                            02.932.074/0001-91



CONTROLLED/AFFILIATED ENTITY
CORPORATE NAME
VERSOIX PARTICIPAÇÕES LTDA.


22.01 – STATEMENT OF INCOME OF CONTROLLED/AFFILIATED ENTITY (Reais Thousand)
       1 – CODE                      2 – DESCRIPTION              03 – 01/01/2010 to 03/31/2010 4 – 01/01/2010 to 03/31/2010    5 – 01/01/2009 to 03/31/2009   6 – 01/01/2009 to 03/31/2009
3.12.01           Equity Interests                                                           0                             0                               0                              0
3.12.02           Contributions                                                              0                             0                               0                              0
3.13              Reversal of Interests on Shareholders’ Equity                              0                             0                               0                              0
3.15              Profit/Loss of the Period                                                (53)                          (53)                              0                              0
                  NUMBER OF SHARES, EXCLUDING                                            2,405                         2,405                               0                              0
                  TREASURY (Thousand)
                  PROFIT PER SHARE (Reais)                                                                                                           0.00000                        0.00000
                  LOSS PER SHARE (Reais)                                             (0.02204)                     (0.02204)




                                                                                                                                                                                              98
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                              Corporate Law
ITR – QUARTERLY INFORMATION                                                                   Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01 – IDENTIFICATION
1. CVM CODE                            2. CORPORATE NAME                                                                                              3. CNPJ
02143-1                                HYPERMARCAS S.A.                                                                                               02.932.074/0001-91


CONTROLLED/AFFILIATED ENTITY
CORPORATE NAME
MY AGÊNCIA PROPAGANDA LTDA.


22.01 – STATEMENT OF INCOME OF CONTROLLED/AFFILIATED ENTITY (Reais Thousand)
       1 – CODE                   2 – DESCRIPTION                    03 – 01/01/2010 to 03/31/2010 4 – 01/01/2010 to 03/31/2010    5 – 01/01/2009 to 03/31/2009   6 – 01/01/2009 to 03/31/2009
3.01              Gross Revenue of Sales and/or Services                                      450                           450                               0                              0
3.02              Deductions from Gross Revenue                                               (64)                          (64)                              0                              0
3.03              Net Revenue of Sales and/or Services                                        386                           386                               0                              0
3.04              Cost of Products and/or Services Sold                                         0                             0                               0                              0
3.05              Gross Income                                                                386                           386                               0                              0
3.06              Operational Expenses/Revenue                                               (178)                         (178)                              0                              0
3.06.01           With Sales                                                                    0                             0                               0                              0
3.06.02           General and Administrative                                                 (179)                         (179)                              0                              0
3.06.03           Financial                                                                     1                             1                               0                              0
3.06.03.01        Financial Revenue                                                             4                             4                               0                              0
3.06.03.02        Financial Expenses                                                           (3)                           (3)                              0                              0
3.06.04           Other Operational Revenue                                                     0                             0                               0                              0
3.06.05           Other Operational Expenses                                                    0                             0                               0                              0
3.06.06           Equity Method Result                                                          0                             0                               0                              0
3.07              Operational Income                                                          208                           208                               0                              0
3.08              Non-Operational Income                                                        0                             0                               0                              0
3.08.01           Revenues                                                                      0                             0                               0                              0
3.08.02           Expenses                                                                      0                             0                               0                              0
3.09              Income Before Tax / Equity Interests                                        208                           208                               0                              0
3.10              Provision for Income Tax and Social Contribution                            (65)                          (65)                              0                              0
3.11              Deferred Income Tax                                                           0                             0                               0                              0
3.12              Equity Interests/Statutory Contributions                                      0                             0                               0                              0


                                                                                                                                                                                                 99
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                                           Corporate Law
ITR – QUARTERLY INFORMATION                                                                Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01 – IDENTIFICATION
1. CVM CODE                            2. CORPORATE NAME                                                                                          3. CNPJ
02143-1                                HYPERMARCAS S.A.                                                                                           02.932.074/0001-91



CONTROLLED/AFFILIATED ENTITY
CORPORATE NAME
MY AGÊNCIA PROPAGANDA LTDA.


22.01 – STATEMENT OF INCOME OF CONTROLLED/AFFILIATED ENTITY (Reais Thousand)
       1 – CODE                      2 – DESCRIPTION              03 – 01/01/2010 to 03/31/2010 4 – 01/01/2010 to 03/31/2010   5 – 01/01/2009 to 03/31/2009   6 – 01/01/2009 to 03/31/2009
3.12.01           Equity Interests                                                           0                             0                              0                              0
3.12.02           Contributions                                                              0                             0                              0                              0
3.13              Reversal of Interests on Shareholders’ Equity                              0                             0                              0                              0
3.15              Profit/Loss of the Period                                                143                           143                              0                              0
                  NUMBER OF SHARES, EXCLUDING                                                9                             9                             10                             10
                  TREASURY (Thousand)
                  PROFIT PER SHARE (Reais)                                            15.88889                      15.88889                        0.00000                        0.00000
                  LOSS PER SHARE (Reais)




                                                                                                                                                                                             100
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                       Corporate Law
ITR – QUARTERLY INFORMATION                            Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


_______________________________________________________________________
02143-1                  HYPERMARCAS S.A.              02.932.074/0001-91
_______________________________________________________________________
______________________________________________________________________
23.01    ―     DESCRIPTION        OF     MODIFIED       INFORMATION
______________________________________________________________________

Resubmission owing to change in Share Ownership.




                                                                           101
FEDERAL PUBLIC SERVICE
CVM – SECURITIES AND EXCHANGE COMMISSION                                            Corporate Law
ITR – QUARTERLY INFORMATION                                                 Base-Date – 03/31/2010
COMMERCIAL, MANUFACTURING AND OTHER COMPANIES


Spontaneous Resubmission
01.01 - IDENTIFICATION
1. CVM CODE     2. CORPORATE NAME                                                 3. CNPJ
02143-1         HYPERMARCAS S.A.                                                  02.932.074/0001-91


INDEX
GROUP   TABLE                                       DESCRIPTION                                          PAGE
  01      01    IDENTIFICATION                                                                               1
  01      02    REGISTERED ADDRESS                                                                           1
  01      03    INVESTORS’ RELATIONS OFFICER (Mail Address)                                                  1
  01      04    ITR REFERENCE                                                                                1
  01      05    COMPOSITION OF CAPITAL STOCK                                                                 2
  01      06    CHARACTERISTICS OF THE COMPANY                                                               2
  01      07    COMPANIES NOT INCLUDED IN THE CONSOLIDATED FINANCIAL STATEMENTS                              2
  01      08    CASH PROCEEDS                                                                                2
  01      09    PAID-IN CAPITAL AND CHANGES DURING THE CURRENT FISCAL YEAR                                   3
  01      10    INVESTORS’ RELATIONS OFFICER                                                                 3
  02      01    BALANCE SHEET - ASSETS                                                                       4
  02      02    BALANCE SHEET - LIABILITIES                                                                  5
  03      01    STATEMENT OF INCOME                                                                          7
  04      01    04 - STATEMENT OF CASH FLOWS                                                                 9
  05      01    05 - STATEMENT OF CHANGES IN OWNERS’ EQUITY FROM 01/01/2010 TO 03/31/2010                    11
  05      02    05 - STATEMENT OF CHANGES IN OWNERS’ EQUITY FROM 01/01/2010 TO 03/31/2010                    12
  08      01    CONSOLIDATED BALANCE SHEET - ASSETS                                                          13
  08      02    CONSOLIDATED BALANCE SHEET - LIABILITIES                                                     14
  09      01    CONSOLIDATED STATEMENT OF INCOME                                                             16
  10      01    10.01 - CONSOLIDATED STATEMENT OF CASH FLOWS                                                 18
  11      01    05 - STATEMENT OF CHANGES IN OWNERS’ CONSOLIDATED EQUITY FROM 01/01/2010 TO                  20
                03/31/2010
  11      02    05 - STATEMENT OF CHANGES IN OWNERS’ CONSOLIDATED EQUITY FROM 01/01/2010 TO                  21
                03/31/2010
  06      01    EXPLANATORY NOTES                                                                            22
  07      01    COMMENTS ON COMPANY’S PERFORMANCE DURING THE THREE-MONTH PERIOD                              71
  12      01    COMMENTS ON COMPANY’S CONSOLIDATED PERFORMANCE DURING THE QUARTER                            72
  13      01    INTERESTS HELD IN CONTROLLED/AFFILIATED ENTITIES                                             87
  20      01    OTHER INFORMATION DEEMED RELEVANT BY THE COMPANY                                             88
  21      01    SPECIAL REVIEW REPORT                                                                        92
                                          COSMED IND. DE COSM. E MED. S/A
  22      01    STATEMENT OF INCOME OF CONTROLLED/AFFILIATED ENTITY                                          95
                                           VERSOIX PARTICIPAÇÕES LTDA.
  22      01    STATEMENT OF INCOME OF CONTROLLED/AFFILIATED ENTITY                                          97
                                         MY AGÊNCIA DE PROPAGANDA LTDA
  22      01    STATEMENT OF INCOME OF CONTROLLED/AFFILIATED ENTITY                                          99
  23      01    DESCRIPTION OF MODIFIED INFORMATION                                                          101




                                                                                                       102

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:0
posted:4/27/2014
language:Unknown
pages:102
 wuzhenguang wuzhenguang
About